Development of MRI techniques for the assessment of chronic kidney disease by Buchanan, Charlotte E.
  
Development of MRI techniques for the 
assessment of Chronic Kidney Disease  
 
 
 
 
Charlotte E. Buchanan, MMath&Phys. 
 
 
Thesis submitted to the University of Nottingham for the degree of 
Doctor of Philosophy 
 
March 2016 
 
                                                                                                       i 
Abstract 
 
It is well established that patients with Chronic Kidney Disease (CKD) are 
more susceptible to develop cardiovascular disease in comparison to the 
healthy population. This thesis aims to develop and apply MRI techniques to 
assess the human heart and kidney in patients with chronic kidney disease 
(CKD).  
 
Magnetic resonance imaging (MRI) can be used to inform on structure, 
function, perfusion and blood flow, without the need for ionizing radiation. In 
order to assess blood flow using MRI, gadolinium based contrast agents are 
often used. Patients with compromised kidney function are contraindicated to 
these contrast agents and so it is necessary to develop imaging techniques that 
can be used without a contrast agent.  
 
Arterial spin labelling (ASL) is an MRI technique that provides a non-contrast 
enhanced method to assess tissue perfusion using the intrinsic signal from the 
water in the body. ASL is now becoming a well-established technique in the 
brain, however applications of ASL in the body are currently limited. In this 
work, a cardiac ASL technique is developed using a modified Look-Locker 
scheme to study the myocardium of the heart. This technique is then applied 
in patients with CKD Stage 3 and age-matched healthy control subjects to 
assess the changes in myocardial perfusion during a handgrip exercise 
challenge.  
 
MRI measurements of cardiac index and stroke volume index, global and 
regional contractile function (myocardial strain), coronary artery flow and 
myocardial perfusion using ASL are applied to assess changes in cardiac 
function in CKD Stage 5 patients during dialysis treatment. The measures are 
ii 
 
performed in a randomised design to assess the cardiovascular effects in 
patients undergoing both haemodialysis and haemodiafiltration.  
 
Finally, a comparison of 2D readout schemes for renal ASL is performed. 
Gradient and spin echo based readout schemes for multi-slice ASL of the 
kidney at 3 T are evaluated and directly compared in terms of temporal SNR, 
image SNR, spatial coverage, perfusion quantification and variability across 
slices/subjects. This work aims to determine the optimal readout scheme for 
pulsed ASL (PASL) of the kidneys at 3 T in healthy volunteers with normal 
renal function. In future work this could be applied to patients with 
compromised renal function where a robust imaging technique is needed. 
Finally, a summary of the key findings of this thesis and an outline of the 
potential future directions of this work is provided. 
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1.    Introduction: context of thesis  
 
The primary aim of this thesis is to develop MRI haemodynamic measures of 
blood flow and perfusion for the assessment of cardiac and kidney function in 
people with Chronic Kidney Disease (CKD).  
 
This chapter provides an introduction to the methods and clinical conditions 
studied in this thesis. Firstly, the structure and function of the kidney and 
heart are outlined. The deficits that occur in these organs in CKD are 
described and the use of dialysis treatment in CKD is then explained. Finally, 
this chapter provides an evaluation of the current methods used to assess 
blood flow and perfusion of the heart and kidney. Firstly, the methods of 
ultrasound, positron emission tomography (PET) and single positron emission 
computed tomography (SPECT) are outlined. This is followed by an overview 
of the MR methods that can be used. Specifically, a focus is provided on the 
use of arterial spin labelling (ASL) for the measurement of perfusion and its 
application in the heart and kidneys, to address the primary aim of using 
these methods in the study of people with CKD. 
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1.1. Anatomy  
The following sections provide an outline of the anatomy of the human heart 
and kidney.  
1.1.1. Heart structure and function 
 
The human heart comprises 4 chambers; the right atrium and the right 
ventricle and the left atrium and left ventricle. The left and right sides of the 
heart are separated by a wall of muscle called the septum. The basic anatomy 
of the heart is shown in the schematic in Figure 1.1-1. The external wall of the 
heart contains three layers; the epicardium, which is the outer most layer, the 
myocardium, which contains the muscle that contracts, and the endocardium 
which is the inner wall. The atria and ventricles are separated by the 
atrioventricular valves; the tricuspid valve on the right side and the mitral 
valve on the left. The pulmonary semi-lunar valve separates the right ventricle 
from the pulmonary artery, and the left ventricle and aorta are separated by 
the aortic valve.  
 
 
 
 
 
 
Figure 1.1-1: A) Schematic showing the basic anatomy of the human heart adapted 
from (1) and B) a coronal MR image through the heart collected using a bFFE 
localizer scheme. The red dotted line shows the short axis and the blue dotted line 
shows the long axis of the left ventricle. 
A B 
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Blood circulates around the body via the pulmonary circuit and the systemic 
circuit. In the pulmonary circuit, deoxygenated blood leaves the right 
ventricle of the heart through the pulmonary artery and travels to the lungs. 
This blood is then oxygenated in the lungs and returns to the left atrium via 
the pulmonary veins. In the systemic circuit, oxygenated blood leaves the 
heart via the left ventricle to the aorta. It then supplies the body’s organs with 
oxygen through the arteries and capillaries. Once this blood has been 
deoxygenated it returns to the heart’s right atrium via the superior and 
inferior vena cava.  
The cardiac cycle describes the series of events that occur when the heart 
beats. The RR-wave defines the spacing between two consecutive peaks in the 
cardiac cycle, typically around 1 s in humans. The cardiac cycle consists of two 
phases: the diastolic phase and the systolic phase as shown in Figure 1.1-2.  
 
 
 
 
Figure 1.1-2: Schematic of an electrocardiogram trace indicating ventricular systole 
and diastole in an RR-interval. 
During the diastolic phase, the atria and ventricles are fully relaxed and the 
atrioventricular valves are open. Deoxygenated blood enters the right atrium 
via the superior and inferior vena cavae. The open atrioventricular valves 
allow blood to move into the ventricles. The sinoatrial (SA) node acts as the 
heart’s natural pacemaker and is situated in the upper part of the wall of the 
right atrium. Here electrical impulses are generated which trigger the atria to 
contract and then blood in the right atrium moves into the right ventricle. The 
tricuspid valve prevents blood from moving back into the right atrium. 
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Simultaneously, blood from the pulmonary veins fills the left atrium. When 
the atria contract, the contents of the left atrium are moved into the left 
ventricle, the mitral valve then stops oxygenated blood from moving back into 
the left atrium. 
In the systolic phase, the ventricles contract and the atrioventricular valves 
close whilst the aortic and pulmonary valves open. Deoxygenated blood then 
travels from the right ventricle into the pulmonary artery and is prevented 
from flowing back into the right ventricle by the pulmonary valve. The 
pulmonary artery carries deoxygenated blood to the lungs where it becomes 
oxygenated and returns to the left atrium via the pulmonary veins. At the 
same time, the left ventricle contracts and oxygenated blood moves to the 
aorta to circulate the body, whilst the aortic valve prevents blood from 
travelling back into the left ventricle. Oxygenated blood then circulates in the 
body.  
The heart muscle, myocardium, is perfused by the left and right coronary 
artery, as shown in Figure 1.1-3A. The average tissue perfusion of the 
myocardium is approximately 1 ml/g/min.  
 
Figure 1.1-3: A) A schematic showing left and right coronary artery, adapted from 
(2) and B) an MR image showing the right coronary artery acquired using an axial 
bFFE localizer scheme. 
A B 
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The left main coronary artery branches into the left anterior descending artery 
and the left circumflex artery. The right coronary artery branches on the right 
side of the aorta into the distal right coronary artery. The coronary arteries are 
approximately 3 mm in diameter with a blood flow rate of approximately 10 
ml/s. 
 
1.1.2. Kidney structure and function  
 
The kidneys (Figure 1.1-4) are two intra-abdominal organs whose purpose is 
to filter the blood. The kidneys remove waste metabolites, control the body’s 
fluid balance and regulate the balance of electrolytes.  
 
 
 
 
 
 
Figure 1.1-4: Basic kidney anatomy, highlighting a nephron with the Bowman’s 
capsule and glomerulus, adapted from (3). 
The basic functional component of the kidney is the nephron; this is where 
blood is filtered to produce fluid which then undergoes multiple reabsorption 
and secretion processes to produce urine which drains into the renal pelvis. 
There are around one million nephrons in each human kidney. Each nephron 
is composed of a filtering component known as the renal corpuscle (composed 
of a glomerulus surrounded by the Bowman’s capsule) and the renal tubule 
for reabsorption and secretion. The renal corpuscle filters solutes from the 
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blood and then delivers water and small solutes to the renal tubule. Each 
nephron starts in the cortex where there is a knot of capillaries known as the 
glomerulus. In these glomeruli, blood is filtered so that waste metabolites and 
excess water are removed from the blood. Greater resistance in the efferent 
versus afferent arteriole increases local hydraulic pressure in the glomerulus, 
which results in fluid being squeezed out of the capillaries. This fluid is 
collected in the Bowman’s capsule which surrounds the glomerulus. The fluid 
moves from the Bowman’s capsule into the tubule. The process of moving the 
fluid from the glomerulus into the Bowman’s capsule is known as 
ultrafiltration. In ultrafiltration, large molecules such as proteins and blood 
cells are kept in the blood whereas smaller molecules, such as sodium, pass 
into the Bowman’s capsule. The renal tubule transports fluid which has been 
filtered through the glomerulus to the collecting duct system. During the 
passage through the renal tubule a large number of substances are reabsorbed 
from the tubular fluid and others are secreted into it.  
The kidney can be separated into the renal cortex and renal medulla. The renal 
cortex is the outer portion of the kidney which contains the renal corpuscles 
and the renal tubules, as well as blood vessels and the cortical collecting ducts. 
It is in the renal cortex that the ultrafiltration process occurs. The renal 
medulla is the inner most part of the kidney and is split into a number of 
sections called the renal pyramids. The interstitium (tissue between the 
tubules) in the renal medulla contains the renal tubules and those parts of the 
nephrons responsible for maintaining salt and water balance within the blood. 
The renal medulla is hypertonic to the filtrate in the nephron and so aids in 
the reabsorption of water. Despite being only 0.2 % of the body weight, the 
kidneys receive around 20 % of the cardiac output via the renal artery (with a 
flow of approximately 20 ml/s) which branches from the abdominal aorta. The 
blood flow to the renal cortex is much higher than that to the renal medulla 
with the cortex receiving approximately 80 % of the total blood flow to the 
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kidneys. The approximate perfusion of the kidney is 300 ml/100g/min to the 
cortex and 60 ml/100g/min to the medulla. 
The renal arteries divide into smaller arteries in the kidneys which eventually 
lead to afferent arterioles that supply blood to the glomeruli. After passing 
through the glomeruli, blood recollects in efferent arterioles which lead to 
peritubular capillaries that descend into the renal medulla and merge to form 
veins which later meet to become the large renal vein. The renal vein exits the 
kidney to join the inferior vena cava from which blood is carried to the heart.  
1.2. Chronic Kidney Disease 
1.2.1. Aetiology of CKD  
 
Chronic Kidney Disease (CKD) is a condition characterised by gradual loss of 
kidney function over time. CKD is described in five stages, each representing 
a worsening disease state of the kidney, as outlined in Table 1.2-1. Clinically, 
the stage of kidney disease is determined by the glomerular filtration rate 
(GFR) which provides an estimate of how much filtrate is produced by the 
glomeruli each minute. GFR is calculated mathematically from serum 
creatinine levels in blood taking into account a person’s size, age, sex and race. 
Table 1.2-1: Stages of Chronic Kidney Disease with corresponding GFR values, 
description of disease and typical treatment (4). 
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CKD is characterised by a GFR < 60 ml/min/1.73m2  that persists for more than 
3 months. In CKD, it is thought that renal tissue hypoxia (oxygen deficiency) 
plays an important role. This is complex and can be influenced by multiple 
factors. It may be related to altered renal blood flow and perfusion or altered 
renal oxygen consumption. Thus measures to assess these parameters are 
important in understanding CKD progression.  
Patients with CKD have a very high risk of developing cardiovascular disease 
(CVD) (5). The pathophysiology and mechanics underlying the increased 
incidence of CVD in CKD remain incompletely understood (6), but disease of 
one organ causes dysfunction in the other, ultimately leading to organ failure 
in both. These factors are well recognized in advanced kidney disease but the 
increased risk of mortality from heart disease begins to occur at an early stage 
of CKD. CKD Stage 3 is the most commonly diagnosed stage of the disease. 
Even at this relatively early stage patients are prone to changes in blood 
pressure and other risk factors that could lead to compromised cardiovascular 
function. Chapter 3 of this thesis assesses blood flow and perfusion of the 
heart in patients with CKD Stage 3.  
When the GFR falls below 15, CKD Stage 5 is diagnosed and at this point 
patients have end stage renal disease (ESRD).  Most patients then either 
undergo a kidney transplant or begin preparation for dialysis treatment. The 
effect of haemodialysis on the cardiac function in CKD Stage 5 patients is 
assessed in Chapter 4 of this thesis.  
1.2.2. Dialysis in end-stage renal disease (ESRD) patients 
 
Dialysis is the procedure that is used to perform many of the normal excretory 
functions of the kidney, such as the removal of waste products and excess 
fluid from the blood. Dialysis works by the principal of diffusion, removing 
solutes from the blood through a concentration gradient across a semi-
permeable membrane. This semi-permeable membrane ensures that larger 
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proteins and blood cells are not removed from the blood. There are two main 
dialysis modalities: peritoneal dialysis and haemodialysis.   
In peritoneal dialysis (7), a catheter is implanted in the peritoneal cavity, a 
space between the parietal peritoneum and visceral peritoneum in the 
abdominal cavity, and anchored in the subcutaneous tissues. Dialysate fluid 
flows through the catheter into the peritoneum where it remains for several 
hours. In that time, dialysis is performed as waste products and excess fluid 
diffuse across the semi-permeable peritoneal membrane. Excess fluid is 
removed by osmosis as the dialysate fluid is hypertonic compared to plasma. 
When this process is completed the remaining dialysis fluid and waste 
products are drained from the abdomen and the process is repeated. 
Peritoneal dialysis is preferable for patients who wish to maintain an active 
lifestyle as it can be performed at home and so removes the need for regular 
hospital trips. Peritoneal dialysis is performed up to 4 times a day and takes 
around 30 minutes per exchange. It can also be performed during the night by 
a machine that performs automated exchanges during a 10-12 hour dialysis 
session.  
Haemodialysis (8) works by moving the patients’ blood through an 
extracorporeal system which contains a semi-permeable membrane with 
blood moving down one side and dialysate (dialysis fluid) flowing along the 
other side in the opposite direction. This counter-current flow maintains a 
concentration gradient across the membrane which increases the efficiency of 
the dialysis treatment. Waste products are free to move through the 
membrane, but the holes are only large enough to let small molecules through 
and so proteins and blood cells remain in the blood. By altering the 
hydrostatic pressure of the dialysate fluid, ultrafiltration (fluid removal) is 
achieved as excess fluids are removed from the blood when free water and 
some dissolved solutes move across the membrane along the created pressure 
gradient. Haemodialysis is usually performed three times a week and each 
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session takes approximately 4 hours; however more frequent, shorter 
schedules (including nocturnal haemodialysis) are becoming more common 
with an increasing drive to support home therapies.  
Haemodiafiltration (HDF) is a modified form of haemodialysis that increases 
clearance of larger uremic toxins via convection, in this procedure 
ultrafiltration volumes are higher and coupled with greater fluid replacement. 
Water and solutes move from the blood to the dialysate at a much higher rate 
and solutes of both large and small molecular weights are removed. 
Replacement fluid is infused into the patient to ensure enough fluid is in the 
body.   
 
It is well established that patients on dialysis treatment display a greatly 
elevated rate of mortality due to an excess of cardiovascular complications (9). 
This increase in all-cause mortality is over 30 times greater than that of age 
matched controls (Figure 1.2-1) 
 
 
 
 
 
 
 
 
Figure 1.2-1: All-cause mortality in general population and ESRD                                                      
patients on dialysis, figure adapted from (4). This figure shows the general healthy 
population (black markers), and dialysis patients (white markers).  
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The high levels of CVD in patients on dialysis is in part due to traditional risk 
factors for cardiac disease that are more prevalent in CKD patients. However, 
the treatment of these risk factors in dialysis patients has not been shown to 
significantly decrease the number of cardiovascular related deaths. For 
example, no benefit was observed with cholesterol lowering in diabetic 
haemodialysis patients (10). The mechanisms for such an extreme increase in 
mortality rates is not fully understood. However, it has been shown that the 
circulatory stress of dialysis treatment itself can result in ischemia of the heart 
muscle in vulnerable vascular beds. Myocardial ischemia can lead to left 
ventricular dysfunction which may not recover once normal perfusion is 
returned following dialysis. This effect is known as myocardial stunning (11). 
Studies have shown that repeated ischemic episodes can lead to prolonged left 
ventricular dysfunction. As such myocardial stunning is thought to be a 
causative mechanism for heart failure in dialysis patients (11). Since dialysis 
patients receive treatment multiple times per week they are subjected to 
frequent ischemic episodes which can lead to chronic cardiac damage. 
Chapter 4 of this thesis aims to perform intradialytic MR measures, and 
compares cardiac function in response to haemodialysis and 
haemodiafiltration as assessed by MRI.  
1.3. Assessment of blood flow and tissue perfusion 
Blood flow is the continuous circulation of blood in the cardiovascular system 
and can be used to assess delivery of blood to a given organ in ml/min. 
Perfusion describes the volume of blood that passes through the capillary bed 
per unit time to deliver nutrients to the tissue. It is typically measured in units 
of millilitres per gram per minute (ml/g/min), to provide a measure of the 
number of millilitres of blood that is delivered to each gram of tissue in a 
minute. Blood flow and perfusion measurements can potentially inform on 
tissue function, disease progression and therapy efficacy. A robust technique 
for measurement of absolute blood flow and perfusion in the kidney and 
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myocardium of the heart is important. The following section describes 
methods for such assessment, which is the main aim of this thesis. 
1.3.1. Methods to Measure Blood Flow and Perfusion 
 
There are a number of techniques used for the measurement of blood flow and 
perfusion. To acquire information about the structure and function of the 
heart, an echocardiogram is generally used. Electrocardiographic imaging 
measures the reflection of sound waves from the structure of the heart and 
movement of blood in the heart. Doppler ultrasound measures the direction of 
blood and speed of blood flow through the heart. An echocardiogram can be 
used to assess ventricular mass. Previously, myocardial perfusion was 
measured using microspheres labelled with radioactive isotopes. These 
radioactively labelled particles were injected into the patient and the 
radioactivity of the tissue of interest was then measured to determine how 
much blood had travelled into the tissue (12). Perfusion can also be measured 
using positron emission tomography (PET) (13) and single positron emission 
computed tomography (SPECT) (14), where radiopharmaceuticals are injected 
into the body and PET or SPECT scanners are used to visualise where the 
radioactively labelled blood has travelled to. There has previously been work 
using PET in patients with CKD Stage 5 to assess myocardial perfusion in 
response to dialysis (15). However, there are a number of limitations to the 
use of PET and SPECT, including a lower signal in comparison to MRI, limited 
spatial resolution and also exposure to ionising radiation, which prevents PET 
and SPECT studies being repeated multiple times.  
Magnetic Resonance imaging (MRI) allows assessment of blood flow and 
voxel-by-voxel assessment of perfusion. Blood flow can be measured using 
phase contrast MRI (see Chapter 2). Perfusion assessment with MRI is 
classically performed using dynamic contrast-enhanced MRI (DCE-MRI) 
which uses the administration of a contrast agent, typically gadolinium 
(DTPA) (16). However, in patients with compromised kidney function, 
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gadolinium-based contrast agents can lead to side-effects including 
Nephrogenic Systemic Fibrosis (NSF) (17), highlighting the need for the 
development of reliable non-invasive techniques to assess perfusion. Arterial 
spin labelling (ASL) provides an alternative to DCE-MRI for the non-invasive 
quantitative assessment of tissue perfusion. ASL does not require injection of a 
contrast agent, but instead uses the magnetisation of endogenous labelled 
blood as a contrast agent. Development of ASL methods in the heart and 
kidney are the focus of Chapters 3 and 5. The following sections provide an 
overview of the current status of these methods in the literature. 
1.3.2. Arterial Spin Labelling 
 
Arterial Spin Labelling (ASL) is a non-invasive technique for the measurement 
of perfusion (18–24). The first studies using ASL were published over 15 years 
ago (18), and since then there has been a wide development of techniques for 
both brain and body applications, including those for the assessment of 
kidney and cardiac perfusion. 
ASL uses magnetically labelled water protons as an endogenous tracer. An 
ASL image is formed from the difference between a label and control image. 
The label image of the tissue is collected under the condition of the inflowing 
arterial blood being inverted or saturated, whilst for the control image the 
longitudinal magnetisation of the inflowing blood is fully recovered. There are 
3 variants of the labelling techniques for ASL; pulsed ASL (PASL), continuous 
ASL (CASL) and pseudo-continuous ASL (pCASL). These techniques are 
described in Chapter 2 and PASL is used in Chapters 3-5 of this thesis. 
 
To date the majority of ASL studies have been carried out in the brain. 
However, the number of studies performed in other organs in the body has 
increased in recent years. In particular, a number of studies have used ASL to 
assess perfusion of the kidneys (25–33), lungs (34), skeletal muscle (35,36) and 
the heart (37–42). Since CKD leads to both changes in cardiac and renal 
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function, the ability to measure myocardial and renal tissue perfusion with the 
development of ASL methods is of great importance.  
1.3.2.1. Cardiac ASL 
 
There are a number of challenges associated with cardiac ASL. Firstly, due to 
the motion of the heart during the cardiac cycle, the scans must be 
synchronised to a fixed point in the cardiac cycle (typically end-diastole is 
chosen). This can be achieved using cardiac gating which matches the scan 
acquisition to the heartbeat using the signal from a vector cardiogram (VCG) 
thus minimising motion artefacts. In addition to the motion of the heart, 
cardiac MRI has to overcome the movement of the diaphragm during the 
respiratory cycle. There are a number of techniques that can be used to 
overcome respiratory motion including triggering scans on both the cardiac 
and respiratory cycle, using respiratory bellows, asking the subject to perform 
a breath hold during the scan, using a navigator scan or retrospective motion 
correction or sorting of the data.  
There has recently been a small number of studies published using ASL 
techniques to assess myocardial perfusion in both animals (43–45) and 
humans (38,42,46–49). A number of papers have validated the measurement of 
myocardial perfusion values using a stress test, such as an injection of 
adenosine (48) or the use of an exercise challenge (37). Myocardial ASL is 
developed and discussed in more depth in Chapter 3 of this thesis, and a 
stress test using a handgrip task is used to assess the validity of the developed 
cardiac ASL technique. In Chapter 4, myocardial ASL is applied to the study 
of perfusion of the heart during dialysis.  
1.3.2.2. Renal ASL 
 
Typically, renal function is assessed via serum creatinine concentration and 
glomerular filtration rate (GFR) measures (50) or a renal biopsy. However, 
these methods are not highly specific or sensitive at an early stage of disease, 
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and changes in these parameters may arise only later in the development of 
CKD. As such, more sensitive measures are needed and MRI provides a 
method for voxel-by-voxel quantification of renal perfusion. In patients with 
advanced renal insufficiency, the administration of contrast agents should be 
avoided due to the risk of nephrogenic systemic fibrosis (NSF) (17). This has 
led to the drive for the development of ASL methods to quantify perfusion of 
the kidney.   
The main challenge associated with ASL of the kidney is the need to overcome 
respiratory motion. If there is movement between the acquisition of the label 
and control image, this results in the subtraction images being poorly aligned 
leading to an error in quantified perfusion. This can be overcome with a 
breath hold strategy (28), but this places a constraint on acquisition time and 
may not be feasible for all patients. Also, since ASL relies on averaging over 
multiple repeats of label and control pairs, this would necessitate multiple 
breath holds, with the subject holding their breath such that their diaphragm 
is in the same position for each breath hold. An alternative to breath-holding 
is to acquire data using respiratory bellows which monitor the breathing cycle 
and trigger each ASL label and control image at the same point in the 
respiratory cycle (27), typically end expiration. Alternatively, post-processing 
approaches can be applied to overcome kidney movement (32). 
To date, there have been a number of papers using a variety of ASL 
techniques for measurement of kidney perfusion. ASL has been applied in the 
kidney for the assessment of kidney transplants (29), renal masses (33,51) and 
acute kidney injury (AKI) (26). Chapter 5 of this thesis aims to develop robust 
renal perfusion measures by evaluating the optimal 2D readout scheme for 
respiratory triggered renal ASL.  
 
 
 1.4   Thesis Structure                                                                16 
 
 
1.4. Thesis Structure 
The following lists the material covered in the remainder of this thesis.  
Chapter 2 describes the origin of the NMR signal and MRI theory. This 
includes a more detailed description of the haemodynamic measures of blood 
flow and perfusion using the MR methods of phase contrast (PC) MRI and 
Arterial Spin Labelling (ASL) which are developed throughout this thesis. 
Chapter 3 describes the development of cardiac ASL. First the method is 
developed and optimised in healthy volunteers. The technique is then applied 
to CKD Stage 3 patients and age-matched volunteers to assess changes in 
cardiac perfusion in response to a handgrip stress challenge. This work was 
presented at the International Society for Magnetic Resonance in Medicine 
(ISMRM) as an oral presentation (p0538) and a poster (p2749) in 2015.  
Chapter 4 studies CKD Stage 5 patients by performing MRI during 
haemodialysis to determine the cardiac stress this places on the patient. 
Intradialytic MRI measures of cardiac function and structure (including 
assessment of cardiac output, stroke volume, myocardial tagging, and 
myocardial perfusion as measured using the ASL technique developed in 
Chapter 3) are assessed. This work will be presented at the International 
Society for Magnetic Resonance in Medicine (ISMRM) as an oral presentation 
(p146) in 2016. 
Chapter 5 aims to develop renal ASL measures for future studies of Chronic 
Kidney Disease (CKD) and Acute Kidney Injury (AKI) patients. Renal ASL 
measures are acquired in healthy subjects using a pulsed ASL scheme and the 
optimal readout scheme for quantification of renal perfusion is assessed. This 
work was presented at the International Society for Magnetic Resonance in 
Medicine (ISMRM) as an oral presentation (p0256) in 2015. 
Chapter 6 concludes with an overview of the findings of this thesis. An outline 
of the future direction in which these developed MRI methods can be applied 
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in improving the understanding of the pathophysiology of CKD and AKI, and 
the study of the consequences of dialysis is provided.   
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2 Principles of MRI 
 
This chapter provides an overview to nuclear magnetic resonance (NMR) and 
the magnetic resonance imaging (MRI) techniques necessary to understand 
the work presented in this thesis. This chapter begins with an overview of the 
origins of the NMR signal, the specific physics of MRI, and how image 
contrast is formed. MRI techniques developed and used in this thesis to assess 
blood flow and tissue perfusion using phase contrast MRI (PC-MRI) and 
arterial spin labelling (ASL) are then described and subsequently applied in 
Chapters 3-5. Finally, the method of cardiac tagging is outlined which is then 
implemented in Chapter 4. 
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2.1 Origin of NMR signal  
 
A nucleus has three fundamental properties: mass (m), electronic charge (q) 
and spin (I). Magnetic resonance is based on the interaction between a nucleus 
that possesses spin and an applied magnetic field (𝐵 =  𝐵0𝒌). Since nuclei are 
charged they also possess a magnetic moment 𝝁, and as they have mass this 
generates spin angular moment, 𝑷, where: 
 𝝁 = 𝛾𝑷 
 
2-1 
and 𝛾 is the gyromagnetic ratio which is a property specific to each nucleus; 
𝛾 = 267.5 𝑥 106 𝑟𝑎𝑑𝑠−1  𝑇−1 for the hydrogen nucleus. Table 2.1-1 shows the 
spin and gyromagnetic ratio of common nuclei.  
 
Table 2.1-1: Table of common isotopes and their nuclear spin (I) and gyromagnetic 
ratio (γ). 
Nuclear spin is an intrinsic quantum mechanical property of the nucleus. 
When a nuclei consists of multiple protons and neutrons, the spins combine to 
result in a net nuclear spin (I). Unlike macroscopic angular momentum, 
nuclear spin can only take integer or half integer values (0, 1 2⁄ , 1,
3
2⁄  etc..). 
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In non-relativistic quantum mechanics, the magnitude of the spin angular 
momentum vector 𝑷 of a nucleus with spin I is  
 𝑷 =  ℏ√𝐼(𝐼 + 1) 
 
2-2 
where ℏ = ℎ/2𝜋 and ℎ is Planck’s constant. For nuclei with spin 𝐼, there are 
2𝐼 + 1 spin states (or eigenstates) given by the quantum number 𝑚𝐼 , where 
𝑚𝐼 =  𝐼, (𝐼 − 1), (𝐼 − 2), … ,
1
2⁄ … −
1
2⁄ , … . , −𝐼. 
The z-component of the spin angular momentum of a spin state 𝑚𝐼 is defined 
as  
 𝑃𝑧 =  ℏ𝑚𝐼 
 
2-3 
The orientation of 𝑃𝑧 is shown in Figure 2.1-1 for a nuclei with spin 
1
2⁄ . 
 
 
 
 
 
 
 
Figure 2.1-1: The relationship between the z-component of spin angular momentum 
𝑷𝒛 and quantum number 𝒎𝑰. 
An NMR signal can be detected from any nuclei with spin, but MRI is most 
often tuned to the signal from hydrogen nuclei contained in water, as this is 
the most abundant nucleus in the human body. Protons have spin 𝐼 =  1 2⁄  and 
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spin states of 𝑚𝐼 = +
1
2⁄  or –
1
2⁄ . In the absence of a magnetic field, magnetic 
moments align in various directions. When the magnetic moments are placed 
in an external magnetic field, 𝐵 =  𝐵𝑜𝒌, they align in parallel or anti-parallel to 
the external field as illustrated in Figure 2.1-2. 
 
 
Figure 2.1-2: Illustration showing (A) in the absence of a magnetic field, the magnetic 
moments (shown by arrows) align in various directions. (B) In the presence of a 
magnetic field, the magnetic moments align either parallel or anti-parallel with the 
applied field. 
When a nucleus with magnetic moment 𝝁 is placed inside a magnetic field, B, 
the associated energy, 𝐸, is given by 
 𝐸 =  −𝝁. 𝑩 
 
2-4 
Combining this expression with Equation 2-1, gives 
 𝐸 =  −𝛾𝑷. 𝑩 2-5 
Since the main magnetic field, Bz, is defined to be along the z-axis, 𝑩 =  𝐵𝑧𝒌, 
this gives 
 𝐸 =  −𝛾ℏ𝐵𝑧𝑚𝐼 2-6 
A B 
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For a proton, with spin 𝐼  = 1 2⁄ , 𝑚𝐼 = ± 
1
2⁄   and so the energy difference 
between the two spin states in an external magnetic field Bz is  
 ∆𝐸 =  𝛾ℏ𝐵𝑧. 
 
2-7 
This separation in energy levels is known as Zeeman splitting, as illustrated in  
Figure 2.1-3. 
 
 
 
 
 
 
 
 
 
Figure 2.1-3: Zeeman splitting illustrating the energy difference between protons in 
the higher and lower energy states as a function of applied magnetic field 𝑩𝒛.   
When a single spin, 𝝁, is placed in a magnetic field, 𝑩, its magnetic moment 
will experience a torque which can be equated to the change in spin angular 
momentum,  
 𝑑𝑷
𝑑𝑡
=  𝝁 𝐱 𝑩 
 
2-8 
Using Equation 2-1,  
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 𝑑𝝁
𝑑𝑡
=  𝛾𝝁 𝐱 𝑩 
2-9 
which is the equation of precession of motion. Solving this equation in the 𝑥, 𝑦 
and 𝑧 directions, whilst assuming the applied magnetic field Bz is along the z 
axis, gives 
 𝜇𝑥(𝑡) =  𝜇𝑥(0) cos(𝛾𝐵𝑧𝑡) + 𝜇𝑦(0) sin(𝛾𝐵𝑧𝑡) 
𝜇𝑦(𝑡) =  −𝜇𝑥(0) 𝑠𝑖𝑛(𝛾𝐵𝑧𝑡) + 𝜇𝑦(0) cos(𝛾𝐵𝑧𝑡) 
𝜇𝑧 = 0 
2-10 
These equations describe the precession of the magnetic moment about the z-
axis with an angular frequency, 𝜔, of 𝛾𝐵𝑧. This rate of precession is known as 
the Larmor frequency. For protons in a 3 Tesla MR system, the Larmor 
frequency of a proton is -128 MHz. Most nuclei have a positive gyromagnetic 
ratio resulting in a negative Larmor frequency which indicates that the spins 
precess clockwise about the z-axis, as illustrated in Figure 2.1-4. 
 
 
 
 
 
 
 
 
Figure 2.1-4: Precession of a spin, µ, about the z-axis inside a magnetic field of 
𝑩 = 𝑩𝒛𝒌. 
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In NMR, an oscillating, time dependent, magnetic field 𝑩𝟏(𝑡) of frequency 𝜔 is 
then applied perpendicular to the z-axis, 
 𝑩𝟏(𝑡) = 2𝐵1 cos(𝜔𝑡) 𝒊 2-11 
𝑩𝟏(𝑡) is linearly polarised along the x-axis, and so can be resolved into circular 
components rotating in the clockwise and anti-clockwise directions at Larmor 
frequency, 𝜔.  
 𝑩𝒂(𝑡) = 𝐵1[cos(𝜔𝑡) 𝒊 + sin(𝜔𝑡) 𝒋] 
𝑩𝒄(𝑡) = 𝐵1[cos(𝜔𝑡) 𝒊 − sin(𝜔𝑡) 𝒋] 
2-12 
where 𝑩𝒂(𝑡) denotes the anti-clockwise component and 𝑩𝒄(𝑡) is the clockwise 
component. If 𝜔 is matched to the Larmor frequency, 𝜔𝐿 , the contribution 
from 𝐵𝑎 is negligible as it rotates at a frequency of −2𝜔𝐿, far off-resonance. In 
contrast, 𝑩𝒄(𝑡) rotates at the Larmor frequency, 𝜔𝐿, and is on-resonance. This 
leads to a constant torque due to 𝑩𝒄(𝑡) on the magnetic moment which 
perturbs the motion of magnetic moment, such that  
 𝑑𝝁
𝑑𝑡
=  𝛾𝝁 𝐱 [𝑩 +  𝑩𝒄(𝒕)] 
2-13 
 
This additional rotation about the x-axis causes a change in the precessional 
angle of the magnetic moment.  
To understand the effect of the applied radiofrequency pulse, 𝑩𝒄(𝑡), it is 
simpler to move into a rotating frame of reference. In a frame of reference 
rotating around the z-axis at the Larmor frequency, 𝑩𝟏(𝑡) is stationary along 
the x-axis as shown in Figure 2.1-5.  
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Figure 2.1-5: Laboratory frame of reference showing the precession of a spin about the 
x- and z-axis and the corresponding rotating frame of reference with µ rotating about 
the x’ axis.  
In the rotating frame, the unit vectors can be written as (𝒊′,  𝒋′, 𝒌) within an 
axis system (𝑥′, 𝑦′, 𝑧) and the time dependency of 𝑩𝟏(𝑡) is removed such that 
the 𝑩𝟏 field can be described by 
 𝑩𝟏(𝑡) =  𝐵1𝒊′ 
 
2-14 
This results in the equation of motion of the magnetic moment in the rotating 
frame of 
 
(
𝑑𝝁
𝑑𝑡
)
𝑥′,𝑦′,𝑧
=  𝛾𝝁 𝐱 (𝐵1𝒊′ + (𝐵𝑧 −
𝜔
𝛾
) 𝒌) 
2-15 
which can be simplified to  
 
(
𝑑𝝁
𝑑𝑡
)
𝑥′,𝑦′,𝑧
=  𝛾𝝁 𝐱𝑩𝒆𝒇𝒇 
2-16 
 
where  
 𝑩𝒆𝒇𝒇 =  𝐵1𝒊
′ + (𝐵𝑧 −
𝜔
𝛾
) 𝒌 
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This equation shows that in the rotating frame of reference, the magnetic 
moment, 𝝁, rotates about 𝑩𝒆𝒇𝒇 at a precessional frequency, 𝜔𝑒𝑓𝑓 =  𝛾𝐵𝑒𝑓𝑓. 
When 𝑩𝟏(𝒕) is applied on resonance, 𝑩𝒆𝒇𝒇 =  𝑩𝟏𝒊′, and the magnetic moment 
will rotate in the 𝑦’𝑧 plane at a frequency 𝜔 =  𝛾𝐵1. 
If a radiofrequency pulse with frequency 𝜔𝐿 is applied to a system for a time 
𝑡𝑤, the magnetic moment will tip through a precessional angle 𝜃 given by 
 
𝜔 =  
𝑑𝜃
𝑑𝑡
= 𝛾𝐵1    ∴     𝜃 =  𝛾𝐵1𝑡𝑤 
2-18 
which corresponds to inducing transitions from the lower to higher energy 
state of the system.  
So far only a single spin with magnetic moment, 𝝁, has been considered. 
However, in a single voxel in MRI there will be of the order 1020 protons. The 
bulk magnetisation, M, is calculated as the sum of the individual magnetic 
moments in the system per unit volume, V. 
  
𝑴 =  
1
𝑉
∑ 𝝁𝒊
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓
 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 𝑖𝑛 𝑉
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In an ensemble of spins, such as the human body, most of the magnetic 
moments will cancel out due to the parallel/anti-parallel alignment. However, 
a net spin will result in the lower energy state (Figure 2.1-6); with the 
distribution of spins across the two energy states being determined by the 
Maxwell-Boltzmann distribution: 
 𝑁−
𝑁+
 =  𝑒
−Δ𝐸
𝑘𝐵𝑇 =  𝑒
−ℏγ𝐵𝑧
𝑘𝐵𝑇  
2-20 
where 𝑁+ denotes the number of spins in the lower energy state (𝑚𝐼 =
1
2⁄ ) 
and 𝑁− is the number of anti-parallel spins, in the higher energy state (𝑚𝐼 =
− 1 2⁄ ).  𝑘𝐵 is the Boltzmann constant, 𝑇 is the temperature in Kelvin, and Δ𝐸 is 
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the energy difference between the two energy states caused by Zeeman 
splitting. 
 
Figure 2.1-6: (A) Protons move in either the positive or negative direction. (B) There 
are more protons in the positive direction resulting in a non-zero net magnetisation 𝑴 
in the positive direction parallel to 𝑩𝟎. 
In the high temperature limit,  𝑘𝐵𝑇 ≫  Δ𝐸. Equation 2-20 can be written as  
 𝑁−
𝑁+
= 1 − 
ℏγ𝐵𝑧
𝑘𝑇
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The population difference, 𝑛, between the lower and higher energy state can 
then be approximated as  
 
𝑛 =  𝑁+ −  𝑁− =  
𝑁+ℏγ𝐵𝑧
𝑘𝑇
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As 𝑁+  ≈  𝑁−, the population difference between the lower and higher energy 
states is given by  
 
𝑛 =  
𝑁ℏγ𝐵𝑧
2𝑘𝑇
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where 𝑁 =  𝑁+ +  𝑁− = 2𝑁−, the total number of spins. The bulk magnetisation 
is then given by  
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and is proportional to the applied magnetic field 𝐵𝑧 and inversely 
proportional to the temperature of the system, T. This bulk magnetisation, M, 
obeys the same classical equation of motion as a single spin and can be 
described by the Bloch equation 
 𝑑𝑴
𝑑𝑡
=  𝛾𝑴 x 𝑩 
2-25 
The radiofrequency pulses that are most often used in MRI pulse sequences 
include an excitation pulse where the flip angle 𝜃 is 90𝑜, or an inversion pulse 
for which the flip angle is 180𝑜. A radiofrequency pulse with flip 
angle  𝜃 of 90𝑜 results in net magnetisation 𝑀0 in the xy’- plane and zero in the 
z plane. When 𝜃 =  180𝑜, the magnetisation is tipped along the negative z-axis 
and there is no component in the xy’ plane. The effect of an excitation and 
inversion pulse is shown in Figure 2.1-7. Refocusing pulses can also be applied 
which act to bring the magnetisation back into phase (see section 2.5.2). 
 
 
 
 
Figure 2.1-7: Effect of a  𝟗𝟎𝒐and 𝟏𝟖𝟎𝒐 pulse where the blue arrow shows the 
magnetisation 𝑴𝒛.  
 
𝑴 = 𝑛𝝁 =
1
4
𝑁(ℏ𝛾)2𝐵𝑧
𝑘𝐵𝑇
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2.2 Relaxation  
The spin system is classified in thermal equilibrium such that longitudinal 
magnetisation 𝑀𝑧 =  𝑀0 and transverse magnetisation 𝑀𝑥 =  𝑀𝑦 = 0. 
When a radiofrequency 𝑩𝟏(𝒕) pulse is applied, the magnetisation M is tipped 
away from the z-axis, and will gain phase coherence whilst precessing in the 
xy’ plane. A 90o pulse results in equalisation of spin states with no component 
of 𝑴 remaining in the z direction, and 𝑀𝑥𝑦 takes a finite quantity. On cessation 
of the radiofrequency pulse, the spins return to their lowest energy state and 
dephase to regain equilibrium. There are two modes of relaxation to return to 
equilibrium: longitudinal (𝑇1) relaxation is the process whereby longitudinal 
spin populations return to equilibrium. Transverse (𝑇2 or 𝑇2
∗) relaxation is the 
process of the decay of spin coherence. These are two independent relaxation 
processes, typically 𝑇2 relaxation is a faster process than 𝑇1relaxation with T1 
in the abdomen being around 1000 ms at 3T and T2 approximately 70 ms. 
2.2.1  Longitudinal (𝑻𝟏) Relaxation  
Longitudinal (𝑇1) relaxation is the process by which the net longitudinal 
magnetisation returns to the equilibrium Boltzmann distribution. As the 
longitudinal component of the magnetisation returns towards 𝑀0 the energy 
of the spin system decreases with the spin system moving from a high to low 
energy state. Energy leaves the spin system with heat being transferred into 
nearby nuclei via collisions, rotations or electromagnetic interactions. This 
energy is very small compared to typical molecular kinetic energies. The 
𝑇1 relaxation time differs between biological materials depending on the 
efficiency of the energy transfer between protons and the surrounding lattice. 
𝑇1 relaxation time values are longer for water and tissue as the energy transfer 
is inefficient due to their natural motional frequency being much greater than 
the Larmor frequency. In contrast, fat has a short efficient 𝑇1 relaxation since 
the natural motional frequency is equal to the Larmor frequency. Recently, 𝑇1 
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relaxation time values have been suggested to indicate areas of fibrosis, as the 
𝑇1 relaxation time increases with an increased composition of oedema and 
pooling of water molecules (1). This is discussed further in Chapter 4. 
 
 
 
 
 
Figure 2.2-1: 𝑻𝟏 relaxation. The magnetisation M0 (blue line) is knocked into the xy-
plane by a 90o pulse. Following the RF pulse, the magnetisation then returns to 
equilibrium with the recovery governed by the T1 relaxation time.   
2.2.2 Quantification of Longitudinal relaxation time (T1) 
The simplest and most commonly used pulse sequence for accurate 
quantification of T1 values is the inversion recovery scheme.  
 
Figure 2.2-2: Inversion recovery curve for a sample with T1 of 1.6 s. 
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In an inversion recovery scheme, a 180o RF pulse is applied to invert the 
magnetisation. This is followed at a given inversion time (TI) by a 90o RF pulse 
which rotates the residual magnetisation into the transverse plane where it 
can be detected by the RF coil. By repeating the experiment for multiple TI 
values, (Figure 2.2-2) data can be fit to the solution of the Bloch equation: 
 𝑑𝑀𝑧
𝑑𝑡
=  
𝑀0 − 𝑀𝑧
𝑇1
, 
 
2-26 
to estimate 𝑇1. Integrating between the limits of −𝑀0 to 𝑀𝑧(𝑡) from time  𝑡 = 0 
to t = TI results in the equation 
 𝑀𝑧(𝑡) = 𝑀0(1 − 2𝑒
−𝑇𝐼/𝑇1) 2-27 
It is important that the magnetisation is fully recovered between each 180o 
pulse, so a repetition time (TR) of greater than 5 times 𝑇1 is left between 
repeats.  This can result in a very time consuming acquisition to sample a 
number of TI values over the inversion recovery curve. 
2.2.3 Look Locker (LL) readout scheme 
To speed up the acquisition of multi-time point 𝑇1 imaging, the Look-Locker 
(LL) 𝑇1 mapping scheme was introduced (2). A Look-Locker readout scheme 
allows multiple low flip angle readouts to be acquired at different TIs  
following a single inversion pulse in a reduced scan time, as shown in Figure 
2.2-3, to sample the  𝑇1  recovery. 
Low flip angle (𝛼) readouts which are equally temporally spaced (𝑇𝐼2) result 
in an apparent 𝑇1 being measured, as the magnetisation is partially saturated 
by the Look-Locker readout pulses, this is known as 𝑇1,𝐿𝐿. The true 𝑇1 value 
can then be calculated using the equation  
 1
𝑇1,𝐿𝐿
=  
1
𝑇1
−  
ln (𝑐𝑜𝑠𝛼)
𝑇𝐼2
 
2-28 
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Alternatively, 𝑇1  can be quantified by iteratively modelling the Look-Locker 
recovery curve. The first time point after the inversion pulse follows a 
standard inversion recovery (Equation 2-27), with the longitudinal 
magnetisation at this time point being given by 𝑀𝑧 = 𝑀𝑖 sin 𝛼 and the 
transverse magnetisation, 𝑀𝑥𝑦 = 𝑀𝑖 cos 𝛼. For subsequent time points the 
transverse magnetisation is iteratively fit from the magnetisation of the (i-1) 
time point such that  
  
𝑀𝑖 = 𝑀0  (1 − 𝑒
−
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1 ) + 𝑀𝑧(𝑖 − 1)𝑒
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1  
2-29 
  
where 𝑖 denotes the current time point. By iteratively fitting to these equations 
an estimate of the T1 can be obtained.  
 
 
 
Figure 2.2-3: Look locker readout scheme and resulting recovery curve simulated for a 
T1 of tissue of 1600ms, flip angle of 45o and readout spacing of 400ms.  
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For T1 mapping of the heart, an adaptation of a Look-Locker scheme, known 
as a modified Look-Locker inversion recovery (MOLLI), can be used (3). In 
cardiac imaging, the readouts must be synchronised to the cardiac cycle in 
order to eliminate motion of the heart. This results in a readout temporal 
spacing of approximately one second. For such a scheme there would only be 
enough time to acquire approximately three readouts before the signal has 
fully recovered (~3 s). To overcome this, the MOLLI scheme acquires multiple 
Look-Locker datasets, each with a different initial post-label delay, and then 
combines these datasets to span the T1 recovery curve. This technique is 
described further in Chapter 3.  
2.2.4 Transverse Relaxation 
Transverse (𝑇2) relaxation is the process by which the transverse component of 
the magnetisation 𝑀𝑥𝑦 dephases. Immediately after a radiofrequency pulse is 
applied, all the spins are in phase and precess at approximately the same 
frequency. On cessation of the RF pulse, the spins de-phase over time, Figure 
2.2-4, and the 𝑀𝑥𝑦 component of the magnetisation decreases exponentially as 
a function of 𝑇2  (Figure 2.2-4).  
 
Figure 2.2-4: 𝑻𝟐 relaxation (a) Magnetisation immediately after a 90o pulse and (b) 
dephasing of spins in the rotating frame of reference.  
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The 𝑇2 relaxation time is long in pure water (~ 3 − 4 seconds), as water 
molecules move faster that the Larmor frequency, but is much shorter in other 
fluids and tissues.  
The T2 relaxation time can be derived from solving the coupled Bloch 
equations  
  𝑑𝑀𝑥
𝑑𝑡
= −
𝑀𝑥
𝑇2
+ 𝛾𝑀𝑦𝐵𝑧 ,  
 
𝑑𝑀𝑦
𝑑𝑡
= −
𝑀𝑦
𝑇2
− 𝛾𝑀𝑥𝐵𝑧 , 
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Following a 90o pulse, this can be integrated with the limits 𝑀0 to 𝑀𝑥𝑦(𝑡) and 
𝑡 = 0 to echo time, TE, giving 
 𝑀𝑥𝑦(𝑡) = 𝑀0𝑒
−𝑇𝐸/𝑇2 
 
2-31 
 
Figure 2.2-5:  𝑇2 decay curve for a T2 of 80ms.  
In practice, the transverse magnetisation decays faster than the T2  relaxation 
time as it also depends on the external magnetic field inhomogeneities (e.g. 
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interactions between the samples which can lead to a 𝑇2′ relaxation term. This 
results in a 𝑇2
∗ relaxation rate which is given by 
 
 1
𝑇2
∗  
=
1
𝑇2  
+
1
𝑇2′  
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The received decaying MR signal is known as the free induction decay (FID).  
2.3 Contrast 
Image contrast can be broadly classified from a gradient echo or spin echo 
based scheme.  
2.3.1 Gradient echo scheme 
A gradient-echo (GE) is produced by a single radio-frequency pulse followed 
by a gradient reversal, as shown by Figure 2.3-1.  
 
Figure 2.3-1: Gradient-echo scheme showing refocussing of signal at the centre of the 
gradient reversal.  
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The magnetisation dephases in the transverse plane under a negative read-out 
gradient which causes the spins to dephase faster. The readout gradient is 
then reversed which cause the spins to refocus and create an echo at the centre 
of the gradient. The echo time is defined as the time between the excitation 
pulse and the echo. Field homogeneity is important for GE imaging as the 
gradient reversal only refocuses spins that had been dephased by the gradient 
itself, and so phase shifts resulting from field inhomogeneities, static tissue 
susceptibility gradients and chemical shifts are not corrected.  
2.3.2 Spin echo  
In a spin-echo (SE) pulse sequence (Figure 2.3-2), a 180o RF pulse is used to 
refocus the magnetisation in the transverse plane. Spins are first excited using 
a 90o pulse.  Due to the local inhomogeneity, some spins may precess faster 
relative to others and so spread out across the transverse plane. A 180o pulse is 
then applied which flips the magnetisation about the y-plane causing the 
spins to refocus. When the spins refocus, an echo occurs at a time twice the 
time between the 90o and 180o pulse.  The time between the application of the 
90o pulse and the peak of the echo signal is known as the echo time (TE). 
 
 
 
 
Figure 2.3-2: Spin-echo scheme shown in the rotating frame A) A 90o pulse is applied 
to tip the magnetisation into the xy-plane then the spins begin to dephase. A 180o 
pulse is applied causing the spins to rephase in the xy plane at time TE. B) The 90o and 
180o gradients applied during the SE-EPI sequence and resulting MR signal.  
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2.4 Image formation 
The following section describes techniques for image formation. 
2.4.1 Slice selection 
Applying an on-resonance radiofrequency pulse to a sample in a uniform 
magnetic field will excite the entire volume, which is not medically useful. In 
order to be selective about which area is excited, slice selection can be used. 
If a field gradient 𝐺𝑧 is applied, spins will experience a magnetic field,  
 𝐵 =  𝐵0 +  𝐺𝑧𝑧, 
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at a given position 𝑧. This results in the sample’s resonant frequency being 
dependent on the spins position along the z-axis  
 𝜔 =  𝛾(𝐵0 + 𝐺𝑧𝑧),   2-34 
Use of a frequency selective radiofrequency pulse will therefore excite a slice 
containing nuclei with the same bandwidth in resonant frequency. The 
thickness of this slice can be changed by adjusting the magnitude of the field 
gradient, 𝐺𝑧 , and the bandwidth of the RF pulse, Δ𝜔.  
 Δ𝑧 =  
Δ𝜔
𝛾𝐺𝑧
 
 
  2-35 
Generally, a rectangular slice profile is desired. To achieve a rectangular slice 
profile in the Fourier domain, a sinc RF pulse is used. In practice, RF pulses 
are truncated to limit the duration of the excitation pulse, leading to some 
imperfections in the pulse profile. Since the gradient applied in combination 
with the RF pulse will result in the dephasing of the spins, a gradient of 
opposite polarity and half the magnitude of the original gradient is applied to 
re-establish the original phase of the spins. 
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Figure 2.4-1: Slice selection showing RF pulses with central frequency 𝝎𝟏 and 𝝎𝟐 of 
bandwidth  ∆𝝎𝟏 and ∆𝝎𝟐. In combination with a gradient 𝑮𝒛 this results in slice 
thicknesses ∆𝒛𝟏 and ∆𝒛𝟐 centred at position 𝒛𝟏 and 𝒛𝟐. 
2.4.2 Phase and frequency encoding 
Information from the excited slice is then encoded to an image using phase 
and frequency encoding. A phase encoding pulse is applied in the y-direction 
prior to sampling the data. This results in nuclei precessing at different rates 
according to their position in the y-direction. After a time t, the phase shift is 
given by 
 Δ𝜙 =  𝛾𝐺𝑦𝑦𝑡 
 
  2-36 
and proportional to the y-coordinate, gradient strength, 𝐺𝑦, and the amount of 
time the gradient was applied for, 𝑡. In order to sample the whole of k-space, 
the phase encoding gradient amplitude changes with every repetition, as 
shown in Figure 2.4-2.  
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Figure 2.4-2: Phase and frequency encoding gradients used to form a 2D image. 
Dashed lines represent the different phase encoding steps.  
A frequency encoding then follows phase encoding. By applying a linear 
gradient (also known as the read-out gradient) during image acquisition. The 
gradient in the frequency-encoding direction results in a spatial dependency 
on the frequency. These frequencies are then read out by summing the signal 
amplitude across the frequency encoding direction to result in a single line of 
k-space. When the whole of k-space has been filled, a Fourier transform is 
applied to the frequency data to form an image.    
2.4.3 k-space 
MRI images are spatially encoded in k-space, a two dimensional array (𝑘𝑥 , 𝑘𝑦) 
of spatial frequencies which contains raw data. 𝑘𝑥 corresponds to time points 
in the readout direction and 𝑘𝑦 to points in the phase encoding direction. Each 
(𝑘𝑥, 𝑘𝑦) coordinate gives a signal influenced by a combination of readout and 
phase encoding points  
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 𝑘𝑥 =  𝛾𝐺𝑥𝑡𝑥 
 
  2-37 
 𝑘𝑦 =  𝛾𝐺𝑦𝑡𝑦 
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where 𝐺𝑥 and 𝐺𝑦 are gradients in the readout and phase encoding directions 
respectively, and 𝑡𝑥 and 𝑡𝑦 are the duration of the readout and the phase 
encoding gradients. The change in k in each direction (Δ𝑘𝑥, Δ𝑘𝑦)  is inversely 
related to the field of view (FOV), the distance over which the image is 
acquired, in that direction whilst the extent of k-space is proportional to the 
spatial resolution of the image. Data in the centre of k-space provides 
information on image contrast whereas the edge of k-space informs on high 
definition in the image. To achieve artefact free MR data, k-space needs to be 
well sampled, and is often sampled with a Cartesian configuration using 
uniform spacing in Δ𝑘𝑥 and Δ𝑘𝑦.  
2.5 Imaging Sequences 
 
A number of different imaging schemes can be applied. The following sections 
overview those used in this thesis.  
2.5.1 Echo planar imaging  
Echo-planar imaging (EPI) is a fast imaging technique that was developed to 
speed up image acquisition time, thus motion related artefacts can be 
eliminated and fast changing physiological processes can be imaged. EPI 
samples all of k-space following a single excitation pulse. A train of gradient 
echoes are created by alternating the frequency encoding gradient from 𝐺𝑥 to 
−𝐺𝑥. The first line of k-space is acquired by traversing from –𝑘𝑥 to 𝑘𝑥. After 
one line of k-space is sampled, a blipped phase encoding gradient (𝐺𝑦) is 
applied, so the next line of k-space in the 𝑘𝑦 direction is filled. The next 
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frequency echo gradient is then applied with opposite polarity to the first so 
that the next line of k-space is acquired in the  𝑘𝑥 direction by traversing from 
𝑘𝑥 to −𝑘𝑥. This technique is then repeated until all of k space is filled (Figure 
2.5-1). An EPI scheme can be acquired using either a gradient echo (GE-EPI) or 
a spin echo (SE-EPI) sequence. The echo time of the EPI acquisition is 
governed by the time from the excitation pulse to the centre of k-space.  
Figure 2.5-1: EPI pulse sequence and corresponding k-space diagram. The first line of 
k-space is acquired by traversing from –𝑘𝑥 to 𝑘𝑥, a blipped phase encoding gradient is 
then applied so the next line of k-space in the 𝑘𝑦 direction is filled and a frequency 
echo gradient then again applied. This is repeated until all of k-space is filled.    
2.5.2 Fast imaging in the steady state 
When RF pulses are applied repeatedly to a spin system, the magnetisation 
approaches a steady state. The number of pulses it takes to reach the steady 
state depends on the T1 and T2 of the tissue and the flip angle of the applied 
RF pulse. Steady state imaging can be divided into coherent and incoherent 
pulse sequences. In steady state incoherent pulse sequences, any residual 
transverse magnetisation is spoilt before the application of the next RF pulse. 
In steady state coherent sequences, the transverse magnetisation is not spoilt 
but contributes to the signal along with the longitudinal magnetisation. The 
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following section outlines the incoherent fast low angle shot (FLASH) 
sequence and coherent balanced fast field echo (bFFE) sequence. 
2.5.2.1 Fast Low Angle Shot (FLASH) 
In a fast low flip angle shot (FLASH) scheme, RF excitation pulses are applied 
with low flip angles of approximately 10o which are followed by gradient 
reversals to produce a gradient echo signal. The low flip angle creates an 
equilibrium of longitudinal magnetisation and spoiler gradients are applied to 
eliminate transverse magnetisation. A FLASH pulse sequence is shown in 
Figure 2.5-2. The magnetisation after the first RF pulse with flip angle 𝜃 is:   
 𝑀𝑧 =  𝑀0 cos 𝜃           𝑀𝑥𝑦 =  𝑀0𝑠𝑖𝑛𝜃    2-39 
Between the first and second RF pulse, the longitudinal magnetisation 
recovers towards 𝑀0 and the transverse magnetisation decays. This process 
repeats with every RF pulse until a steady state is reached. If TR >> T2 then the 
sequence is naturally spoilt since the system has enough time for the 
transverse magnetisation to decay. The magnetisation, 𝑀𝑆𝑆, of the longitudinal 
steady state signal is 
 
𝑀𝑆𝑆 =  
𝑀0(1 − 𝑒
−𝑇𝑅
𝑇1⁄ )
1 − 𝑒
−𝑇𝑅
𝑇1⁄ cos 𝜃
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and the transverse magnetisation decays as  
𝑀𝑥𝑦 = 𝑀𝑆𝑆sin (𝜃) 𝑒
−𝑡
𝑇2⁄    2-41 
The maximum signal will occur at the Ernst angle 𝜃𝐸 
𝜃𝐸 =  𝑐𝑜𝑠
−1 (𝑒
−𝑇𝑅
𝑇1⁄ )   2-42 
For TR << T1, this can be simplified to  
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𝜃𝐸 = √
2𝑇𝑅
𝑇1
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The FLASH sequence is T2 weighted at a short TR.  
 
Figure 2.5-2: FLASH pulse sequence. 
2.5.2.2 Balanced fast field echo (bFFE)  
 
An alternative gradient echo based readout technique is balanced fast field 
echo (bFFE), also known as true fast imaging with steady state precession 
(TrueFISP). The image contrast from a bFFE image is determined by 𝑇2/𝑇1. If 
the residual magnetisation is not eliminated and TR ≤ T2, the signal moves 
towards the steady state and is dependent on the initial magnetisation, the flip 
angle, 𝜃, TR, T1 and T2. The magnetisation also depends on the phase angle β 
through which the spins precess between each RF pulse. When the gradients 
are balanced, the transverse spin is preserved and all spins evolve under the 
same free precession conditions over each TR period without being affected 
by the phase and frequency encoding gradients.  
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For TR << T2, and T1 and β = π, the transverse magnetisation components are 
given as  
 𝑀𝑥 = 0   2-44 
 
𝑀𝑦  ≈  
𝑀0 𝑠𝑖𝑛𝜃
(
𝑇1
𝑇2
+ 1) − 𝑐𝑜𝑠𝜃 (
𝑇1
𝑇2
− 1)
 
  2-45 
 
and so the contrast is T2/T1 weighted. The optimal signal will occur at the flip 
angle 𝜃𝑜𝑝𝑡 where 
cos(𝜃𝑜𝑝𝑡) =
𝑇1
𝑇2
⁄ − 1
𝑇1
𝑇2
⁄ + 1
 
  2-46 
 
For short TR, the peak signal can be simplified to: 
𝑀𝑦 ≈
1
2
𝑀0 √
𝑇2
𝑇1
 
  2-47 
 
Figure 2.5-3: bFFE pulse sequence diagram.  
For a long TR, FLASH and bFFE sequences have similar properties for a given 
TE and flip angle. In a bFFE scheme, the echo is typically recorded at the 
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middle of the interval between two RF pulses and TE is half TR. In a bFFE 
scheme the number of TFE factors controls the number of phase encodings 
applied during each shot.  
2.5.3 Turbo spin echo  
The turbo spin echo (TSE) scheme is an extension of a basic spin echo 
sequence, using a series of 180o refocusing pulses after a single 90o to generate 
an echo train, as shown in Figure 2.5-4. Echoes in the centre of k-space 
providing information on image contrast and the edge of k-space determine 
the spatial resolution. The phase encoding gradient changes for each of the 
echoes resulting in multiple lines of k-space being acquired in one TR. The 
number of echoes in one TR is called the turbo factor or the echo train length 
(ETL), the effective echo time (TEeff) is the time from the 90o pulse to the centre 
of k-space (i.e. where the phase encoding gradients are zero). This 
significantly decreases scan time compared to a standard spin echo scheme.   
 
 
 
 
 
 
Figure 2.5-4: TSE pulse sequence diagram showing the echo train length (ETL). 
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2.5.4 Partial Fourier Imaging 
One technique to decrease the scan time needed to acquire an image is partial 
Fourier imaging, in which only select lines of k-space are sampled. The real 
and imaginary components of the Fourier transform are respectively 
symmetric and asymmetric about the centre of k-space, and so images can be 
reconstructed from under-sampled k-space. Theoretically, only half of k-space 
needs to be acquired to reconstruct a full image, however in practice a few 
extra lines in the un-sampled half of k-space are collected to create an image. 
To decrease the echo time, a partial Fourier technique can be employed in the 
frequency encoding direction and to reduce scan time, the technique is 
applied in the phase encoding direction. Partial Fourier imaging however 
reduces SNR and introduce image artefacts if large half scan factors are 
employed.  
 
Figure 2.5-5: Partial Fourier imaging. Two positions mirrored in k-space (shown in 
blue) have identical amplitude with opposite phases. If the data at x is the complex 
number a + bi then the data at y is its complex conjugate a – bi. 
2.5.5 Sensitivity Encoding (SENSE) 
Most MRI scanners use radiofrequency coils that have multiple receive 
channels. All data in this thesis was collected with an XL Torso body coil with 
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16 receive channels. SENSE (sensitivity encoding) (4) is a technique that uses 
these parallel receive channels to reduce scan time. Since the signal received is 
dependent upon its position relative to the receive coil, by knowing the 
sensitivity of each receive coil, information about the origin of the signal can 
be used to construct an image. SENSE involves creating an aliased image for 
each element in the receiver array using a Fourier transform. These images can 
then be used to reconstruct an image of the entire field of view. A reference 
scan must be performed to provide a sensitivity map of each of the receiver 
coils which can then be used to unfold the signal superposition. The SENSE 
factor refers to the factor by which the amount of k-space is under-sampled, 
with the maximum SENSE factor determined by the number of receiver coils. 
Applying a SENSE factor results in a decrease in scan time, but reduces signal-
to-noise ratio (SNR), so these factors need to be balanced to achieve an image 
with sufficient SNR within an acceptable scan time.   
2.5.6 Multi-transmit 
Multi-transmit divides the RF coil into separate independently powered and 
controlled elements that each have their own B1. The sum of each separate B1 
field constitutes the new B1 field experienced by the tissue being imaged. 
Using multi-transmit; it is possible to increase the homogeneity of the RF 
excitation, and minimise RF-energy deposition in tissues. This technique was 
used for all data collected in this thesis. 
2.6 Using MRI techniques to measure blood flow and perfusion  
 
The following sections provide an outline of the pulse sequences used to 
measure blood flow and tissue perfusion. 
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2.6.1 Phase Contrast (PC) MRI  
Magnetic resonance angiography (MRA) uses the motion sensitivity of MRI to 
measure blood flow in vessels. In this thesis, phase contrast (PC) MRI is used 
to assess blood flow to the kidney and heart.  
 
 
 
 
 
Figure 2.6-1: A) Pulse sequence for PC-MRI showing slice selection, Gz, phase 
encoding, Gy and frequency encoding, Gx. B) Effect of bipolar gradients on the phase of 
moving and stationary spins. 
PC-MRI takes advantage of the velocity-induced phase changes resulting from 
blood flow. Protons moving along the direction of a magnetic field gradient 
will experience a phase shift proportional to their velocity. To perform PC-
MRI sequence a bipolar gradient of two gradient pulses with the same 
magnitude but opposite direction is applied to sequentially de-phase and then 
re-phase spins. This gradient will result in a zero phase shift for stationary 
spins and non-zero phase shift for non-stationary spins. This is shown in 
Figure 2.6-1.  
The relationship between velocity and phase is adjusted by setting the velocity 
encoding value, known as the VENC. This is the maximum velocity that will be 
encoded correctly by the scanner. If the velocity of the blood exceeds the VENC 
value then aliasing can occur. 
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To calculate the velocity of blood flow from the induced phase shift, the 
following equations are used. The phase shift (𝜙) is given by the time integral 
of the Larmor frequency 
 𝜙 = ∫ 𝜔 𝑑𝑡 
 
  2-48 
In a magnetic field gradient 𝐺𝑥, this can be written as 
 𝜙 = 𝛾 ∫(𝐵0 + 𝐺𝑥𝑥) 𝑑𝑡 
 
  2-49 
For spins moving at a constant velocity 𝑣 in the 𝑥 direction, the phase shift is 
 𝜙 = 𝛾 ∫(𝐵0 + 𝐺𝑥(𝑥 + 𝑣𝑡)) 𝑑𝑡 
 
  2-50 
For a single gradient pulse of amplitude G and duration T, the phase shift will 
be 
 
𝜙 = 𝛾 ∫ 𝐺𝑣𝑡 𝑑𝑡 = [
1
2
𝛾𝑣𝐺𝑡2]
0
𝑇
=
1
2
𝛾𝑣𝐺𝑇2
𝑇
0
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The product 𝐺𝑇2 is known as the ‘first moment’ of the gradient, 𝑀1, so  
 𝜙 =
1
2
𝛾𝑣𝑀1 
 
  2-52 
If a second gradient of the same duration (T) but opposite amplitude (-G) is 
applied, this bipolar gradient will result in a total phase shift of 
 𝜙 = −𝛾𝑣𝑀1 
 
  2-53 
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If this acquisition is then repeated with the polarity of the bipolar pulse 
reversed and the phases subtracted, then the phase difference in the moments 
Δ𝑀1 of the two bipolar pulses is 
 Δ𝜙 = 𝛾𝑣Δ𝑀1 
 
  2-54  
The VENC is defined as the velocity that produces a phase shift Δ𝜙 of 𝜋 or 180o  
 𝜋 = 𝛾𝑣𝐸𝑁𝐶  Δ𝑀1 
 
  2-55 
Therefore, 
 𝑣𝐸𝑁𝐶 =
𝜋
𝛾Δ𝑀1
 
 
  2-56 
PC-MRI is sensitive to the direction of the flow of blood. Only blood moving 
in the same direction of a bipolar flow encoding gradient will result in a phase 
shift. For blood flowing in different directions, a bipolar gradient pair must be 
applied in each direction resulting in six acquisitions. In practise this can be 
reduced to four acquisitions by using no velocity sensitizing in one direction.  
Two-dimensional (2D) PC-MRI images flow through a single thick slice. Since 
the blood vessels will only occupy a small volume of the slice, an extra de-
phasing gradient is applied in the slice-selective direction to reduce the signal 
from stationary tissue. Secondly, instead of subtracting the phase angles, 
vector subtraction is used. For quantitative measurement of flow the slice 
plane must be perpendicular to the direction of flow. A flow velocity curve is 
then obtained as a function of time. PC-MRI is applied in Chapters 3 and 4. 
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2.6.2 Arterial Spin Labelling 
Arterial Spin Labelling (ASL) (5) is a non-invasive technique for the 
quantification of tissue perfusion. Perfusion provides an estimate of the 
volume of blood that passes through the capillary bed per unit time to deliver 
nutrients to the tissue, typically expressed in units of ml g-1 min-1.  ASL uses 
magnetically labelled water protons as an endogenous tracer. During an ASL 
scan, label and control images are acquired and then subtracted to form a 
perfusion weighted (PW) image.  
 
Figure 2.6-2: Control, label and perfusion (PW) difference image for a coronal oblique 
slice through the kidneys. 
 
The label image of the tissue is collected under the condition of the inflowing 
arterial blood being labelled, typically inverted by inverting the water 
molecules of the blood supplying the imaging region using an off-resonance 
single adiabatic radiofrequency pulse. The control image is collected for fully 
recovered inflowing blood. A PW image is then created showing labelled 
blood that has perfused into the tissue by subtracting the label image from the 
control image. A typical ASL signal curve is shown in Figure 2.6-3, in which 
the arrival time of the blood in the capillary bed, ∆𝑐, can be seen, after which 
the signal begins to increase from zero.  
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Figure 2.6-3: Example of an ASL signal curve for arrival time (∆𝒄) of 800ms, T1 of 
600 ms and perfusion of 60 ml/100g/min. The blue curve shows the ASL signal when 
the label has bolus duration of 1000ms whereas the green shows the signal following a 
label of infinite thickness and thus infinite bolus width.   
A post-label delay (PLD) is left between the labelling module and the imaging 
module to allow time for the labelled blood to travel from the labelling plane 
to imaging slice.  
2.6.3 Pre and post saturation pulses 
In order to ensure the signal in the imaging plane is in the same state at the 
beginning of each TR period, pre and post saturation pulses are used to null 
the signal in the imaging plane. Pre-saturation pulses are applied prior to the 
labelling and post-saturation follow the labelling pulse as shown in Figure 
2.6-4. 
Pre-saturation pulses typically use a WET (water suppression enhanced 
through 𝑇1 effects) scheme whilst post-saturation uses a single sinc pulse. 
These pre and post saturations ensure there is no offset between the label and 
control conditions which could cause an artificial ASL signal. However, the 
use of additional RF pulses leads to increased SAR.   
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Figure 2.6-4: ASL pulse sequence showing pre- and post-saturation pulses placed 
around the labelling pulse. This is followed by the readouts after a post label delay 
(PLD) time.  
2.6.4 Magnetisation Transfer  
Magnetisation transfer causes magnetisation of stationary tissue to be present 
in the imaging slice in ASL. Protons that are bound to macromolecules have a 
much larger frequency range than free water molecules, as illustrated in 
Figure 2.8-5. When an ASL labelling pulse is applied off-resonance to the 
imaging slice this can affect both water-bound protons and macromolecule-
bound protons from an exchange of magnetisation between the free protons 
and the bound protons via spin-spin interactions or water diffusion. To 
compensate for these effects, magnetisation transfer must be matched between 
the label and control conditions in ASL. 
 
 
 
 
 
 
Figure 2.6-5: The reduction in magnetisation in tissue due to magnetisation transfer 
for water and macromolecules.  
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2.6.5 Variants of ASL  
There are distinct ASL variants of continuous arterial spin labelling (CASL) 
(5), pulsed arterial spin labelling (PASL) (6–8) and pseudo-continuous ASL 
(pCASL) (11), an intermediate method between CASL and PASL. PASL, CASL 
and pCASL schemes are shown in Figure 2.6-6. 
 
 
Figure 2.6-6: ASL labelling schemes  
CASL is the original ASL method and uses a continuous flow-driven adiabatic 
inversion scheme to invert the inflowing blood as it flows through a plane 
below the imaging volume. This scheme uses a long low powered continuous 
radiofrequency pulse which is applied concurrent with a magnetic field 
gradient in the direction of flowing blood, causing moving arterial blood spins 
to experience a slow variation of the resonance frequency resulting in these 
spins being inverted. The inversion efficiency of CASL is dependent on the 
mean velocity of the blood, angulation of the vessels to the plane, the 
amplitude of the RF pulse and the strength of the gradient. CASL provides a 
high SNR ASL image, but high SAR and magnetisation transfer effects 
associated with CASL can limit its use.  
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In pulsed arterial spin labelling (PASL), a large spatial slab of arterial blood is 
labelled typically by a single spatially selective adiabatic inversion RF pulse. 
There are a number of variants of PASL; the most commonly used are echo 
planar imaging and signal targeting with alternative radiofrequency 
(EPISTAR) (9) and flow-sensitive alternating inversion recovery (FAIR) (10) 
(Figure 2.6-7). In the FAIR approach, the label condition is created using a 
global (or non-selective) inversion pulse to invert inflowing blood. The control 
state is achieved using a slice selective inversion centred on the imaging slice, 
so inflowing blood is unlabelled. The work described in this thesis uses the 
FAIR technique. In EPISTAR, a single 180o RF pulse is applied with a magnetic 
field gradient to invert a slab of inflowing blood below the image slice. A 
control image is then acquired, created using two 180o pulses which sum to 
give a nominal 360o pulse. For the label and control conditions, the RF power 
is matched to match magnetisation transfer effects. 
 
 
 
 
 
Figure 2.6-7: FAIR and EPISTAR PASL labelling schemes  
 
pCASL uses a train of discrete radio frequency pulses to mimic continuous 
tagging, typically 1500 pulses with a flip angle of 18o. The control image is 
acquired by alternating the sign of the pulses in the RF train to result in an 
average 𝑩𝟏 of zero whilst maintaining MT effects between label and control 
images.  
PASL 
 
 
CASL 
 
 
pCASL 
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2.6.6 Quantification of Pulsed ASL  
PASL data can be quantified using the modified Bloch equation (12). 𝑀𝑑𝑖𝑓𝑓(𝑡), 
the total magnetisation in a tissue voxel in the difference image can be 
calculated by solving the single compartment model; 
 𝑑𝑀𝑑𝑖𝑓𝑓(𝑡)
𝑑𝑡
= −
𝑀𝑑𝑖𝑓𝑓(𝑡)
𝑇1
+ 𝑓 (𝑀𝑏(𝑡) −
𝑀𝑑𝑖𝑓𝑓(𝑡)
𝜆
)    2-57  
 
where 𝜆 is the blood tissue partition coefficient which describes the freedom of 
exchange between the tissue and blood supply and 𝑀𝑏(𝑡) is the magnetisation 
of inflowing arterial blood. The amount of blood entering the imaging slice is 
given by 𝑓𝑀𝑏(𝑡) and the amount leaving the slice is 𝑓𝑀(𝑡)/𝜆. By assuming 
that no perfusing blood leaves the tissue voxel during the imaging time then 
𝑓𝑀(𝑡)/𝜆 = 0, the differential equation can be written 
 𝑑𝑀𝑑𝑖𝑓𝑓(𝑡)
𝑑𝑡
= −
𝑀𝑑𝑖𝑓𝑓(𝑡)
𝑇1𝑏
+ 𝑓𝑀𝑏(𝑡) 
 
   2-58 
This equation can then be solved using the integrating factor method to give  
 
𝑀𝑑𝑖𝑓𝑓(𝑡) =
1
𝑒
t
𝑇1𝑏⁄
∫ 𝑒
t
𝑇1𝑏⁄ 𝑓𝑀𝑏(𝑡)𝑑𝑡 
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At a time 𝑡 > 0 , 𝑀𝑏 = 2𝑀0𝑒
−t
𝑇1𝑏⁄   where 𝑀0 is the equilibrium magnetization 
of the arterial blood and so   
 
𝑀𝑑𝑖𝑓𝑓(𝑡) =
1
𝑒
t
𝑇1𝑏
⁄
∫ 2𝑓𝑀0𝑒
−
𝑡
𝑇1𝑏  𝑒
𝑡
𝑇1𝑏𝑑𝑡
𝑡
0
, 
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which when integrated between the limits gives,  
 
 
𝑀𝑑𝑖𝑓𝑓(𝑡) = 2𝑓𝑀0(𝑡)𝑒
−
𝑡
𝑇1𝑏 
 
  2-61 
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This describes the signal difference between the FAIR selective and non-
selective acquisitions ignoring the transit time for the labelled blood to arrive 
in the imaging plane. For a more complex analysis, the equation can be solved 
iteratively assuming a transit delay. 
2.6.7 Single time point ASL  
Initial ASL experiments were performed at a single post-label delay (PLD) 
time, and the perfusion signal fit from a single time point. This single TI 
approach is easy to implement, but can introduce an error in quantification as 
it does not take account of the arrival time of the blood to the imaging plane. 
Single TI measurements can be repeated multiple times at a range of PLDs to 
sample the ASL signal curve, and provide information on arrival time for the 
fit, however this leads to an increased total scan time. 
2.6.8 Look-Locker or Multiphase ASL  
Alternatively, a Look-Locker or multiphase ASL scheme can be used to collect 
multiple low flip angle readouts at different inversion times after a single 
labelling pulse (13–15) . Acquiring ASL with a Look-Locker readout provides 
temporal information on the ASL signal curve in a much shorter time than 
repeating the single TI approach. However, the use of multiple readout pulses 
perturbs the recovery of the magnetisation resulting in a lower signal and 
more complex modelling being required for quantification. The Look-Locker 
recovery curve can be described using the Bloch equation (15), with the 
magnetisation of the tissue signal (M(t)) at time t following a Look-Locker 
recovery being given by:  
 𝑑𝑀(𝑡)
𝑑𝑡
=
𝑀0−𝑀(𝑡)
𝑇1
+
𝑓
𝜆
[𝑆𝑟𝑖𝑒
−(𝑘+𝑡)/𝑇1𝑏𝑙𝑜𝑜𝑑 − 𝑀0 (1 − 𝑒
−
𝑘+𝑡
𝑇1𝑏𝑙𝑜𝑜𝑑)] −
𝑓
𝜆
𝑀(𝑡)  
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where Sri is the initial magnetisation of blood, k is the time from the 
label/control to the previous pulse over which the magnetisation is being 
evaluated; t is the time since the previous readout pulse, as shown in Figure 
2.6-8. 
Figure 2.6-8: Schematic of the ASL pulse sequence with the timing of k and t shown 
for the third readout.  
From this equation, a general solution to a Look-Locker recovery can be 
computed. Rearranging 2.61 gives 
   
𝑑𝑀(𝑡)
𝑑𝑡
+
𝑀(𝑡)
𝑇1𝑎𝑝𝑝
=
𝑀0
𝑇1
+
𝑓
𝜆
[𝑆𝑟𝑖𝑒
−(𝑘+𝑡)/𝑇1𝑏𝑙𝑜𝑜𝑑 − 𝑀0(1 − 𝑒
−(𝑘+𝑡)/𝑇1𝑏𝑙𝑜𝑜𝑑]
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where  
     
1
𝑇1𝑎𝑝𝑝
=
1
𝑇1
+
𝑓
𝜆
 .  
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Solving this differential equation using an integrating factor of  𝑒𝑡/𝑇1𝑎𝑝𝑝  gives:  
 
𝑀(𝑡) =
1
𝑒𝑡/𝑇1𝑎𝑝𝑝
∫ 𝑒𝑡/𝑇1𝑎𝑝𝑝 [
𝑀0
𝑇1
+
𝑓
𝜆
[𝑆𝑟𝑖𝑒
−(𝑘+𝑡)/𝑇1𝑏𝑙𝑜𝑜𝑑 − 𝑀0(1 − 𝑒
−(𝑘+𝑡)/𝑇1𝑏𝑙𝑜𝑜𝑑]] 𝑑𝑡 
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which can be rearranged to 
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𝑀(𝑡) =
1
𝑒𝑡/𝑇1𝑎𝑝𝑝
∫
𝑒𝑡/𝑇1𝑎𝑝𝑝𝑀0
𝑇1
+
𝑓
𝜆
[𝑆𝑟𝑖𝑒
𝑡(
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
)
𝑒−𝑘/𝑇1𝑏𝑙𝑜𝑜𝑑 +
𝑀0𝑒
𝑡/𝑇1𝑎𝑝𝑝 − 𝑀0𝑒
𝑡(
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
)
𝑒−𝑘/𝑇1𝑏𝑙𝑜𝑜𝑑] 𝑑𝑡  
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Solving this expression yields: 
  
𝑀(𝑡) =
1
𝑒𝑡/𝑇1𝑎𝑝𝑝
[
𝑒𝑡/𝑇1𝑎𝑝𝑝𝑀0𝑇1𝑎𝑝𝑝
𝑇1
+
𝑓
𝜆
𝑆𝑟𝑖
𝑒
𝑡(
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
)
𝑒−𝑘/𝑇1𝑏𝑙𝑜𝑜𝑑
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
+
𝑓
𝜆
𝑀0𝑒
𝑡
𝑇1𝑎𝑝𝑝𝑇1𝑎𝑝𝑝 −
𝑓
𝜆
𝑀0
𝑒
𝑡(
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
)
𝑒
−
𝑘
𝑇1𝑏𝑙𝑜𝑜𝑑
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
+ 𝐶]  
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where C is a constant of integration. Substituting in T1app (equation 2-64) gives: 
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If at time 𝑡 = 0𝑠 the initial tissue signal 𝑀(𝑡) = 𝑀𝑑  the constant, C, is 
 
𝐶 = −𝑀0 (1 −
𝑓
𝜆
𝑒
−
𝑘
𝑇1𝑏𝑙𝑜𝑜𝑑
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
) − 𝑆𝑟𝑖 (
𝑓
𝜆
𝑒
−
𝑘
𝑇1𝑏𝑙𝑜𝑜𝑑
1
𝑇1𝑎𝑝𝑝
−
1
𝑇1𝑏𝑙𝑜𝑜𝑑
) + 𝑀𝑑  
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This results in the final solution: 
 
 
                             𝑀(𝑡) = 𝑀0 (1 −
𝑓
𝜆
𝑒
−
𝑘
𝑇1𝑏𝑙𝑜𝑜𝑑𝑒
−
𝑡
𝑇1𝑏𝑙𝑜𝑜𝑑
1
𝑇1𝑎𝑝𝑝
−
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where 𝑆𝑟𝑖 = −𝑀0 for the non-selective signal and 𝑆𝑟𝑖 = +𝑀0  for the selective 
signal. 𝑀𝑑 = −𝑀0 when no pre-saturation pulses are used and 𝑀𝑑 = 0 with 
pre-saturation. Chapter 3 uses this iterative modelling for cardiac ASL data. 
2.7 Myocardial Tagging  
Myocardial tagging creates visible markers or tags on an image by applying 
slice selective RF pulses perpendicular to the imaging plane to saturate the 
longitudinal magnetisation. These tags can then be used to follow the 
movement of the myocardium to show the deformation of the tissue. Tagging 
is typically applied at end-diastole imaging with performed at end-systole. 
Figure 2.7-1 shows an example of a tagging image of the short axis of the 
heart. 
Figure 2.7-1: Short axis slice acquired from a cine scan and corresponding myocardial 
tagging of the short axis using SPAMM. 
There are a number of tagging techniques available the most common are 
spatial modulation of magnetisation (SPAMM) (16) and complementary 
spatial modulation of magnetisation (CSPAMM) (17). SPAMM is used in 
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Chapter 4 of this thesis. A schematic of the SPAMM pulse sequence is shown 
in Figure 2.7-2.  
 
 
 
 
 
 
 
 
Figure 2.7-2: Pulse sequence for a SPAMM tagging scheme. The first RF pulse 
moves the magnetisation into the transverse plane. This is followed by a gradient 
pulse to modulate the transverse magnetisation sinusoidally along the gradient 
direction. Subsequently, another RF pulse moves the magnetisation back to the 
longitudinal plane and a spoiler gradient is used to eliminate any residual transverse 
magnetisation.  
  
SPAMM involves applying two equal-strength, non-selective RF pulses 
separated by a wrapping gradient. The first RF pulse tilts the magnetisation 
into the transverse plane. This is followed by a gradient pulse along the 
desired tagging direction which modulates the transverse magnetisation 
sinusoidally along the gradient direction through incremental phase shifting 
of the spins in this direction. The second RF pulse is used to restore the 
modulated magnetisation back to its longitudinal position. After the second 
RF pulse a spoiler or crusher gradient is applied to eliminate any residual 
transverse magnetisation before image acquisition. For grid tagging, this 
process is repeated with the modulating gradient placed at 90o to the first tag. 
The grid pattern is then imaged to measure any deformation. 
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2.8 Discussion  
This chapter has introduced the basic NMR and MRI principles needed to 
understand the work in this thesis. The includes the basic principles of NMR 
and MRI, and the techniques of phase contrast MRI (PC-MRI), arterial spin 
labelling (ASL) and myocardial tagging. These latter techniques are then 
applied to the heart and kidney in experimental Chapters 3 – 5 of this thesis 
for assessment of blood flow, perfusion and myocardial strain.  
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3. Development of Cardiac Arterial Spin 
Labelling and application to patients with 
Chronic Kidney Disease (CKD) 
 
Cardiovascular disease is the leading cause of mortality for patients with 
Chronic Kidney Disease (CKD). Currently, there are limited methods to assess 
cardiac function using Magnetic Resonance Imaging (MRI), particularly in 
CKD patients where the use of MR contrast agents is contraindicated. 
This chapter aims to develop a cardiac Arterial Spin Labelling method for 
application in the human heart to non-invasively quantify myocardial 
perfusion.  
Firstly, previous studies using ASL to measure myocardial perfusion are 
discussed and the use of a modified Look-Locker inversion recover (MOLLI) 
scheme for T1 mapping is introduced. A method is then developed to assess 
myocardial perfusion using MOLLI-ASL and optimised first in a phantom 
study and then in healthy volunteers. This method is then applied in a study 
of cardiac function in CKD Stage 3 patients in comparison to age-matched 
healthy volunteers, with a hand grip challenge used to modulate cardiac 
stress. 
The work in this chapter has been presented as an oral presentation (p0538) and a 
poster (p2749) at the annual conference of the International Society of Magnetic 
Resonance in Medicine (ISMRM), Toronto, 2015.  
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3.1  Introduction  
 
ASL techniques are widely used in the brain (1–5). More recently these 
techniques have been adapted for use in the body, including the heart (6–19). 
However, there are unique challenges to cardiac ASL that are not present in 
cerebral ASL. Firstly, due to the motion of the heart during the cardiac cycle, 
the image readouts of the ASL scheme need to be synchronised to the same 
time point in the cardiac cycle, which is typically chosen to be end-diastole. As 
a consequence, the spacing between the ASL label and subsequent readouts is 
limited to an integer number of RR-intervals and so acquiring multiple 
inversion times can be limited. Secondly, respiratory motion can also influence 
cardiac imaging, and so data is often acquired during a breath hold, with 
synchronized breathing or retrospective motion correction performed. There 
have been a small number of studies to date that have used cardiac ASL for 
the measurement of myocardial perfusion. This has been done both in the 
human heart and in an animal model in the rat or mouse.  
In the work by Do et al (10), myocardial ASL was performed at 3 T in 7 healthy 
human subjects using FAIR labelling combined with a bFFE readout scheme 
to collect data from a single slice through the centre of the short axis of the left 
ventricle. SENSE was used in an attempt to reduce physiological noise by 
decreasing the scan acquisition time. This work found that the signal to noise 
ratio (SNR) was greatly improved with the use of SENSE and this was 
particularly beneficial in subjects with higher heart rates (and so shorter RR 
intervals) and for imaging the myocardium during systole. To remove 
respiratory motion, breath holds were used, with the data acquired in 7 breath 
holds, which resulted in between 2 – 3 minutes to acquire the cardiac ASL 
protocol.  
Zun et al (20) measured myocardial blood flow (MBF) in healthy volunteers at 
3 T using a cardiac gated FAIR labelling scheme with a bFFE readout scheme. 
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The labelling and readout pulses were positioned at the same point in the 
cardiac cycle (end-diastole) in successive RR intervals. To decrease the noise 
from respiratory motion, one pair of label and control images was acquired in 
a breath hold and six seconds were left between each image acquisition for 
near complete recovery of the longitudinal relaxation. This study assessed the 
sensitivity of myocardial ASL using a stress challenge of either passive leg 
elevation or a handgrip exercise. This work also assessed the effect of 
physiological noise and it was shown that for myocardial ASL, the 
physiological noise is 6.5 times higher than the thermal noise, suggesting the 
main contributing factor to the low signal-to-noise ratio (SNR) associated with 
cardiac ASL is due to motion from the subject’s respiratory or cardiac cycle. 
The study concluded that MBF measurements using ASL was feasible and 
sensitive to changes such as a challenge. However, it was determined that the 
SNR was only high enough for region of interest (ROI) rather than voxel-wise 
analysis. 
The study by Wacker et al (15) assessed the use of ASL for use in patients with 
coronary artery disease (CAD) in which there was hypothesised to be 
variations in myocardial perfusion between the anterior and posterior 
myocardium. 12 healthy volunteers and 16 patients were scanned using a 2 T 
scanner and perfusion was measured using a comparison of T1 selective and 
non-selective values. T1 measurements were implemented using a fast ECG-
gated saturation recovery FLASH sequence with 9 inversion times between 
100 ms and 1400 ms. This study determined that as a non-invasive and 
repeatable measure, ASL could become a useful tool for the assessment of 
myocardial perfusion which was capable of assessing differences between 
areas of hyper- and hypo-perfusion.  
Wang et al (16) used ASL for the estimation of myocardial perfusion and tissue 
transit time whilst free breathing using a navigator-echo. In this work, a single 
TI technique was repeated multiple times between 200 and 1700 ms.  11 
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healthy volunteers were scanned using a 1.5 Tesla scanner. FAIR labelling was 
used and a navigator echo was acquired immediately prior to the bFFE 
readout. To assess the sensitivity and reproducibility of the technique, the 
scan at a single time point (900 ms) was repeated during a stress challenge by 
asking the subject to squeeze a foam stress ball during the scan. This work also 
assessed the use of non-rigid motion correction to correct for any residual 
motion following the free breathing technique. Data was fit to a kinetic model 
to estimate both perfusion and arterial transit time. This work determined that 
free-breathing myocardial perfusion imaging with ASL was feasible with use 
of a navigator echo and with retrospective non-rigid motion correction.  
A study by Northrup et al (13) compared 1.5 T and 3 T MR measures for 
myocardial ASL. Eight healthy volunteers were scanned at both field 
strengths.  This study found that 3T is optimal for cardiac ASL, as less 
variability was seen at 3T and the SNR was higher. The main limitation here 
was the sensitivity of the scanning to motion as ECG triggering and breath-
holding is not entirely effective at the elimination of motion.  The repeatability 
at 3T was found to be 43 % higher than that at 1.5 T although no statistically 
significant differences were seen. 
The work by Zun et al (21) sought to determine whether ASL was capable of 
detecting clinically relevant increases in myocardial blood flow with 
vasodilator stress induced by use of an adenosine infusion. Sixteen patients 
who were suspected of having ischemic heart disease were scanned using a 3 
T scanner with a double-gated FAIR labelling scheme and a bFFE readout. 
ASL results were compared to measurements taken with first pass perfusion 
techniques using a gadolinium based contrast agent. This work showed that 
ASL was capable of detecting perfusion changes following an adenosine 
infusion and as such this could be used to identify myocardial ischemia.  
It is clear from the previous studies using myocardial ASL that an important 
consideration is how to eliminate noise from the data. The previous work 
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indicates that it is feasible to measure myocardial perfusion using cardiac 
ASL; however there are a few limitations that need to be considered. In the 
current myocardial ASL studies in humans, there has been work in which 
single time point ASL has been implemented (10,21,22) (Figure 3.1-1)  and 
studies in which a single time point technique has been repeated across 
multiple inversion times to build up a full ASL signal curve (13,16). Single 
time point measures are more susceptible to error when quantifying 
myocardial perfusion, but a repeated single TI approach can be very time 
consuming. An alternative to this is to use a Look-Locker scheme in which 
multiple images at different label delays are acquired after a single inversion 
using low flip angle excitations. Use of a Look-Locker scheme would decrease 
the scan time and if a breath hold technique was being used, would 
necessitate fewer breath holds.  
 
 
 
 
Figure 3.1-1: Single time point cardiac triggered ASL. The label and control pulses 
are triggered off the cardiac cycle and then collected after an inversion time (TI). 
Look-Locker schemes have been implemented for cardiac ASL in animal 
studies. A cardiac triggered Look-Locker technique is highly effective in the 
rat heart as the RR interval in a rat is approximately 250 ms, there is thus 
sufficient time to acquire multiple cardiac triggered time points before the 
ASL signal has recovered. Campbell Washburn et al (7) employed an ECG-
gated Look-Locker sequence with segmented k-space acquisition with 4 phase 
encoding lines acquired for each heartbeat. This was implemented to acquire 
single slice ASL data sets in the mouse heart. A data logger was used to allow 
automatic rejection of respiration-corrupted images; it also provided 
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additional prospective gating to improve consistency of acquisition timing 
and allow uncorrupted lines of k-space from consecutive data sets to be 
recombined to reduce corruption due to respiration. This study assessed 
variability and reproducibility of perfusion estimation between-animals, 
between-session, within-session and between image rejection criteria, by 
estimating the coefficient of variability (CoV). The results of this work found 
that the between-animals coefficient of variability was the largest at 24 %, 
whereas the between-session variability was 17 %, whilst the within-session 
variability was only 11 %. The magnitude of change in perfusion needed to 
detect differences was 30% within-session and 55% between-session.  
 
 
 
 
 
Figure 3.1-2: A cardiac gated Look-Locker experiment. The label or control pulse is 
triggered off the cardiac trigger, subsequent Look-Locker readouts are then all 
triggered from the cardiac cycle to minimise cardiac motion. 
In the work by Kampf et al (12), the influence of heart anatomy, 
cardiopulmonary blood flow and the Look-Locker readout were assessed in 
the mouse heart. This paper showed that unintentional partial inversion of the 
inflowing blood occurs during the slice selective inversion, and they assessed 
this effect, as well as that of the Look-Locker pulse train, on perfusion 
quantification. This paper concluded that careful consideration of the Look-
Locker readout and the non-ideal slice selective inversion is needed as not 
accounting for the Look-Locker pulses can lead to overestimation of the 
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perfusion whereas not correcting for the partial inversion of the inflowing 
blood can cause an underestimation of perfusion.  
In humans, the RR interval is much longer than in animals (≈ 1000 ms in 
humans compared to ≈ 250 ms in the rat), and so a cardiac triggered Look-
Locker readout alone will not achieve enough data points for accurate 
quantification in the time that there is sufficient signal. This is also relevant for 
T1 mapping of the myocardium. To overcome this problem, Messroghli et al 
(23) developed a modified Look-Locker inversion recovery (MOLLI) scheme. 
In this chapter the MOLLI scheme is outlined for T1 mapping and then 
adapted for use for ASL. This developed ASL scheme can then be used for 
assessment of perfusion in a CKD patient group.  
3.2 MOLLI T1 Mapping 
 
Modified Look-Locker inversion recovery (MOLLI) (23–26) is typically used in 
conjunction with a contrast agent for T1 mapping.  A MOLLI scheme works by 
repeating a cardiac triggered Look-Locker experiment with different inversion 
times. In a standard MOLLI scheme for T1 mapping, three successive Look-
Locker experiments are performed with three, three and five single shot 
cardiac triggered Look-Locker readouts. Each of the readouts is acquired 
using a low flip angle excitation pulse, generally of 35o. There is a recovery 
time of a minimum of four seconds between each Look-Locker experiment to 
ensure full recovery of the longitudinal relaxation before the next set of Look-
Locker data is acquired. A trigger delay (TD) is introduced between the 
cardiac trigger and the inversion pulse which is changed for each Look-Locker 
set. By changing the trigger delay, the time between the inversion and first 
readout is then different for each of the Look-Locker sets. Due to this trigger 
delay, the scans performed will all have different TIs which will be 
determined by the initial TI plus the length of the cardiac cycle that has 
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occurred since the acquisition of the first image. The images are then 
reordered according to their effective TI as if they had been acquired in one 
Look-Locker experiment (Figure 3.2-1) each LL set would be fit separately to 
calculate T1. Each LL set would be fit iteratively to an inversion recovery with 
𝑀𝑧 = 𝑀𝑖 sin 𝛼 for the longitudinal magnetisation and 𝑀𝑥𝑦 = 𝑀𝑖 cos 𝛼 for the 
transverse magnetisation for the first time point and subsequent time points 
are fit from the magnetisation from the previous time point such that  
 
𝑀𝑖 = 𝑀0 + 𝑀𝑖 = 𝑀0  (1 − 𝑒
−
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1 ) + 𝑀𝑧(𝑖 − 1)𝑒
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1                                 
 
 
 
 
 
 
 
 
 
 
Figure 3.2-1: A) A Standard MOLLI T1 mapping scheme with three separate Look 
Locker experiments (LL-1, LL-2, LL-3) with 3, 3 and 5 readouts respectively. B) the 
resulting recovery curve from these three Look-Locker experiments simulated with T1 
of 1600 ms, RR interval of 1000 ms and trigger delays of 400 ms 100 ms and 0 ms. 
The colour bars on each of the readouts in A correspond to the points on the graph 
with the same colours.  
A 
B 
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3.3 MOLLI-ASL 
MOLLI T1 mapping can be used as a method to develop a modified Look-
Locker ASL scheme (MOLLI-ASL) for the assessment of myocardial perfusion. 
In this work, a MOLLI-ASL scheme was developed using a similar method to 
MOLLI T1 mapping, but using selective or non-selective inversion labelling 
pulses in place of the non-selective inversion, and placing pre- and post- 
saturation pulses around the selective and non-selective labelling pulses. In 
the MOLLI-ASL scheme, FAIR selective/non-selective inversions are triggered 
from the cardiac trigger and followed by multiple cardiac triggered readouts. 
In order to minimise motion between scans, all readouts are triggered at the 
same point in the cardiac cycle which was chosen to be at end diastole (Figure 
3.3-1). A trigger delay (TD) is introduced which changes the time between the 
cardiac trigger and the label pulse and so changes the readout times (TIs) of 
the LL readout pulses. An increase in the trigger delay will decrease the 
inversion time (TI) as the time between the cardiac trigger and the inversion is 
increased so the time between the inversion and first readout decreases 
(assuming the RR-interval stays constant).  In each separate Look-Locker 
experiment, a number of images are collected at end-diastole of consecutive 
heart beats to sample the recovery of longitudinal magnetization after the 
inversion pulse. At the end of each experiment an end delay of 3 seconds was 
applied to ensure full recovery of the longitudinal magnetisation between 
selective and non-selective pairs.  
As for T1 mapping, the scans all have different TIs or post-label delays which 
will be determined by the initial TI plus the length of the cardiac cycles that 
have occurred since the acquisition of the first image. The images can then be 
reordered according to their effective TI as if they had been acquired in one 
Look-Locker experiment, leading to a MOLLI recovery curve. However, data 
would be fit as separate LL experiments. 
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Figure 3.3-1:  MOLLI ASL schematic for two different LL-ASL experiments with 
different trigger delays (TD1 and TD2) and three Look Locker readouts for each 
experiment. The sequence starts with a cardiac triggered selective or non-selective 
inversion which occurs after a trigger delay following the cardiac trigger. This is 
followed by three readouts which are all cardiac triggered to be at the same point in the 
cardiac cycle.  
3.3.1 Pulse programming 
A MOLLI ASL scheme was coded on a Philips Achieva 3T scanner using the 
pulse programming environment (PPE). This was performed by enabling 
cardiac trigging for the FAIR arterial spin labelling module and the 
subsequent bFFE image readouts. A ‘Trigger-delay’ (TD) was added prior to 
the label module to allow data to be collected at a range of post-label delay 
(PLD) times. An ‘End-delay’ period was added following the LL readout 
pulses to ensure full recovery of longitudinal magnetisation between each 
selective (S) and non-selective (NS) inversion (Figure 3.3-1). Optional pre- 
(WET scheme) and post-saturation pulses were placed around the S/NS 
inversion pulse to minimize inversion efficiency differences in the imaging 
plane between the slice-selective and non-selective conditions.  
 
3.3.2 Techniques to model cardiac ASL data 
There are two different methods that have generally been proposed in the 
literature to model the ASL signal; the Belle model (27) and an approach using 
iterative Bloch equations (8). These two techniques are described here.  
 3.3  MOLLI-ASL 81 
 
 
3.3.3 Belle Model  
Previously, Belle et al (27) developed a model for the quantification of 
myocardial perfusion using a FAIR ASL scheme. This model considers two 
compartments; one compartment of intravascular capillary blood and the 
second of extravascular tissue.  The contribution of magnetisation inside the 
venous and arterial system is assumed to be negligible which is a valid 
assumption as the arterial and venous volume are less than 3 % of the 
myocardium. In this model, myocardial perfusion is calculated from the 
difference between the longitudinal relaxation (𝑇1) computed following the 
selective and non-selective inversions. After the selective pulse, it is assumed 
that all blood flowing into the imaging slice is fully relaxed and this results in 
a shorter 𝑇1 than for the non-selective case which has been influenced by 
blood following a non-selective inversion recovery. 
The longitudinal relaxation for the selective inversion (𝑇1𝑆𝐸𝐿) is described by  
 1
𝑇1𝑆𝐸𝐿
=  
1
𝑇1
+
𝑃
𝜆
 
  3-1 
where 𝑇1 is the 𝑇1 of the tissue, 𝑃 is the tissue perfusion and 𝜆 is the blood-
tissue partition coefficient of water (0.92 in the heart). The T1 for the non-
selective condition  (𝑇1𝑁𝑆) is given by 
 1
𝑇1𝑁𝑆
=  
1
𝑇1
⁄ + 𝑃 𝜆⁄
1 +
𝑃𝑇1𝑏
𝜆⁄
 
  3-2 
where 𝑇1𝑏 is the 𝑇1 of blood. These equations can be combined to give an 
expression for myocardial perfusion (P): 
 
𝑃 =  
𝜆
𝑇1𝑏
(
𝑇1𝑁𝑆
𝑇1𝑆𝐸𝐿
− 1) 
  3-3 
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The assumption that selective blood is always fully relaxed is not strictly 
correct as when a slice selective inversion is applied, a volume of blood in the 
right ventricle, left ventricle, capillary bed of the lung and vessels will also be 
inverted (Figure 3.3-2). This blood is then recirculated through the left 
ventricle and then perfuses the myocardial tissue and so may still be labelled 
as it reaches the tissue. Also, as the ejection fraction of the left ventricle is < 100 
%, some of the blood delivered to the myocardium will still be inverted for 
many heartbeats following inversion.  However if the slice selective inversion 
is narrow, as used in this thesis, this volume of blood will be small. This issue 
is particularly problematic in multi-slice ASL where a larger volume is 
labelled in the slice selective condition.  
 
Figure 3.3-2: Schematic showing the placement of single and multiple slices (red) 
across the heart. In the multi-slice case, the right ventricle and lungs are also labelled 
by the slice selective inversion (blue). 
3.3.3.1 Iterative Bloch equations  
Campbell-Washburn et al (8), proposed an alternative to the Belle model for 
use with multi-slice FAIR ASL in the mouse model, where this is a greater 
issue due to the large volume of blood that is inverted following slice selective 
inversion in the multi-slice case. Thus in this case it is likely that a simple Belle 
model is not sufficient for precise quantification of perfusion and also due to 
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the short RR wave of the rat. The model that was derived in this work is 
known as the blood pool MBF (bpMBF) quantification model. This bpMBF 
model involves using the measurement of the blood magnetisation from the 
blood pool as the input signal and fitting the signal iteratively to a modified 
Bloch equation (3) which describes the longitudinal magnetisation and the 
effect of perfusion. This model assumes that there is sufficiently fast exchange 
of spins between the intravascular and extravascular compartments. This has 
been demonstrated to be a valid assumption in both animals (28) and humans 
(29). The modified Bloch equation is given by  
 𝑑𝑀𝑡𝑖𝑠𝑠𝑢𝑒(𝑡)
𝑑𝑡
=
𝑀0,𝑡𝑖𝑠𝑠𝑢𝑒(𝑡)
𝑇1,𝑡𝑖𝑠𝑠𝑢𝑒
−  (
1
𝑇1,𝑡𝑖𝑠𝑠𝑢𝑒
+
𝑀𝐵𝐹
𝜆
) 𝑀𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) 
+𝑀𝐵𝐹. 𝑀𝑏𝑙𝑜𝑜𝑑(𝑡)  
 
  
 
3-4 
which can be simplified to  
 
𝑀𝑡𝑖𝑠𝑠𝑢𝑒(𝑡) =  𝑀0,𝑡𝑖𝑠𝑠𝑢𝑒
𝑇1,𝑎𝑝𝑝
𝑇1,𝑡𝑖𝑠𝑠𝑢𝑒
(1 − 𝑒
−𝑡
𝑇1,𝑎𝑝𝑝⁄ ) + 𝑀𝑡𝑖𝑠𝑠𝑢𝑒(0)𝑒
−𝑡
𝑇1,𝑎𝑝𝑝⁄
+ 𝑀𝐵𝐹 ∫ 𝑀𝑏𝑙𝑜𝑜𝑑(𝜏)
𝑡
0
𝑒
𝜏−𝑡
𝑇1,𝑎𝑝𝑝⁄ 𝑑𝜏 
  
 
3-5 
  
Where  
1
𝑇1,𝑎𝑝𝑝
=
1
𝑇1,𝑡𝑖𝑠𝑠𝑢𝑒
+
𝑀𝐵𝐹
𝜆
 
A thorough derivation of this model is given in Chapter 2. 
This work also showed that in the mouse heart it takes approximately 3 
seconds for the blood pool magnetisation to return to equilibrium following 
slice selective inversion, highlighting the need for an end-delay to ensure all 
data has returned to equilibrium before acquiring the next LL data set.  
3.3.4 Simulations  
To assess the sensitivity of the LL-ASL technique, and to understand the 
source of potential errors in perfusion quantification, Monte Carlo simulations 
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were performed in MATLAB (Matlab version 8.1, The MathWorks, Inc., 
Natick, MA, USA). The Monte Carlo simulation was performed by adding 
random Gaussian noise to simulated ‘perfect’ data to achieve simulated data 
with asymptotic SNR up to an SNR of 70:1.  
Simulations were first performed to determine how the signal-to-noise ratio 
(SNR) and flip angle of Look-Locker readout pulses affects the measured 
signal, the quantified T1 measurements and calculated perfusion values for a 
standard Look-Locker readout as shown in Figure 3.3-3. 
 
 
 
 
 
 
 
 
Figure 3.3-3: A Look-Locker recovery curve simulated for a T1 of tissue of 1600ms, 
flip angle of 45o and readout spacing of 400ms.  
The optimal flip angle for different Look-Locker readout spacings (defined by 
the RR-wave) was then assessed. From the literature (7,8), the optimal flip 
angle for a Look-Locker scheme to study the  mouse heart, where the RR-
wave interval and hence readout spacing is small at approximately 100 ms, 
has been shown to be approximately 20o. In humans, the RR-wave and hence 
readout spacing is approximately 1000 ms, suggesting a larger readout flip 
angle is required.   
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Data was simulated for a Look-Locker readout of 1000 ms (as typically found 
in the human heart), T1 non-selective (T1NS) of 1300 ms, T1 slice-selective (T1SEL) 
of 1250 ms and T1 of blood (T1blood) of 1870 ms which gave a MBF of 1 ml/g/min 
using the Belle model. 1000 repeats were performed for each Monte Carlo 
simulation.  
i) Choice of flip angle for LL-scheme 
Firstly, the effect of choice of flip angle on the accuracy and error in the fitted 
value of T1SEL, T1NS and calculated value of perfusion was investigated, 
performing a Monte Carlo simulation, simulating data using the Belle model, 
with 1000 repeats. This was first assessed for an RR interval of 100 ms similar 
to that of a mouse and thus a LL spacing of 100 ms.  
 
Figure 3.3-4: Graph to show A) the percentage error and B) the standard deviation in 
T1SEL (blue), T1NS (green) and perfusion (red) values for increasing flip angle for a Look-
Locker ASL scheme with LL readout spacing of 100 ms.  
Figure 3.3-4 shows that the optimal flip angle for the mouse heart would be 
20o which is the same as was found in the literature (7) thus providing 
confidence that the technique used is correct. 
A B 
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This was repeated for a LL readout spacing of 1000 ms (similar to the RR-
interval for a human heart). From Figure 3.3-5 it can be seen that for a spacing 
of 1000 ms, the optimal flip angle is ~ 70o when ignoring any SAR constraints.  
 
Figure 3.3-5: A) Percentage error (%) and B) Standard deviation (%) in T1SEL (blue), 
T1NS (green) and perfusion (red) values for increasing flip angle for a Look-Locker ASL 
scheme with LL readout spacing of 1000 ms. 
Although the optimal flip angle for a LL acquisition with readout spacing of 
1000 ms is around 70o, in practice the flip angle is restricted to 35o  due to SAR 
constraints.     
ii) Effect of SNR for LL scheme   
Secondly, the effect of the SNR on the error and standard deviation of fitted 
T1SEL, T1NS and resulting myocardial perfusion values was assessed. This was 
again performed by Monte Carlo simulation, simulating data using the Belle  
equation, with 1000 repeats, assuming a LL readout spacing of 1000 ms with 
11 readouts, a flip angle of 35o. The SNR was varied from 10:1 to 100:1 in steps 
of 10. 
A B 
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Figure 3.3-6 shows that, as expected, increasing the SNR decreases the 
standard deviation  and the percentage error in all fitted variables, and for a 
SNR 50:1 the error becomes approximately constant.  
 
Figure 3.3-6: A) Percentage error (%) and B) Standard deviation (%) in T1SEL (blue), 
T1NS (green) and perfusion (red) values for increasing SNR. T1 selective and non-
selective give a similar result and so are overlapping. 
iii) MOLLI-ASL simulations  
Having simulated a standard Look-Locker ASL scheme, simulations were 
performed for a MOLLI-ASL scheme to assess the effect of changing (a) the 
number of readouts following each selective and non-selective inversion and 
(b) increasing the number of Look-Locker sets that were performed, thus 
increasing the number of trigger delays and increasing the maximum trigger 
delay. All simulations were performed with a Look-Locker spacing of 1000 ms 
and a flip angle of 35o, as this was the maximum flip angle achievable when 
scanning patients due to SAR constraints. 1000 iterations of the simulation 
were performed. Perfusion measures were calculated from the selective and 
non-selective T1 values using the Belle model. The number of readouts for 
each Look-Locker experiment was assessed from between 3 and 5, and the 
number of separate Look-Locker sets was varied from 1 to 11 each having 
trigger delays increasing by 50 ms (8 LL sets would give a maximum trigger 
A B 
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delay of 350 ms whereas 11 LL sets would have a maximum trigger delay of 
550 ms).  
 
Figure 3.3-7: A) Percentage error and B) Standard deviation in fitted T1 values with 
increasing maximum trigger delay times (corresponding to 1 – 11 different Look-
Locker sets) for 3 (red), 4 (green) and 5 (blue) Look-Locker readouts.  
Figure 3.3-7 shows the standard deviation and percentage error in T1 for 
increasing number of readouts and increasing number of Look-Locker sets 
with increasing maximum trigger delay. The same result was seen for both 
T1SEL and T1NS and so only one result for T1 is shown here. It can be seen from 
this graph that the standard deviation decreases as the number of readouts 
increases and as the number of LL experiments increases. These results are as 
expected, as more data points are used for the fit as the number of readouts 
increases. The error in the fit is small (< 1%) which shows that the fit is 
accurate and errors come from the standard deviation and thus the error  will 
come from lower precision rather than low accuracy.  
 
 
 
 
A B 
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Figure 3.3-8: Standard deviation in fitted myocardial perfusion values with 
increasing maximum trigger delay times (corresponding to 1 – 11 different Look-
Locker sets) for 3 (red), 4 (green) and 5 (blue) Look-Locker readouts. 
 
 shows results for the standard deviation in perfusion. Similar to the T1 results, 
as the number of LL sets and the number of readouts increases, the standard 
deviation in the calculated perfusion value decreases. It should be noted that 
for only 3 readouts with a maximum pre-label delay of 350 ms the standard 
deviations is less than 1.5 % for T1 and  4 % for perfusion and so accurate 
results can be measured whilst using only 3 readouts for each trigger delay. 
Again, similar to T1 the error in the fit is small (< 1%). The small errors in T1 fits 
should also be noted as when the Belle model is used for fitting the ASL data, 
accurate T1 values are required. Using less Look-Locker sets and less readouts 
following each selective or non-selective pulse also decreases the total scan 
time and so makes the sequence more tolerable for patients. If it was decided 
that a breath hold was needed then a shorter scan time would be desirable to 
acquire data within a tolerable breath hold time. All simulations here assume 
only thermal noise and so the error would increase if any physiological noise 
was present. 
 
B 
A 
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3.3.5 T1 validation  
To assess whether the pulse programming had successfully provided an 
accurate MOLLI scheme on the Philips system, T1 data was collected on an 
agar four quadrant phantom using a simulated RR-interval of 1000 ms. The 
MOLLI-ASL scheme was performed using a bFFE readout scheme without 
any pre- and post- saturation pulses. For this quantification, data was 
acquired using a non-selective label with an inversion slab of 300 mm. This 
then leads to a standard T1 inversion recovery technique repeated multiple 
times with a MOLLI readout. The MOLLI scheme was validated using a 
phantom with 3 readouts per Look-Locker experiment and 9 trigger delay 
times starting at 0 ms and increasing to 400 ms in increments of 50 ms. Data 
was also collected for a standard inversion recovery scheme (TI values of 0 - 
5000 ms with 14 steps) for comparison.  Data was acquired in the short axis 
which was defined using bTFE localiser scans. All imaging was performed 
using a bFFE readout with FOV 288 x 288 mm2, spatial resolution 3 x 3 mm2, 
slice thickness 5 mm, SENSE 2, TE/TR 1.5/3.1 ms, FA 35o, centric half Fourier 
acquisition with 12 start-up echoes.  
 
 
 
 
Figure 3.3-9: A) Inversion recovery phantom data acquired at 17 TIs between 0 and 
5000 ms and B) MOLLI data acquired at 9 trigger delay times starting at 0 ms and 
increasing to 400 ms in increments of 50 ms. The maximum number of readouts was 
acquired at each TD dependent on SAR restrictions.  
A B 
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Figure 3.3-10: Recovery curves for A) MOLLI T1 data and B) inversion recovery 
data for the upper right quadrant. The fit is shown by the solid line.  
Using a least squares fitting algorithm in MATLAB (Matlab version 8.1, The 
MathWorks, Inc., Natick, MA, USA), T1 and M0 values were fit for all 
quadrants. The MOLLI data was fitted iteratively to an inversion recovery 
with 𝑀𝑧 = 𝑀𝑖 sin 𝛼 for the longitudinal magnetisation and 𝑀𝑥𝑦 = 𝑀𝑖 cos 𝛼 for 
the transverse magnetisation for the first time point and subsequent time 
points were fitted from the magnetisation from the previous time point such 
that  
 
𝑀𝑖 = 𝑀0 + 𝑀𝑖 = 𝑀0  (1 − 𝑒
−
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1 ) + 𝑀𝑧(𝑖 − 1)𝑒
𝑇𝐼(𝑖)−𝑇𝐼(𝑖−1)
𝑇1                                 
The inversion recovery data was fit to the equation  
    𝑀𝑧(𝑡) = 𝑀0(1 − 2𝑒
−𝑇𝐼/𝑇1)                                                                                        
When fitting the data to these models, the MOLLI data gave similar results to 
the inversion recovery scan with approximately 10 % difference between the 
measures from the two techniques for T1.  
Recovery curves for MOLLI T1 data and inversion recovery data is shown in  
 
A B 
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Figure 3.3-10. T1 values were fitted to all quadrants. The fitted T1 values from 
this data for the two quadrants (shown as 1 and 2 in Figure 3.3-9 A)  are 
shown in Table 3.3-1.  
 
Table 3.3-1: Calculated T1 values from the MOLLI acquisition and inversion 
recovery curves. 
Good agreement is shown in the T1 values between the two schemes. The 
other two quadrants had a similar T1 to quadrant 1 and so were omitted from 
the results. 
3.4 Testing MOLLI-ASL on healthy volunteers  
Having validated T1 measures in a phantom, this section now assesses the 
application of MOLLI-ASL to the human heart.  In this work, a total of 6 
subjects were scanned (21-24 years) on a 3T Phillips Achieva scanner with a 
16-channel XL Torso coil with multi-transmit. A FAIR labelling scheme was 
used with selective thickness of 35 mm and non-selective thickness of 350 mm. 
Imaging was performed using a bFFE readout with FOV 288 x 288 mm2, 
spatial resolution 3 x 3 mm2, slice thickness 5 mm, SENSE 2, TE/TR 1.5/3.1 ms, 
FA 35o, centric half Fourier acquisition with 12 start-up echoes. bTFE localiser 
scans were used to define the short axis of the left ventricle and all ASL 
images were acquired in this plane. In order to know the correct timings of 
each readout in the LL set, the MR scanner physiological logs were saved from 
the scanner and timings were calculated using a MATLAB script (Matlab 
version 8.1, The MathWorks, Inc., Natick, MA, USA). This script identified the 
 MOLLI scheme Inversion Recovery scheme 
Quadrant 1 
T1 (s) 1.3265 1.2845 
Quadrant 2 
T1 (s) 0.313 0.26 
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timing of selective and non-selective inversion pulses and subsequent 
readouts, allowing the spacing between each of these to then be calculated.  In 
this work 9 LL sets were acquired with trigger delays of 0 ms to 400 ms in 
steps of 50 ms. Up to 5 readouts were acquired in each LL set dependent on 
SAR restrictions. 
3.4.1 Motion correction 
To minimise movement due to the respiratory cycle, breath holds are used in a 
number of studies using cardiac imaging. However, in a patient population, 
breath holds are not always tolerable, require patients to hold their breath at 
the same point in the respiratory cycle, and may not be practical if subjects are 
also performing a task. An alternative to a breath hold technique would be to 
retrospectively discard images where there is motion. This would be beneficial 
as it would remove the necessity for a breath hold which some patients would 
struggle to tolerate.  
 
3.4.2 Need for an in-plane saturation scheme 
For assessment of ASL measures, the MOLLI-ASL data was acquired both 
with and without in plane saturation to determine the necessity of an in-plane 
saturation scheme to the quality of the ASL data. An in-plane saturation 
scheme ensures that the signal in the imaging plane is in the same state at the 
beginning of each TR period, by nulling the signal in the imaging plane. Pre–
saturation pulses using the WET scheme (30) were applied prior to the 
labelling pulse and post-saturation pulses were applied following the labelling 
pulse. These pre and post saturations ensure there is no offset between the 
inversion efficiency of label and control conditions (selective and non-selective 
inversion) which could cause an artificial ASL signal. However, the use of 
additional in-plane saturation RF pulses leads to increased SAR, and so limits 
the number of readouts that can be acquired. Figure 3.4-1 shows MOLLI 
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selective and non-selective signal curves for both the myocardium and left 
ventricular blood with and without in-plane saturation.  
 
 
 
 
 
 
Figure 3.4-1: MOLLI signal for the myocardium and left ventricular blood pool A) 
without and B) with in-plane saturation. The blood signal is shown in red and tissue 
signal in blue for the selective (SEL) and non-selective (NS) case. 
The data follows the trends that are expected for blood and tissue data, with 
the blood signal (red) being fully recovered for the selective case and 
following an inversion recovery for the non-selective case. The tissue signal 
(blue) can be seen to follow an inversion recovery in A) and a saturation 
recovery in B). It was found that the results were overestimated when an in-
plane saturation pulse was not used and there was more variance in the 
values calculated. Perfusion was fit to the Belle model to be 1.98 ± 0.5 
ml/g/min when no in-plane saturation was used versus 0.71 ± 0.1 ml/g/min 
when an in-plane saturation was used.  
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3.4.3 Modelling schemes  
In order to assess the optimal model for fitting this single slice data, the data 
for all six patients was fitted to both the Belle model (Section 3.3.3) and the 
iterative Bloch equations (Section 3.3.3.1) using a least squares regression 
algorithm in MATLAB (Matlab version 8.1, The MathWorks, Inc., Natick, MA, 
USA). The fitted values of perfusion and T1 and the associated sum of square 
errors were recorded. Using the Belle model, the average perfusion value (± 
standard error) was found to be 0.71 ± 0.1 ml/g/min and from the iterative 
Bloch equation, the average perfusion value was found to be 1.45 ± 0.22 
ml/g/min. In the literature, a perfusion value of approximately 1 ml/g/min is 
found and so both models provide a perfusion value consistent with this 
however the Belle model provides a value with less variance. As this 
technique is a single slice acquisition, there is less of an issue with 
unintentional labelling during the selective inversion and so the assumption 
made in the Belle model that all inflowing blood in the selective case is fully 
recovered is likely to be valid.   
 
3.4.4 Exercise challenges 
In a number of papers, the ability of techniques to measure perfusion and 
assess changes in cardiac function is validated via an exercise challenge 
(22,31–33) or by use of a drug such as adenosine (18) to modulate myocardial 
perfusion. Alternatively, in the work by Capron et al (9), a cold pressor test 
(CPT) was performed on healthy volunteers in which the subjects’ hand was 
immersed in cold water for a short amount of time during scanning. In the 
work by Zun et al (20) a simple leg raise challenge was performed and 
compared to the use of isometric hand grips as a stress test to measure 
myocardial perfusion. Another alternative is use of an MR compatible 
ergometer (34,35), where subjects are asked to exercise on supine bicycle 
whilst in the scanner. In this work, the choice of two methods available in the 
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SPMIC of either an MR compatible bicycle (Ergospect Medical Technology, 
Austria) or hand grips using a Grip Force Bimanual Optic Response Pad 
(Current Designs, Philadelphia) was assessed to determine which method had 
the minimal effect from motion and could be well tolerated by a patient 
group, whilst also inducing a noticeable change in perfusion.  
 
A number of previous exercise studies have been performed using a MR 
compatible bike to look at the effect of exercise on cardiac function (18). For 
example, in the work of Hjortdal et al (35), real time MRI was used to measure 
blood flow in the inferior vena cava, superior vena cava and ascending aorta 
under inspiration and expiration during supine lower limb exercise using an 
MR compatible ergometer bicycle. Heart rate was monitored by an ECG and 
by pulse oximetry. The study concluded that aortic and inferior vena cava 
blood flow increases with exercise but the superior vena cava blood flow does 
not change.  
For a CKD patient group who were the group of interest in this thesis, the use 
of a bicycle challenge was considered to be too demanding. Thus the 
alternative use of a cardiac stress challenge using a handgrip challenge 
(20,31,33) was considered most suitable. In the work by Zun et al (20), 
myocardial blood flow was assessed using a single TI ASL approach and 
perfusion was modulated using a handgrip challenge. Subjects were asked to 
maintain an isometric handgrip challenge at 40 % of their maximum voluntary 
contraction. This exercise was initiated 1-2 minutes before the ASL scan was 
started and then maintained and monitored throughout the ASL scan. They 
showed that in a healthy population, the average increase in myocardial blood 
was 29 % with a handgrip challenge.  
3.5 Assessment of cardiac function in CKD patients 
Patients with chronic kidney disease (CKD) have significantly higher rates of 
cardiovascular mortality compared to the normal healthy population. The link 
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between end-stage CKD and heart disease is known, but it has not been 
established at what stage of CKD cardiovascular function begins to decline. 
This study evaluates cardiac function in CKD Stage 3 patients by assessing 
cardiac function at baseline and in response to a handgrip challenge (33). The 
assessment of the dynamic change in cardiac function may be more effective 
at discriminating normal from abnormal cardiovascular function. The aim was 
to compare the cardiac response in patients with CKD with age-matched 
controls. A grip force challenge using bimanual handgrips was chosen for this 
study as an exercise technique that would be tolerated by the entire patient 
group. This study is used as a validation of the MOLLI-ASL scheme to assess 
its sensitivity to changes in perfusion following an exercise challenge, and in 
addition phase contrast MRI blood flow data is also collected for comparison.  
3.5.1 Methods 
10 Stage 3 chronic kidney disease (CKD) patients and 10 healthy age-matched 
controls (HC) took part in the study. All patients gave written informed 
consent and the study was approved by Derbyshire Research Ethics 
Committee. Clinical measures and patient recruitment was performed by Dr 
Claire Grant at the Royal Derby Hospital. Blood tests were performed on all 
subjects to confirm the stage of kidney disease for patients and to confirm that 
the healthy controls had normal kidney function. All scanning was performed 
on a 3 Tesla Phillips Achieva scanner using MultiTransmit and a 16-channel 
SENSE torso receive coil. Localiser scans were acquired in 3 orthogonal planes 
to define the short axis of the left ventricle and the aorta.  
3.5.1.1 Patient cohort and healthy volunteer recruitment  
CKD patients (male or female) were identified by the clinical care team at the 
Royal Derby Hospital following the inclusion and exclusion criteria in Table 
3.5-1.  
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Table 3.5-1: Inclusion and exclusion criteria for CKD Stage 3 patients. 
Healthy controls were recruited following the criteria listed in Table 3.5-2 
Inclusion Exclusion 
Age 18-65 CKD of any stage 
 
Able to give informed consent Known cardiac disease 
 Taking beta blockers, calcium channel blockers or 
other rate/rhythm controlling medication 
Major organ pathology, active infection or 
malignancy 
Smokers 
Pregnant, breastfeeding or intending pregnancy 
Contraindications to MRI  
Unable to sustain 20 mins of light exercise 
 Diabetes 
Table 3.5-2: Inclusion and exclusion criteria for healthy control subjects. 
 
Inclusion Exclusion 
Age 18-65 Known cardiac disease 
Able to give informed consent Taking rate/rhythm controlling medication 
CKD Stage 3b Unstable CKD  
 Unable to give consent or understand information 
NYHA Stage IV heart failure 
Contraindications to MRI  
 Unable to sustain 20 mins of light exercise 
 Diabetes 
 3.5  Assessment of cardiac function in CKD patients 99 
 
 
 
3.5.1.2 Phase Contrast MRI (PC-MRI) of aortic flow 
Phase contrast (PC-MRI) data was acquired using a single slice TFE sequence 
with the imaging slice placed perpendicular to the aorta in all three directions. 
Scanning was performed whilst free breathing and 30 phases were acquired 
across the cardiac cycle. Scan parameters were FOV 280 x 264 mm2, spatial 
resolution = 0.97 x 0.97 mm2, slice thickness 10 mm, no SENSE, TE/TR = 
2.3/3.7ms, FA = 15o, TFE factor = 5, TFE shots 25, VENC = 300 cms-1, NSA = 3. The 
scan was performed whilst free breathing and triggered on the cardiac cycle 
from the VCG data, scan time was approximately 1 minute dependent on the 
patient’s heart rate.  
3.5.1.3 Data Analysis of Phase Contrast data 
PC-MRI data was analysed using ViewForum software (Philips Medical 
Systems, Best, NL) which was used to draw a region of interest over the aorta. 
This region of interest was then applied to all phases of the PC-MRI data. This 
ROI was then to calculate the mean velocity (cm/s) and vessel area (mm2) 
across the cardiac cycle. From this the stroke volume was calculated, which 
defines the amount of blood pumped out of the heart per heart beat (in units 
of ml), and the cardiac output, which describes the volume of blood pumped 
out of the heart in a minute (in units of L/min). In addition to this, stroke 
volume index and cardiac index was calculated by dividing the stroke volume 
and cardiac output by the body surface area BSA respectively. Aortic strain 
was also measured, which is the percentage change in aortic area between 
diastole and systole across the cardiac cycle. The heart rate over the exercise 
paradigm was calculated from the MR scanner physiological logs. Note that 
heart rate and stroke volume interact to determine cardiac output. All 
comparisons of measures between groups were made using a student t-test in 
SPSS v22. 
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3.5.1.4 Arterial Spin Labelling  
Having defined the short axis of the left ventricle using TFE localiser scans in 
three orthogonal planes, a free breathing cardiac triggered MOLLI ASL 
scheme (Figure 3.5-1) was performed using a FAIR labelling scheme with a 
selective slab with width 35 mm and non-selective slab of width 350 mm. In-
plane WET pre-saturation pulses were placed before the FAIR selective and 
non-selective inversions, and these inversions were followed by sinc post 
saturation. Images were acquired using a bFFE readout with FOV 288 x 288 
mm2, spatial resolution 3 x 3 mm2, slice thickness 5 mm, SENSE 2, TE/TR 
1.5/3.1 ms, FA 35o, centric half Fourier acquisition with 12 start-up echoes. 
For the MOLLI ASL timings, trigger delays from 0 – 350 ms in 50 ms steps 
were collected with three readout pulses for each trigger delay and an end 
delay of 3000 ms following each LL set of three readouts. Three readouts were 
used as it was seen from the previous data that the signal had fully recovered 
after three readouts. The maximum trigger delay was set to 350 ms due to 
SAR restraints. This resulted in a MOLLI-ASL recovery curve with 24 time 
points with the minimum time point being the length of the subjects RR-wave 
minus 350 ms and the maximum being three times the length of the subjects 
RR-wave. Following each set of three Look-Locker readouts, an end delay 
period of 3000 ms was applied to ensure that the longitudinal magnetisation 
had fully recovered before the next selective/non-selective pulse. In order to 
determine the readout times for each of the scans, physiological logs were 
recorded from the scanner throughout. A schematic of the MOLLI-ASL 
scheme used is shown in Figure 3.5-1. 
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Figure 3.5-1: A) Schematic of MOLLI-ASL scheme showing 5 of the 8 different Look-
Locker sets (LL1 to LL5) each with a different trigger delay (TD). B) Resulting ASL 
recovery curve with from 8 LL sets with trigger delays from 0 – 350 ms, with each LL 
set comprising three readouts.  
When the data is collected this way, the data can be reordered according to the 
TI of the image in order to view the data as the contrast changes. Figure 3.5-2 
shows the data in order of acquisition and then reordered according to TI of 
the image. This data is reordered using the physiological logs from the 
scanner to know the timings of the images.  
A         B 
Figure 3.5-2: A) Data in the order it is acquired in the scheme for 3 readouts for each 
LL set. B) Reordered data according to the readout time which show the change in 
contrast as the post label delay increases.  
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3.5.1.5 Data analysis of ASL data  
ASL data was analysed using custom written MATLAB software (Matlab 
version 8.1, The MathWorks, Inc., Natick, MA, USA). Data was loaded into the 
programme and inspected for motion and image volumes with motion were 
discarded when necessary. Regions of interest were drawn in the myocardium 
and left ventricular blood pool using the ROI function within MATLAB. The 
non-selective data from the left ventricular blood pool was fitted to estimate 
the T1 of blood (T1b). It was assumed that all blood flowing into the left 
ventricle was fully recovered for the selective case. The timings of each 
readout was calculated using the physiological logs recorded from the scanner 
and using these timings, the selective and non-selective curves were fitted 
separately to a saturation recovery using a least squares regression algorithm 
to calculate T1S and T1NS respectively. The fitted values for T1NS, T1S and T1b 
were then used in the Belle Model to calculate perfusion.    
 
3.5.1.6 Handgrip Challenge 
A handgrip exercise paradigm (Figure 3.5-3) was performed using a Grip 
Force Bimanual Fibre Optic Response Pad (Current Designs, Philadelphia). 
During the ‘Exercise’ blocks, subjects were visually cued to squeeze against 
the resistance in the hand grips until they reached a target maximum force 
level of 100 N and to remain still during the ‘Rest’ blocks. The paradigm 
comprised two ‘Rest’ and two ‘Exercise’ blocks to assess both recovery and 
response to a second exercise session. Visual feedback was given to subjects 
and the scanner operator throughout the exercise challenge; this was visible in 
the scan room and in the control room. This programme was written in 
Presentation software (Neuro Behavioural Systems) to allow the subjects to 
gauge the force they were using and to ensure this paradigm was linked to the 
MR scanner triggers. 
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Subjects were asked to maintain the force level for 8 minutes whilst both PC-
MRI and ASL scans were acquired. Before scanning patients and age-matched 
controls, healthy volunteers were scanned to assess the feasibility of using the 
handgrips, to determine what the maximum force level that could be set and 
the amount of time that was tolerable to maintain the handgrip. 
 
Figure 3.5-3: Schematic of the exercise paradigm showing a block of ‘Rest’ period of 
approximately 8 minutes followed by a block of ‘Exercise’ period of 8 minutes, this was 
repeated twice. During each block, MOLLI-ASL and PC-MRI data was acquired. This 
was then repeated a second time to acquire an additional set of ‘Rest’ and ‘Exercise’ 
data. 
3.5.2 Results 
There was no significant difference in age, gender or BMI between the healthy 
age-matched control subjects and CKD Stage 3 patients. The average age for 
both the groups was 54 ± 9 yrs with BMI  25 ± 3 kg/m2. Baseline markers of 
cardiac function for CKD Stage 3 patients and healthy age-matched controls 
are summarised in Table 3.5-3. 
There were no baseline differences in diastolic or systolic blood pressure, 
cardiac index or stroke volume index. Heart rate (HR) measured from the MRI 
physiological logs was significantly higher in CKD Stage 3 patients in 
comparison with healthy age-matched controls (p = 0.02). CKD Stage 3 
patients had a significantly lower aortic strain than healthy controls.  
Cardiac function in response to the handgrip exercise challenge is shown in 
the figures below for heart rate, aortic velocity, aortic strain, aortic area, stroke 
volume index (SVI) and cardiac index (CI). In all figures, healthy age-matched 
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subjects (HC) are shown in blue and CKD patients in red. The percentage 
change graphs show the change from baseline, defined as the first ‘Rest’ 
measurement. Significance is defined as a p < 0.05 using a two tailed students 
t-test or repeated measures ANOVA.  
 
 
 
 
 
 
 
 
 
 
Table 3.5-3: Baseline markers of cardiac function for CKD Stage 3 patients and 
healthy age-matched control subjects. Values given as mean ± standard 
deviation. 
CKD patients had a significantly higher HR at rest compared to HC group (p = 
0.02), Figure 3.5-4. Both groups showed a significant increase in HR between 
‘Rest’ and ‘Exercise’ (p = 0.002 for HC and p = 0.000 for CKD patients), with 
the CKD patients returning to a significantly lower HR during the second rest 
period compared to the first (p = 0.04). This heart rate is measured as an 
average over each 8 minute scan session however it was seen that there was 
an initial increase in heart rate much greater than what is seen when 
averaging the results.  
 Healthy 
Controls (HC) 
Chronic Kidney 
Disease (CKD) 
p- value 
Age (years)  49 ± 9.6  55 ± 10.5 0.18 
BMI 25.1 ± 2.1 26.4 ± 3.0 0.27 
Diastolic Blood 
pressure (mmHg) 
75.6 ± 10.31 79 ± 9.53 0.47 
Systolic Blood 
pressure (mmHg) 
124.7± 15.98 124.4 ± 10.84 0.96 
Heart rate (bpm) 62.16 ± 12.74 72.49 ± 7.45 0.02 
Aortic strain (%) 41.36 ± 8.59 22.6 ± 3.01 0.03 
Stroke volume (ml) 85.53 ± 5.27 79.59 ± 4.34 0.19 
Cardiac Output 
(L/min) 
2.96  ± 0.23 3.02  ± 0.18 0.42 
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Figure 3.5-4: A) Heart rate at four time points of the exercise paradigm for CKD and 
healthy controls. B) Percentage change in heart rate from the first ‘Rest’ scan to the 
points given on the x-axis.  
On exercise, there was a significant increase in aortic velocity (Figure 3.5-5) 
between ‘Rest’ and the first ‘Exercise’ period for both healthy controls and 
CKD patients (p = 0.02 and 0.01 for healthy controls and CKD patients 
respectively).  
 
Figure 3.5-5: A) Mean aortic velocity at four time points across the exercise paradigm 
for CKD and healthy controls. B) Percentage change in mean velocity from the first 
rest scan to the points given on the x-axis. 
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Between the second ‘Rest’ period and the second ‘Exercise’ period, the mean 
aortic velocity increases again, however this increase on the second exercise 
block was only significant for the healthy controls (p = 0.04). 
When compared to healthy controls, there was a trend for a lower baseline 
aortic velocity for CKD patients, although the percentage change from 
baseline were similar for both groups at approximately 10 %. Both groups 
returned to baseline during the second ‘Rest’ period.   
 
Figure 3.5-6: A) Aortic strain at four time points of the exercise paradigm for CKD 
and healthy controls. B) Percentage change in aortic strain from the first rest scan to 
the points given on the x-axis.  
CKD patients had a significantly lower aortic strain (Figure 3.5-6) compared to 
healthy at rest (p = 0.02 for the first block). Aortic strain reduced on exercise 
for both CKD and healthy age-matched control subjects but not significantly, 
but was significantly lower on exercise for CKD patients compared to healthy 
age-matched control subjects (p = 0.009 for first exercise block and p = 0.02 for 
the second exercise block).  CKD patients had a trend for a larger aortic area 
(Figure 3.5-7) in comparison with healthy controls, however this was not 
statistically significant (p = 0.06). 
 In both groups aortic area increased on exercise (Figure 3.5-7) and this was 
determined to be a significant increase for CKD patients (p = 0.02) and 
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returned to baseline following the first exercise block and then increased 
significantly again for the second exercise block.  
 
Figure 3.5-7: A) Aortic area at four time points of the exercise paradigm for CKD and 
healthy controls. B) Percentage change in aortic area from the first rest scan to the 
points given on the x-axis. 
When assessing stroke volume index (SVI) (Figure 3.3-14), there were no 
significant differences at baseline between both groups (p = 0.2). SVI increased 
slightly for both CKD and healthy controls on exercise however this was not 
found to be significant. Both groups returned to baseline in the second rest 
block. 
 
Figure 3.5-8: A) Stroke volume index at four time points of the exercise paradigm for 
CKD and healthy controls. B) Percentage change in stroke volume index from the first 
rest scan to the points given on the x-axis.  
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No significant difference was seen in cardiac index (CI) (Figure 3.5-9) between 
healthy controls and CKD patients at rest (p = 0.421). Cardiac index 
significantly increased on exercise, with the largest change being seen in the 
healthy controls. Healthy controls increased by 15 + 0.3 % from baseline to 
first exercise (p = 0.002) whereas CKD patients’ cardiac output increased by 11 
+ 0.4% (p = 0.01). Both groups returned to baseline in the second rest period (p 
>0.3) and during the second exercise period, cardiac output increased again 
although this was only seen to be significant for healthy controls (p = 0.02).  As 
cardiac index is the product of stroke volume and heart rate, it can be seen 
that as there were no changes in stroke volume on exercise, this difference is 
driven by the change in heart rate.  
 
 
Figure 3.5-9: A) Cardiac index at four time points across the exercise paradigm for 
CKD and healthy controls. B) Percentage change in cardiac index from the first rest 
scan to the points given on the x-axis. 
 
Example images of selective and non-selective MOLLI-ASL data for 2 different 
trigger delays are shown in Figure 3.5-10.  
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Figure 3.5-10: Example images of selective and non-selective data for 2 different 
trigger delays, LL 1 and LL 2. Readout times are given for each image.  
Figure 3.5-11 shows an example of non-selective and selective data from a 
region of interest in the myocardium and the fitted results. In these plots, the 
true data is shown by the red crosses and the fitted curve is shown by the blue 
circles.  
 
 
 
 
 
 
 
Figure 3.5-11: Example selective and non-selective data and the fitted curves. The 
randomness that is seen in the timings in the plot is expected due to the changing 
heart rate in the subjects. 
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Figure 3.5-12 shows that the average increase in perfusion between rest and 
exercise for healthy controls was 163 ± 44 % whereas for CKD patients it was 
found to be 268 ± 68%.  
 
 
 
 
 
 
 
 
Figure 3.5-12: Myocardial Perfusion in healthy age-matched control subjects and 
CKD Stage 3 patients at ‘Rest’ and during ‘Exercise’.  
Perfusion increases were found to be significant with a p-value of 0.01 for 
healthy controls and 0.04 for CKD patients. This result also shows the 
sensitivity of the MOLLI-ASL technique to be able to detect differences in 
perfusion when a modulation in the perfusion is provided by use of a 
handgrip challenge.  
3.6 Discussion 
 
For patients with compromised kidney function, a technique to measure 
perfusion without the use of contrast agents is necessary due to the risk of 
nephrogenic systemic fibrosis when a contrast agent is injected. As kidney 
patients are more susceptible to cardiac problems, a technique to measure 
myocardial perfusion is needed. In this work, a non-invasive cardiac triggered 
 3.6  Discussion 111 
 
 
modified Look-Locker (MOLLI) ASL technique has been developed to 
quantify myocardial perfusion within a scan time of less than five minutes. In 
order to optimise this technique, simulations were first performed to 
determine the optimal flip angle for an average heart rate of 1000 ms and to 
assess the effect of SNR on the accuracy and precision of the fit for T1 and 
perfusion values. The optimal flip angle was simulated to be 70o however due 
to SAR restraints, the flip angle had to be set to 35o. When simulating the effect 
of an increased number of LL readouts and LL set, it was shown that with 3 
repeats for each LL set and with 8 sets, the theoretical standard deviation was 
less than 4 % for perfusion and less than 1.5 % for T1. 
Pulse programming was performed to enable a MOLLI-ASL scheme to be 
implemented. This was tested for T1 mapping in an agar phantom, by 
performing a MOLLI-ASL scheme without in-plane saturation and with a 
non-selective inversion; this was compared to the results of a standard 
inversion recovery scheme. This data showed there to be good agreement 
between the results of the MOLLI scheme and the inversion recovery scheme, 
giving confidence that the pulse programming had been successful.  
Two different modelling schemes were considered for fitting the ASL data. 
The Belle model in which myocardial perfusion is calculated from the 
difference between the longitudinal relaxation (𝑇1) computed following the 
selective and non-selective inversions, and an iterative Bloch equation that 
uses the signal from the left ventricular blood pool and the myocardium as 
input variables and uses these to calculate tissue T1, M0 and perfusion values. 
When the two models were compared for data acquired in healthy volunteers, 
it was decided that the Belle model was optimal due to the smaller variance in 
values measured and the agreement with published values for myocardial 
perfusion, and the simplicity of the model. If a multi-slice technique was 
employed, an iterative Bloch equation could be more appropriate as more of 
the blood pool would be labelled and so the input function from the left 
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ventricular blood pool would have a greater impact on the fit. However, for 
single slice data it can be assumed that all inflowing blood is fully recovered 
before the slice selective inversion.  
The values of myocardial perfusion that were measured in this study for both 
chronic kidney disease patients and healthy volunteers were in agreement 
with those found in the literature and were found to increase when a handgrip 
challenge was performed, as expected. Mean perfusion at rest for healthy age-
matched controls was 1.06 ± 0.17 ml/g/min and for CKD Stage 3 patients was 
1.01 ± 0.22 ml/g/min. 
Phase contrast measures of the aortic flow were performed at ‘Rest’ and 
during ‘Exercise; and the group of healthy age-matched control subjects 
demonstrated a normal physiological response to a short period of exercise 
with an increase in cardiac output achieved primarily through an increase in 
heart rate with a smaller proportional increase in stroke volume. The CKD 
Stage 3 group followed the same response as the healthy control group. Aortic 
strain was significantly lower for CKD patients than healthy age-matched 
control subjects. Aortic strain describes the ability for the aorta to contract 
between diastole and systole and reduced aortic strain is representative of 
arterial stiffness in the CKD group. This has been strongly correlated with 
mortality in many disease states (36–38). As observed in the healthy age-
matched control subjects, one would expect no change in aortic strain with 
resistance exercise for a healthy population (39). It can be hypothesised that 
the increase in perfusion is due to this decrease in aortic strain and thus 
increased aortic stiffness. Both groups had an increase in aortic velocity and 
aortic area on exercise.  
In future studies using the MOLLI-ASL scheme, an additional MOLLI T1 scan 
will be performed from which the T1 of tissue can be measured. This MOLLI 
T1 scan can also be used to segment the myocardium from the blood pool 
which can be used in the analysis of the ASL perfusion data. This developed 
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MOLLI-ASL scheme can now be used for further assessment of myocardial 
perfusion in patients with CKD.  
3.7 Conclusion  
 
A MOLLI-ASL technique has been developed and optimised for measurement 
of myocardial perfusion. This technique was then used in conjunction with 
PC-MRI to assess the response to exercise in a CKD Stage 3 group in 
comparison with healthy age-matched control subjects. The values of 
myocardial perfusion that were measured in this study for both chronic 
kidney disease patients and healthy volunteers were in agreement with those 
found in the literature, and  myocardial perfusion was found to increase 
significantly during a handgrip challenge for both healthy age-matched 
control subjects and CKD stage 3 patients. A greater increase in perfusion was 
seen for CKD stage 3 patients. Phase contrast measures of the aortic flow 
performed at rest and during the handgrip task and the group of healthy 
volunteers demonstrated a normal physiological response to a short period of 
exercise, with an increase in cardiac index achieved primarily through an 
increase in heart rate with a smaller proportional increase in stroke volume. 
The CKD group followed the same response as the healthy control group, but 
aortic strain was significantly lower for CKD patients than healthy controls.  
In this chapter, a novel technique has been developed for non-invasive 
assessment of myocardial perfusion using an arterial spin labelling technique. 
A non-invasive means for measuring perfusion is necessary in the CKD 
population where the use of contrast agents in contraindicated. The ability to 
measure perfusion in patients with CKD allows assessment of cardiac health 
in more information than is currently available using standard MRI 
techniques.  
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4. Intradialytic MRI to assess changes in 
cardiovascular function in CKD patients 
during dialysis  
 
This chapter aims to apply MRI techniques to assess changes in cardiac 
function in CKD Stage 5 patients during dialysis. The measures are performed 
in a randomised design in patients undergoing both haemodialysis and 
haemodiafiltration.  
Firstly, the chapter outlines the association between dialysis and cardiac stress 
and describes the differences between haemodialysis and haemodifiltration.  
The study design and MRI techniques used to evaluate the effects of dialysis 
on cardiac function are then described. Myocardial perfusion measures are 
collected using the MOLLI-ASL technique developed in Chapter 3. The 
cardiac measures that change during dialysis are discussed; results are 
correlated with clinical measures, and a comparison of haemodialysis and 
haemodiafiltration is provided. 
This work will be presented as an oral presentation at the annual conference of the 
International Society of Magnetic Resonance in Medicine (ISMRM), Singapore 2016.  
This work was funded by Fresenius Medical Care.  
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4.1 Introduction  
 
Dialysis is the procedure that is used to perform many of the normal functions 
of the kidney when the kidneys no longer function adequately in end stage 
renal disease ESRD, such as the removal of waste products and excess fluid 
from the blood. Standard dialysis uses haemodialysis (HD), a method which 
uses diffusive clearance.  
In haemodialysis, patients’ blood is moved through an extracorporeal system 
which contains a semi-permeable membrane with blood moving down one 
side and dialysate flowing along the other side in the opposite direction 
(Figure 4.1-1A). This counter-current flow maintains a concentration gradient 
across the membrane at a maximum which increases the efficiency of the 
dialysis treatment. Waste products are free to move through the membrane 
but the pores are only large enough to let small molecules through and so 
proteins and blood cells remain in the blood. By altering the hydrostatic 
pressure of the dialysate fluid, ultrafiltration (fluid removal) is achieved as 
excess fluids are removed from the blood when free water and some dissolved 
solutes move across the membrane along the created pressure gradient.  
Haemodiafiltration (HDF) is a modified form of dialysis that increases 
clearance of larger uraemic toxins via convection (Figure 4.1-1B), ultrafiltration 
volumes are higher coupled with greater fluid replacement. Water and solutes 
move from the blood to the dialysate at a much higher rate than for HD and 
solutes of both large and small molecular weights are removed. Replacement 
fluid is infused into the patient to ensure that extracellular fluid volume is 
maintained.   
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Figure 4.1-1: (A) Haemodialysis via diffusion. (B) Haemodiafiltration via convection.  
Cardiovascular mortality is grossly elevated in patients with (CKD) (1), and is 
associated with a wide variety of structural and functional abnormalities. 
These changes are directed at the cardiovascular system as a whole, from the 
myocardium to peripheral microcirculation. Peripheral cardiovascular factors 
are of great importance, with structure and compliance of peripheral conduit 
arteries increasing the risk of myocardial ischaemia by the alteration of central 
haemodynamics (2). A substantial body of evidence has developed over the 
last decade showing that myocardial ischaemia occurs during haemodialysis 
and this has been summarised in several in-depth reviews (1–4). This is 
thought to be driven by the circulatory stress that results largely from the 
ultrafiltration process and changes in blood pressure during dialysis (5). 
Dialysis induced myocardial ischaemia can be ameliorated by interventions 
that reduce ultrafiltration rate and/or the degree of haemodynamic instability 
(6). Such interventions include reducing dialysate temperature (7) and  
biofeedback dialysis (8). Some, but not all studies have suggested that HDF 
reduces intradialytic hypotension (IDH) (9,10) compared to HD, with a 
number of studies suggesting that benefits in this regard are largely driven by 
thermal effects of patient cooling (11–13).  
A: Diffusion  
B: Convection  
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Dialysis induced hypoperfusion, the reduction in perfusion of the 
myocardium, has previously been shown in a small numbers of patients using 
myocardial positron emission tomography (PET) (14). However, this 
technique is unable to provide contemporaneous measures of cardiac 
function, such as ventricular function or contractility (14,15).  Dialysis stress 
induced reductions in myocardial perfusion are central to the observed cycle 
of recurrent injury leading to fixed contractile defects in the heart (5). This has 
been demonstrated using cardiac PET scanning under the real time stress of 
conventional HD (6). However, the use of PET to study such effects is limited 
by the complexities and costs related to generating suitable isotopes, access to 
appropriate PET facilities, technical limitations relating to resolution and 
quality of data, and patient radiation exposure. Myocardial contractility has 
traditionally been determined using intradialytic echocardiography, which 
has allowed longitudinal follow up in large groups of patients, showing that 
repetitive dialysis-induced myocardial ischaemia results in fixed reductions in 
systolic function and associated increased risk of mortality (16). However, 
echocardiography is subject to some limitations in terms of image quality and 
user dependency. In contrast, magnetic resonance imaging (MRI) provides a 
gold standard for measurements of cardiac structure. MRI also provides the 
only current methodology by which cardiac structure and function, and 
systemic haemodynamics can be assessed in a single session. Furthermore, 
recent advances in MRI have enabled the measurement of myocardial 
perfusion using arterial spin labelling (ASL) (17) and fibrosis using 
longitudinal relaxation time (T1) mapping of the myocardium (18). There are 
obvious technical challenges resulting from the high magnetic field to using 
MRI to study the effects of dialysis on cardiac function. But if these challenges 
can be surmounted to allow intradialytic MRI acquisition, then unparalleled 
image quality coupled with comprehensive measurements would be a 
significant advance.   
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To date, no studies have used MRI to study the effects of dialysis on cardiac 
function. Secondly, HDF has not been studied as an intervention to reduce 
intra-dialytic cardiac injury. This has relevance as there remains a degree of 
uncertainty as to whether HDF benefits patient outcomes, despite several 
large randomised controlled trials. For example, the Turkish Online HDF 
Study (19) and the CONTRAST Study (20) both compared online HDF against 
low flux HD and found no difference in primary outcome of mortality or 
cardiovascular events. Both studies did however report an association 
between HDF with higher substitution volumes and improved survival. 
Conversely, the ESHOL Study (21) randomised patients to high efficiency 
HDF or standard (mainly high flux) dialysis and reported a large (30 %) 
reduction in mortality (with reductions in both stroke and infection related 
deaths). A number of observational studies have also shown associations 
between HDF, higher convection volumes and improved outcomes (22,23); for 
example the Dialysis Outcomes and Practice Patterns Study (DOPPS) 
suggested that higher convection volumes (>55 L/week) were associated with 
reductions in risk of mortality (23). There is a need for mechanistic studies to 
delineate the biological mechanisms by which HDF may impact on patient 
outcomes.  
The purpose of this study is to use MRI to characterise cardiac structure and 
function in dialysis patients during dialysis treatment. The effects of 
haemodialysis and haemodiafiltration are compared to establish whether 
haemodiafiltration is relatively cardio-protective compared to conventional 
haemodialysis. This is the first study ever to perform MRI scans during 
dialysis. 
4.2 Challenges to delivering dialysis treatment in an MR environment 
 
There were challenges associated with delivering dialysis treatment in a 3 
Tesla MRI environment with a number of modifications needed in order to 
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ensure that dialysis treatment was performed correctly. Non-ferrous needles 
were sourced to attach the patients fistula to the dialysis system. The dialysis 
machine was located outside of the scan room with extension lines added to 
the circuit resulting in the distance between the dialysis machine and the 
patient being increased by approximately 3 m and the dialysis system being at 
the 5 Gauss line. In using extension lines, the blood flow rate (BFR) dropped 
by 50 ml/min and so to ensure that an adequate BFR of >300 ml/min was 
achieved, higher gauge blunt needles were used and patients who had a good 
baseline blood flow rate were carefully selected. In order to keep the blood in 
the extension lines at the correct temperature, insulation was applied around 
the lines. A photo of the setup is shown in Figure 4.2-1 showing the dialysis 
machine and its position outside the MR scan room.  
 
 
 
 
 
 
 
 
Figure 4.2-1: Photo of the setup showing the dialysis machine outside of the MR scan 
room and the patient inside the scanner. To the left of the scanner, the extension lines 
with insulation can be seen. 
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4.3 Patient Cohort 
Twelve patients, ten male and two female, with CKD Stage 5 on 
haemodialysis, took part in this study. Subjects were recruited from the renal 
unit at the Royal Derby Hospital. Potential participants were identified by the 
clinical care team with reference to the inclusion and exclusion criteria (Table 
4.3-1).  Patients were excluded if they fulfilled the criteria for Class 4 New 
York Heart Association (NYHA) functional assessment of cardiac failure. All 
patients gave written informed consent and the study was approved by 
Derbyshire Research Ethics Committee. Clinical measures and patient 
recruitment was performed by Dr Azharuddin Mohammed at the Royal 
Derby Hospital.  
 
Inclusion Exclusion 
Age 18-70 Change in ideal dry weight in 4 weeks 
prior to recruitment 
Able to give informed consent Instability on dialysis in 4 weeks prior 
to recruitment  
CKD Stage 5 on chronic 
haemodialysis 
Dialysed via a synthetic line or graft 
Receiving dialysis via an 
arteriovenous fistula 
Qa < 500 ml/min 
 
Able to understand simple 
instruction in English  
NYHA Stage IV heart failure 
 
 Active infection or malignancy 
 Contraindication to MRI scanning 
including claustrophobia 
 Incapacity to consent 
Table 4.3-1: List of inclusion and exclusion criteria for patients. 
All patients were stable and undergoing dialysis with haemodialysis for 3 
sessions a week, with each session lasting four hours. The mean age of the 
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patients was 53 ± 12 years (range 32 – 73 years) with average dialysis vintage 
of 56 ± 6 months (range 3.3 to 263.8 months). The underlying primary 
aetiologies of the patients’ end stage renal disease were diabetic nephropathy 
(2), autosomal dominant polycystic kidney disease (3), renal amyloidosis (1), 
light chain deposition disease (1), anti-neutrophil cytoplasmic antibody-
associated systemic vasculitis (1), focal segmental glomerulosclerosis (1), and 
in three patients the cause was undetermined. Median Charlson co-morbidity 
score was 4 (IQR 3-5). Patients had previously had an electrocardiogram 
(ECG) and echocardiogram at Royal Derby hospital to assess their cardiac 
function. Eight patients had normal LV ejection fraction (> 55 %), two patients 
had mild impairment of systolic function (EF 44-55 %), one patient had 
moderate LV impairment (EF 36-44 %) and on one patient an echocardiogram 
was not performed.  
Established arteriovenous fistulas, to connect the artery to the dialysis 
machine, were used to achieve vascular access in all patients with a mean 
fistula flow rate (Qa) of 1051 ml/min and baseline between 380-450 ml/min. 
The substitution volume during HDF defines how much fluid is removed 
from the body during the treatment, and the mean substitution volume rate 
for this study during HDF was 4.4 ± 0.2 ml/kg/hr per treatment, this is 
classified as high volume online-HDF. Haemodynamic measures including 
heart rate and blood pressure were recorded every 15 minutes on the scan day 
except for during the MRI scans where it was not possible to collect the data, 
though heart rate data was collected from the MR scanner VCG recording. 
4.4 Methodology  
This study was a crossover design in which patients were randomised to 
either haemodialysis (HD) or haemodiafiltration (HDF) treatments (Figure 4.4-
1). Recruited participants began on their first haemodialysis modality, either 
HD or HDF, for 2 weeks to receive their maintenance dialysis. During the 2nd 
week, participants attended a study day at the Sir Peter Mansfield Imaging 
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Centre (SPMIC) where detailed MRI assessment was performed during a 
dialysis session. Thereafter, participants switched to the other modality, either 
HD or HDF depending on their initial treatment, for a further 2 weeks. 
Cardiac assessment was then again performed during the 2nd week of this arm 
of the study. Following the second MRI day, participants could either return 
to their baseline dialysis prescription or choose to stay on the alternative 
treatment.  
Figure 4.4-1: Study setup showing crossover design for patients starting with either 
HD or HDF treatment. 
4.4.1 Scanning Protocol  
Patients attended the SPMIC twice, undergoing an identical scan protocol on 
both visits. Blood samples were taken pre and post dialysis. Five vials of blood 
were collected in total with blood samples being taken from the dialysis port 
needle. Blood tests were performed by Dr Azharuddin Mohammed for 
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standard biochemical and haematological tests including; urea, creatinine, 
sodium, calcium, magnesium, phosphate, albumin, bicarbonate, glucose, 
lactate, prothrombin, Troponin T, nTproBNP and full blood count and liver 
function tests. Troponin T is a protein that is released when damage occurs to 
the heart muscle thus, a higher level of Troponin indicates an increase in 
cardiac damage. nTproBNP also informs on the amount of heart damage that 
occurs.  
 
All data were collected on a 3T Philips Achieva scanner using a 32 channel 
SENSE XL torso receive coil. MRI scans were performed prior to the dialysis 
session (Scan 1), to measure the effect of the two week run in period on 
cardiac function and as a baseline measure to subsequent scans. After the 
baseline scan, the patients’ fistula was connected to the dialysis machine and 
dialysis was started. There was then a 30 minute wait period to ensure 
patients were established on dialysis and then a MR scan (Scan 2) was 
performed. Following this, patients then had up to one hour outside of the 
scanner before MR Scan 3 was performed. A fourth MR scan during dialysis 
was then performed 210 minutes into the dialysis treatment; this is the point at 
which we hypothesised the patients would be at peak stress and the largest 
effects on cardiac function were expected to be seen. Following this scan and 
once the four hour dialysis treatment was completed, patients were 
disconnected from the dialysis machine and a final scan, Scan 5 was 
performed 30 minutes after the treatment ended to assess recovery. In each of 
the MRI scans, a series of MR sequences were performed to assess cardiac 
function, including aortic, coronary artery and inferior vena cava flow, cardiac 
structure, and myocardial tagging, myocardial perfusion and T1 measures.  
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Figure 4.4-2: Summary of scan sessions. This shows MR scans were performed prior 
to dialysis, at 30, 120 and 210 minutes through dialysis, and 30 minutes post-dialysis. 
Timings of individual scans are shown in the table.  
The following sections outline each of the MR sequences performed in each 
MR scan session.  
4.4.1.1 Cardiac Function  
Left ventricular (LV) function was assessed using a ECG-gated cine MRI to 
acquire images at multiple time points across the cardiac cycle with a multi-
slice TFE sequence with FOV 260 x 209 mm2, spatial resolution 1.35 x 1.35 
mm2, slice thickness 10 mm, SENSE 2, TE/TR = 2/4 ms, FA (flip angle) 60o, TFE 
factor 10, TFE shots 6, 30 heart phases. Cine scans were acquired in 6 breath 
holds with 2 slices acquired per 15-20 s breath hold, resulting in a total of 12 
slices. Slices were positioned along the short axis of the heart. An example of a 
cine left ventricle images is shown in Figure 4.4-3.  From this scan cardiac 
output (L/min), stroke volume (ml) and ejection fraction (%) were computed. 
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Figure 4.4-3: Example 2 chamber (2CH) short axis cine image of the left ventricle of 
the short axis collected using a cine acquisition scheme.  
Aortic function was determined from a phase contrast (PC) MRI sequence 
placing the imaging place through the aorta, as shown in Figure 4.4-4. Scan 
parameters were FOV 280 x 264 mm2, spatial resolution = 0.97 x 0.97 mm2, slice 
thickness 10 mm, no SENSE, TE/TR = 2.3/3.7ms, FA = 15o, TFE factor = 5, TFE 
shots 25, VENC = 300 cms-1, NSA = 3. The scan was performed whilst free 
breathing and triggered off the cardiac cycle, scan time was approximately 1 
minute dependent on the patient’s heart rate.  
 
  
 
 
 
Figure 4.4-4: Example of phase contrast measures from the aorta showing A) 
magnitude image, B) phase image, and C) corresponding waveform of flux across the 
cardiac cycle, created using Philips ViewForum software. 
From these PC-MRI scans, aortic blood velocity (in units of mm/s), cross 
sectional area of the aorta (mm2) and aortic strain (%) were measured. Aortic 
A B C 
ml/s 
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strain is defined as the percentage change in aortic cross section between 
diastole and systole. A second independent measure of cardiac output and 
stroke volume could also be estimated from the flux of blood as it moves 
through the aorta.  
PC-MRI scans were also performed on the inferior vena cava (IVC), the vessel 
which returns blood from the body to the heart via the right atrium. Scan 
parameters were: FOV 280 x 140 mm2, spatial resolution 1.2 x 1.2 mm2, slice 
thickness 6 mm, SENSE 2, TE/TR = 3.1/5.6 ms, FA = 25o,  TFE factor = 4, TFE 
shots 13, VENC = 200 cms-1, NSA= 3. Scan acquisition was performed in a 15-
20 s breath hold. From these PC-MRI scans, IVC velocity (mm/s), flux (L/min) 
and cross sectional area (mm2) were calculated.  
4.4.1.2 Cardiac structure 
Cardiac structure was assessed from (i) the longitudinal relaxation time (T1) of 
the myocardial tissue, and (ii) the contractility of the left ventricle using 
cardiac tagging.  
T1 measures of the myocardial tissue were performed using a modified Look-
Locker inversion recovery (MOLLI) T1 mapping technique (18) with a 
balanced fast field echo (bFFE) readout. A MOLLI T1 schematic and resulting 
recovery curve is shown in Figure 4.4-5.  
Imaging was performed with a non-selective slice thickness of 350 mm, FOV 
288 x 288 mm2, spatial resolution 3 x 3 mm2, slice thickness 5 mm, SENSE 2, 
TE/TR 1.5/3.1 ms, FA 35o, centric half Fourier acquisition with 12 start-up 
echoes. For the MOLLI timings, eight trigger delays from 0 – 350 ms in 50 ms 
steps with three readout pulses for each trigger delay were collected with an 
end delay of 3000 ms following each set of three readouts pulses. By 
increasing the trigger delay, the timing between the inversion and first 
readout decreases, resulting in a shorter inversion time. The maximum trigger 
delay was set to 350 ms due to SAR restraints.   
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Figure 4.4-5: A) Schematic of MOLLI scheme showing the first 5 trigger delay times 
(0-200 ms) with three readouts at each. The inversion pulse is shown in red followed 
by the three readouts. The spacing between the cardiac trigger and the inversion pulse 
is given by the trigger delay (TD). B) Graph showing simulated data for a set of 
MOLLI T1 data with 8 trigger delays from 0 to 350 ms in 50 ms steps, for a tissue T1 
of 1.6 s.  
Comparison of myocardium T1 measures in dialysis patients to healthy 
volunteers provides an indication of the degree of fibrosis in the myocardium. 
Comparison of the T1 measures during and between dialysis treatment allows 
the assessment of whether there is increased water content of the myocardial 
tissue on dialysis.  
Contractility and myocardial strain was assessed using a SPAMM tagging 
technique to inform on how the heart contracts and twists between diastole 
and systole. Strain data was acquired with a multi-shot TFE sequence during 
A 
B 
 
4.4   Methodology 135 
 
 
an end-expiration breath-hold. Imaging parameters were: FOV 320 × 320 mm2, 
spatial resolution 1.33 x 1.33 mm2, slice thickness 8 mm, SENSE 2, TE/TR = 
3.5/5.8 ms, FA 10°, 14–16 cardiac phases and 7 mm tag separation using a grid-
tag pattern. Strain was estimated in a single slice in both the long and short 
axis (Figure 4.4-6), with the short axis slice being the same short axis slice to 
that acquired for T1 mapping and ASL perfusion measures.  
 
 
 
 
 
Figure 4.4-6: A) Long and B) short axis views of myocardial tagging. 
 
4.4.1.3 Perfusion and coronary artery flow  
Myocardial perfusion was assessed using a MOLLI-ASL technique (24) as 
described in Chapter 3. Data were collected using a FAIR ASL scheme with 
slice selective thickness of 35 mm and non-selective thickness of 350 mm, in-
plane pre- and post- saturation pulses were applied. Imaging was performed 
using a bFFE readout with FOV 288 x 288 mm2, spatial resolution 3 x 3 mm2, 
slice thickness 5 mm, SENSE 2, TE/TR 1.5/3.1 ms, FA 35o, centric half Fourier 
acquisition with 12 start-up echoes. For the ASL timings, trigger delays from 0 
– 350 ms in 50 ms steps with three readout pulses for each trigger delay and 
an end delay of 3000 ms following each set of the three readouts. The 
maximum trigger delay was set to 350 ms due to SAR restraints. Single slice 
short axis measures of perfusion were acquired in the same spatial location as 
corresponding T1 maps for quantification purposes.  
A B 
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Flow in the right coronary artery was assessed using PC-MRI to determine the 
delivery of blood to the myocardial tissue, a surrogate to inform on changes in 
myocardial perfusion. The coronary artery was identified by acquiring cine 
images in each of the three orthogonal planes in order to plan perpendicular 
to the vessel in all directions and to visualise the movement of the coronary 
artery throughout the cardiac cycle. Data was collected using FOV 280 x 140 
mm2, spatial resolution 1.2 x 1.2 mm2, slice thickness 6 mm, SENSE 2, TE/TR = 
3.8/7.5 ms, FA = 25o,  TFE factor = 2, TFE shots 16, VENC = 50 cms-1, NSA= 3. 
The scan was collected in a 15-20 s breath hold.  Figure 4.4-7 shows an 
exemplar PC MRI of the coronary artery and its corresponding wave form. 
 
 
 
 
 
 
Figure 4.4-7: A) Example right coronary artery PC-MRI modulus image and B) 
corresponding coronary artery flux waveform analysed using Philips ViewForum 
software.  
From this PC scan, coronary artery blood velocity (in units of mm/s), the cross 
sectional area (mm2), and flux of blood through the coronary artery (in units of 
ml/min) and stroke volume (in mL) were computed. 
4.4.2 Data Analysis  
4.4.2.1 Cardiac Function    
Cine MRI data was analysed using the ViewForum software (Philips Medical 
Systems, Best, NL). The epicardium and the endocardium were first identified 
A B 
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by the user, the software then propagates these contours throughout the other 
time points in the image. This was repeated for each slice through the 
myocardium. For this analysis, the basal slice was chosen for end-diastole and 
end-systole for the left ventricle when all of the blood volume was surrounded 
by myocardium. The apical slice was defined as the last slice showing an 
intra-cavity blood pool (Figure 4.4-8).  
 
 
 
 
 
 
 
 
 
Figure 4.4-8: Example image of basal slice showing A) i) a slice surrounded by 
myocardium and i) a slice that would not be included in the analysis and B i) a slice 
that would be included in analysis as there is an intra-cavity blood pool and ii) a slice 
that would be removed from analysis as there is no intra-cavity blood pool.  
Left ventricular (LV) End Diastolic Volume (EDV) and End Systolic Volume 
(ESV), stroke volume, cardiac output, wall mass, and ejection fraction were 
then determined. LV stroke volume (SV) is the volume of blood ejected from 
the LV with each contraction, given by SV = EDV – ESV.  The ejection fraction 
measures the fraction of volume of blood pumped out of the left ventricle in 
each heart beat (Ef = (EDV-ESV)/EDV). Stroke volume and cardiac index were 
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corrected for body surface area (BSA) to give stroke volume index (SVI) and 
cardiac index (CI) respectively.  
PC-MRI data from the aorta and inferior vena cava were also analysed using 
ViewForum software. An ROI was drawn around the walls of the vessel and 
this ROI was propagated through all time points across the cardiac cycle. 
From this, waveforms of the flux and velocity of blood flow over the cardiac 
cycle were derived, and stroke volume of the blood and cross sectional area of 
the vessel was calculated. Stroke volume, vessel cross sectional area and flux 
were BSA corrected.  
4.4.2.2 Cardiac Structure 
Analysis of MOLLI T1 data was performed using dedicated software to form 
short axis T1 maps (in ms) of the myocardium (Matlab version 8.1, The 
MathWorks, Inc., Natick, MA, USA). Images were first assessed for motion, 
discarded if the myocardium was seen to be in a different position and then fit 
to a Look-Locker inversion recovery (as described in Chapter 2). This process 
was performed both on a region of interest within the myocardium, and also a 
T1 map of the myocardium was formed. To calculate the T1 of blood in the left 
ventricular blood pool, the blood signal was fit to an inversion recovery 
assuming that fresh blood entered the left ventricle for each readout. T1 maps 
were then masked to the myocardium by drawing an ROI along the 
epicardium wall. This T1 map was also used in the perfusion quantification 
and to segment the myocardium.  
Myocardial SPAMM tagging data was analysed using CIM2D software 
(Auckland Uni Services). In this programme, the myocardium was defined in 
the long axis by placing markers on the apex, and on points at the top of the 
endocardial and epicardial walls. The short axis was defined by placing 
markers around the epicardium and endocardium. These markers were then 
propagated for both orientations throughout all the time points. The software 
then automatically separated the myocardium into six segments, as illustrated 
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in Figure 4.4-9. In the short axis, segments were anterior septum, anterior, 
anterior lateral, posterior lateral, inferior and inferior septum. In the short axis, 
strain was defined as circumferential strain (%) which describes the strain of 
the short axis as the myocardial wall is contracting inwards. In the long axis, 
segments were base, middle and apex with two segments defined in each 
region (i.e. base 1 and base 2). Long axis strain was defined as longitudinal 
strain (%) which defines how the myocardium is compressed or stretched in 
the direction of the long axis. From this segmentation, the number of stunned 
segments in both the long and short axis was assessed by calculating the 
number of segments that had a reduced strain of greater than 20% on dialysis. 
Since the short axis slice for the tagging slice was in the same space as the ASL 
perfusion and T1 maps the number of stunned segments could be correlated 
with these measures. A decrease in the measured value of strain reflects a 
decrease in the contractility of the myocardium, and so would be expected to 
lead to a decrease in stroke volume, cardiac output and ejection fraction. 
 
 
 
 
 
Figure 4.4-9: Schematic of A) the short and B) the long axes of the left ventricle 
shown split into the six segments used for the tagging analysis. 
4.4.2.3 Perfusion and Coronary Artery Flow  
Myocardial perfusion data acquired using MOLLI ASL was analysed using 
dedicated in-house MATLAB code (Matlab version 8.1, The MathWorks, Inc., 
Natick, MA, USA). In this program, images were first assessed for motion and 
then discarded if necessary, as described in Chapter 3. Non-selective and 
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selective data were each fit to a saturation recovery curve to estimate selective 
and non-selective T1 values.  This process was performed both on a region of 
interest within the myocardium, and also to map the myocardium. These T1 
values were then used to calculate the myocardial perfusion by fitting to the 
Belle model (25) with the T1 of blood calculated from an ROI within the left 
ventricular blood pool of the T1 maps. The Belle model equation is given as: 
 
P =  
λ
T1b
(
T1NS
T1SEL
− 1) 
 
The T1 maps were masked to only contain the myocardium and limited to 
voxels with 0.8 s < T1 < 1.5 s which eliminated signal from outside of the heart. 
Histograms were produced for the non-selective and selective T1 values and 
the median T1 for each was calculated. These T1 values were then used in the 
Belle model to calculate perfusion, assuming a blood tissue partition 
coefficient of 0.92 ml/g.  The standard deviation in the perfusion values was 
calculated by propagation of errors from the standard deviations of T1 
measures.  
4.4.3  Statistical Analysis 
 
Statistical assessment of results was performed in SPSS v22. To assess the 
significance of the change in a variable during the dialysis treatment, and for 
comparison between time points for the HD and HDF treatments, a repeated 
measure ANOVA was performed. To measure the correlation between MR 
measures and clinical data, paired Pearson correlation tests were performed. 
For assessment of the significance in the change from baseline to peak stress 
(defined as 210 minutes into treatment), a paired student T-Test was 
performed and considered at a p-value > 0.05. 
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4.5 Results  
The ultrafiltration volume defines the amount of fluid that is removed from 
the body during dialysis treatment. Overall, UF volumes were small, and did 
not differ between HD and HDF treatment (median UF volume 1.7 l during 
HD (IQR 0.9-2.1 l) versus 1.7 l (IQR 1.2-2.2 l) during HDF, p=0.3). Mean UF 
rate during HD was 3.3 ± 0.2 ml/kg/hr and was 4.4 ± 0.2 ml/kg/hr for HDF 
(p=0.028). Table 4.5-1 shows blood test results.  
 HD HDF p 
value Hemoglobin (g/l) 119.5  7 120.8  3 0.5987 
URR (%) 74.6  9 75.6  9 0.2843 
Bicarbonate (mmol/l) 24 (IQR 21 to 25) 23.5    (IQR 22 to 
24.7) 
0.8330 
Adj.Calcium (mmol/l) 2.38  0.13 2.48  0.11 0.0848 
Phosphate (mmol/l) 1.43  0.38 1.47  0.31 0.6855 
PTH (ng/l) 191. (IQR 146.8 to 
49.3) 
200 (IQR 139 to 
307.8) 
0.5186 
Magnesium (mmol/l) 0.98  0.14 1.03  0.15 0.0995 
Lactate 0.34  0.96 1.03  0.44 0.4152 
nT-proBNP (ng/l) 2145 (1102 to 3379) 1512 (1026 to 2261) 0.0522 
Pre dialysis cTnT (ng/l) 64.7  70 62.4  58 0.65 
Post dialysis cTnT 
(ng/L) 
53.8  57 37.3  32 0.043 
Delta cTnT (ng/l) -18.09  8.9 -37.68  10.1 0.0003 
Serum Na+ (Pre) 
(mmol/L) 
140.5  0.7  140.6  0.5  0.6844 
Serum Na+ (Post) 
(mmol/L) 
139.0  0.5   138.8  0.4 0.7401 
Table 4.5-1:  Biochemical results for HD and HDF. All results are pre-dialysis unless 
specified. Comparison of pre to post dialysis cTnT values for HD p=0.02 and for HDF 
p=0.007. 
The majority of pre-dialysis blood tests were similar in the two treatment 
arms; this included pre-dialysis high sensitivity troponin T levels. cTnT levels 
fell following both HD and HDF with the magnitude of decrease being greater 
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with HDF than HD. There was a trend for pre-dialysis NT-proBNP to be lower 
in the HDF arm, but this did not attain statistical significance. Body 
temperature fell significantly during the MR study sessions (from baseline to 
all time points) in both arms by 1  0.4 0C during HD and HDF but was not 
significantly different between the treatments (p = 0.98). 
Blood pressure did not significantly differ between treatments (Figure 4.5-1). 
Mean systolic blood pressure (SBP) was 141  6 mmHg during HD and 142  
5.1 mmHg during HDF (p = 0.46). Mean diastolic blood pressure (DBP) was 79 
 12 mmHg during HD and 77  12 mmHg during HDF, p = 0.28.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5-1: Mean blood pressure during HD and HDF measured using a blood 
pressure cuff. A) Systolic blood pressure (SBP) and B) Diastolic blood pressure 
(DBP). There were no significant differences between blood pressures for HD and 
HDF at any timepoint.  
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There was no significant difference between blood pressure values at any time 
point during dialysis. Five patients in each group had at least one systolic 
blood pressure value that fell by > 20 % from baseline pre-dialysis values, but 
there was only one episode of symptomatic hypotension which was in the 
HDF arm. 
4.5.1.1 Heart Rate 
Heart rate was monitored throughout the scans via the MRI VCG recording.  
 
 
 
 
 
 
 
Figure 4.5-2: Heart rate measured from the VCG data before (-30 mins), during and 
30 mins post dialysis showing that heart rate stays fairly constant during the dialysis 
treatment. Timings are given for the start of each MR scan session. 
Heart rate was seen to remain fairly stable throughout treatment (Figure 4.5-2) 
with a significant increase in heart rate being seen at the 210 minute scan 
compared to the baseline scan for HDF but not HD (p = 0.04). The difference 
between heart rates for HD and HDF at each scan point was not found to be 
significant apart from the scan at 210 minutes (p = 0.01).   
 
4.5.2 MR Measures  
Results from the MRI measures are provided below. All figures show the time 
from the start of the dialysis treatment to the start of each MRI scan on the x-
axis, from baseline (-30 mins before dialysis has begun), during dialysis and 30 
mins post treatment. Graphs shown are mean values ± standard error.  
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Figure 4.4-2 shows the actual time each MR sequence was collected in the MR 
scan.  
4.5.2.1 Cardiac Function 
Results of cardiac function are shown in Figure 4.5-3 for aortic PC-MRI 
measures. A reduction in cardiac index (CI) (p = 0.001 for both HD and HDF 
for change from baseline to peak stress) and stroke volume index (SVI) (p < 
0.0001 for both HD and HDF for change from baseline to peak stress) was 
observed during dialysis, with the minimal values observed at 210 minutes. 
No significant difference in CV or SVI was found between HDF and HD (p> 
0.1 for all time points and percentage change from baseline to peak stress).  
 
 
 
 
 
 
 
 
 
Figure 4.5-3: A) Cardiac index B) Aortic stroke volume index measured from the PC-
MRI aorta data before (-30 mins), during and 30 mins post dialysis showing that 
aortic SVI and CI both decrease during dialysis, and subsequently increase at 30 
minutes recovery time. Timings are given for the start of each MR scan session. 
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Analysis of cine MRI data also showed a significant reduction in LV SVI 
during dialysis (p < 0.002 for both HD and HDF for change from baseline to 
peak stress), as shown in Figure 4.5-4 which is in agreement with results from 
the PC-MRI aorta measures.  
   
 
Figure 4.5-4: Cine MRI results: A) Left ventricular stroke volume index (ml/mm2), 
B) Left ventricular ejection fraction (%) and C) Left ventricular cardiac index 
(L/min/m2) for the time points pre, during and post dialysis. Data shows that left 
ventricular stroke volume index, cardiac index and ejection fraction all decrease 
during dialysis treatment. Timings are given for the start of each MR scan session. 
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There was a significant decrease in ejection fraction during dialysis for HDF. 
However, no significant difference in ejection fraction was found during HD 
as a result of a corresponding decrease in both EDV and ESV, though there 
was a clear trend for a decrease in ejection fraction during HD. As expected, a 
significant reduction in LV CI (p < 0.001 for HD and p = 0.04 for HDF) was 
also measured during dialysis for both HD and HDF modalities, in agreement 
with the changes shown in the PC-MRI aortic CI. Measures from PC-MRI data 
and MR cine data were significantly correlated (r = 0.609, p = 0.000 for SVI and 
r = 0.49, p = 0.000 for CI). 
 
IVC flux reflects the flow of blood back into the right atrium, defined as the 
venous return. This was shown to significantly decrease for HD (p = 0.02) 
during dialysis treatment and subsequently return to baseline post dialysis, a 
reduction was also seen for HDF but this did not reach significance (p = 0.07). 
There were no significant differences in the response for HD and HDF 
treatment (p = 0.45).  
 
 
 
 
 
 
 
 
 
Figure 4.5-5: Venous return estimated from BSA corrected IVC flux (L/min/m2) 
prior, during and post dialysis treatment showing a decrease in IVC flux during 
dialysis. Timings are given for the start of each MR scan session. 
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4.5.2.2 Myocardial Strain 
Whole wall and segmental myocardial strain was calculated in both the short 
and long axis. Figure 4.5-6 shows the calculated whole wall strain for a single 
short axis slice across the dialysis treatment for both HD and HDF.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5-6: A) Global whole wall short axis strain. Strain is seen to decrease (less 
negative therefore less strain) during dialysis and then return to baseline 30 minutes 
post dialysis. B) Number of stunned short axis segments. Stunned segments are 
evident from 30 minutes and then decrease, but do not return to baseline following 
treatment. Timings are given for the start of each MR scan session.  
A reduction in global whole wall strain is seen across both HD and HDF 
treatments (i.e. less negative strain values reflecting less strain). The baseline 
measures of short axis circumferential strain are identical for HD and HDF 
B 
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treatments, and following dialysis the strain values return to the baseline 
value for both treatments.  Figure 4.5-6B shows the average number of short 
axis stunned segments for HD and HDF treatment with evidence of 
myocardial stunning during the 30 minute scan. The myocardial strain scan 
was performed approximately 1 hour into the dialysis treatment, suggesting 
that cardiac stunning occurs early during dialysis and not only at the 
anticipated time of peak stress at 210 minutes. For scans at 30 minutes post 
dialysis, the number of stunned segments has decreased, but there are still 
stunned segments apparent for both HD and HDF treatments, suggesting that 
stunning has not fully recovered even after one hour.  
Figure 4.4-16A shows the global whole wall longitudinal strain during HD 
and HDF treatment. There is a significant reduction in whole wall 
longitudinal strain (i.e. less negative strain values indicating less strain) 
throughout the dialysis treatment, with a similar response seen for both HD 
and HDF (p < 0.03 between baseline and all time points during dialysis 
treatment for both HD and HDF). Baseline measures of longitudinal strain 
were similar between HD and HDF (p = 0.3, no significant difference). 
Following dialysis, strain values increase towards baseline for both HD and 
HDF. There were no significant differences seen between the baseline and 
recovery scans for either HD or HDF treatment. On performing a repeated 
measure ANOVA between longitudinal strain values for each dialysis 
treatment across the five time points, no significant differences were found 
between treatments.  
Figure 4.4-16B shows the number stunned segments in the long axis for HD 
and HDF. As for the short axis measures, it can again be seen that there is 
evidence of myocardial stunning at approximately an hour into treatment 
(during the 30 minute scan), with this being the time of greatest increase in 
number of stunned segments, stunning occurs following this at 120 and 210 
minutes into treatment. At 30 minutes post dialysis there are still stunned 
 
4.5   Results 149 
 
 
-10
-9
-8
-7
-6
-5
-4
-3
-2
-1
0
0 30 120 210 30-min
POST
 
W
h
o
le
 w
al
l l
o
n
g 
ax
is
 s
tr
ai
n
 
HDF
HD
1
1.5
2
2.5
3
3.5
4
4.5
5
30 120 210 30 min post
N
u
m
b
er
 o
f 
st
u
n
n
ed
 s
eg
m
en
ts
 
HD
HDF
segments apparent for both treatments, with the number of stunned segments 
being less for HD than for HDF (p = 0.007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5-7: A) Whole wall longitudinal strain. Strain is seen to decrease (become 
less negative) during dialysis and then return towards baseline in the MR scan at 30 
minutes post dialysis. B) Number of stunned segments in the long axis at different 
time points during HD or HDF. Stunned segments are evident in the 30 minutes scan 
session during dialysis and decrease towards baseline following treatment, though 
some stunned segments remain.  Timings are given for the start of each MR scan 
session. 
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4.5.2.3 Perfusion and Coronary Artery Flow  
Right coronary artery flow during dialysis as assessed using PC-MRI is shown 
in Figure 4.5-8 for both HD and HDF.  
 
 
 
 
 
 
 
 
Figure 4.5-8: A) Right coronary artery flux pre, during and post dialysis. Data shows 
no clear differences in flux during dialysis treatment. B) Right Coronary artery pre, 
during and post dialysis showing no clear differences in area during treatment. 
Timings are given for the start of each MR scan session. 
There were also no clear changes in coronary artery flux, stroke volume, or 
cross sectional area during dialysis at any time point for either HD or HDF. At 
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-30 minutes, the coronary artery areas are very similar for both treatments and 
these values return to baseline at 30 minutes post treatment.  
It is hypothesised that the cardiac injury apparent during dialysis is due to 
areas of hypo-perfusion and so it is predicted that in areas where stunning 
occurs, there will also be a reduction in myocardial perfusion. Figure 4.5-9 
shows global perfusion for the single short axis slice. 
 
Figure 4.5-9: Single short axis slice myocardial perfusion at different time points 
through dialysis treatment. Timings are given for the start of each MR scan session. 
Perfusion values were obtained on 10 of the 12 patients. There was no clear 
trend in the changes in mean myocardial perfusion during dialysis at any time 
point, and no differences between HD and HDF treatments. However, 
population averaged values masked significant individual variation in 
perfusion during dialysis. Some patients did not demonstrate reductions in 
perfusion; some had an early fall in perfusion with subsequent recovery and 
some had a late or progressive fall in perfusion. To examine this further, nadir 
(minimum) perfusion during treatment was compared with baseline pre-
dialysis values. During both HD and HDF this was significantly lower, for HD 
baseline perfusion was 3.34  1.7 ml/min/100g versus intra-dialytic nadir of 
1.93  1.4 ml/min/100g, p = 0.050; for HDF baseline perfusion was 3.40  1.5 
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ml/min/100g versus intradialytic nadir of 1.99  1.3 ml/min/100g, p = 0.019. 
This is shown in Figure 4.5-10. 
 
 
 
 
 
 
 
 
Figure 4.5-10: Baseline perfusion and nadir perfusion during dialysis for both HD 
and HDF. A significant decrease in perfusion is seen for both treatment modalities. 
The nadir perfusion values did not differ when comparing HD and HDF 
treatments (p=0.9). There were no significant correlations found between 
perfusion and either number of stunned segments in the short axis or whole 
wall strain at any time point. A significant correlation was found between the 
percentage decrease in perfusion from baseline to the scan at 30 minutes (the 
time point when the most newly stunned segments were seen) and the 
number of stunned segments for HD (r = 0.71, p = 0.03), however this result 
was not significant for HDF (r = 0.21, p = 0.59). 
To determine other associations with a fall in perfusion during treatment, both 
HD and HDF treatments were grouped together. There were no differences in 
nadir systolic blood pressure (SBP), percentage change in SBP or maximal 
numerical fall in SBP between those patients who did and did not experience a 
20 % or greater fall in perfusion during dialysis. However, there was a trend 
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towards greater UF volume in patients with a 20 % or greater fall in perfusion 
(0.91  0.7 l versus 1.5  0.5 l, p = 0.06). Baseline perfusion was 2.7  1.6 
ml/g/min in those without a 20 % fall, compared to 3.9  1.3 in those patients 
with a 20 % reduction in perfusion (p = 0.16).  
4.5.2.4  Myocardial T1 
Measurements of T1 in the myocardium can inform of changes in tissue 
content such as fibrosis or inflammation. Figure 4.5-11 shows an example T1 
map of the myocardium in the short axis. 
 
Figure 4.5-11: A) Example myocardial T1 map and scalebar of T1 values in s. B) T1 of 
the myocardium before, during and post dialysis showing no changes in the T1 during 
dialysis treatment are apparent. Timings are given for the start of each MR scan 
session. 
Figure 4.5-11B shows the average T1 value in the myocardium across the five 
time points during dialysis for HD and HDF. There is no difference in the T1 
value at baseline. There is a slight increase seen in T1 values between baseline 
and the 30 minute scan, however this was not statistically significant and the 
increase was low at less than 3% for both HD and HDF.  
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4.5.2.5 Correlations between MRI results and Clinical Measures 
Figure 4.5-12 shows changes in cardiac index (CI) and stroke volume index 
(SVI) correlated with the ultrafiltration volume for HD and HDF treatments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5-12: A) Correlation between UF volume and cardiac index (CI) showing a 
negative correlation (r = -0.831, p= 0.000 for HD and r = -0.845, p = 0.001 for HDF) 
and B) Correlation between UF volume and stroke volume index (SVI)showing a 
negative correlation (r = -0.813, p= 0.001 and r = -0.838, p = 0.001 for HD and HDF 
respectively). 
A negative correlation between percentage change in CI from baseline to 210 
mins and ultrafiltration volume was seen for both HD and HDF (r = -0.813, p= 
0.001 and r = -0.838, p = 0.001 respectively). A similar trend was seen for SVI, (r 
A 
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= -0.831, p= 0.000 and r = -0.845, p = 0.001 respectively). This demonstrates that 
an increase in the ultrafiltration volume is associated with a decrease in the 
cardiac function. No significant correlations were found between 
ultrafiltration volume and ejection fraction, heart rate or IVC flux.  
Figure 4.5-13 shows the number of stunned segments in the long axis 
correlated with ultrafiltration volume for HD and HDF. A positive correlation 
was seen for both treatments (r = 0.707, p= 0.017 for HD, r = 0.594, p = 0.046 for 
HDF) suggesting that an increase in the ultrafiltration volume leads to an 
increase in the number of stunned segments during dialysis treatment. When 
correlating the number of stunned segments in the short axis with 
ultrafiltration volume, a positive correlation (r = 0.661, p = 0.026) was seen for 
HDF whereas no correlation was seen for HD (r = 0.156, p = 0.344). Note 
however that fewer stunned segments were identified in the short axis slice 
compared to the long axis slice.  
 
Figure 4.5-13: Correlation between UF volume and number of stunned segments in 
long axis showing a positive correlation for HDF (r = 0.661, p = 0.026) but no 
significant correlation for HD. 
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On correlating the number of stunned segments in the long axis with 
percentage change in stroke volume index, a negative correlation was seen 
(Figure 4.5-14 A) although this was not found to be a significant correlation for 
HD (r = -0.502, p> 0.1 for HD and r = -0.716, p = 0.015 for HDF) a similar trend 
was seen for cardiac output index (Figure 4.5-14 B) (r = -0.720, p= 0.014 for HD 
and r = -0.698, p = 0.018 for HDF).  This suggests that an increase in the 
number of stunned segments reduces cardiac output and stroke volume.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5-14: A) Correlation between number of stunned segments and the change 
in stroke volume index (SVI) showing a negative correlation (r = -0.502, p> 0.1 for 
HD and r = -0.716, p = 0.015 for HDF). B) Correlation between number of stunned 
segments and the percentage change in cardiac index (CI) showing a negative 
correlation (r = -0.720, p= 0.014 for HD and r = -0.698, p = 0.018 for HDF). 
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On correlating systolic blood pressure with the number of stunned segments, 
Figure 4.5-14, a negative correlation between the minimum systolic blood 
pressure during the treatment and number of stunned segments in the short 
axis was found for HD (r = -0.8, p = 0.004)  (i.e. lower  SBP associated with 
more stunning), this effect was not seen for HDF.   
 
 
 
 
 
 
 
 
 
Figure 4.5-15: Correlation between number of stunned segments in the short axis and 
systolic blood pressure (SBP). A negative correlation between number of stunned 
segments and SBP was found for HD (r = -0.8, p = 0.004) but not HDF.   
4.6 Discussion 
Having overcome technical barriers associated with performing dialysis in a 
MRI scanner, this study has, for the first time, used intra-dialytic MRI with 
novel scanning techniques to provide a comprehensive assessment of cardiac 
function. In addition, differences in response to haemodialysis (HD) and 
haemodifiltration (HDF) were assessed. This set-up now provides a model in 
which other dialysis-based interventions can be characterised in detail to 
study mechanistic effects directly.  
We have demonstrated a clear reduction in stroke volume index and cardiac 
index during HD and HDF. These data confirm previous observations in other 
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studies that used less robust imaging techniques (16), and also show that a 
decline in cardiac index is evident as early as 50 minutes from the start of 
treatment. The lowest values in cardiac index were observed at 210 minutes 
and cardiac index recovered after treatment, as previously reported.  
A fall in stroke volume index and cardiac index was found to correspond to a 
reduction in myocardial contractility (less negative strain values) which was 
more evident on the long axis than the short axis. Similarly we observed the 
presence of stunning in segments of the myocardium as early as 1 hour from 
the start of treatment. Interestingly, recovery from stunning was incomplete at 
approximated one hour after treatment. These data describe regional changes 
in contractility with much greater precision that has previously been possible 
with echocardiography. 
Myocardial perfusion was assessed in only a single short-axis view, due to 
technical reasons associated with arterial spin labelling. There was wide inter- 
and intra-individual variation in perfusion, a feature not evident in previous 
studies of healthy controls. Analysis of baseline to nadir values did show a 
significant decline in myocardial perfusion during HD and HDF, as shown in 
previous studies employing positon emission tomography (14). Crucially, no 
reduction in right coronary artery blood flow was observed during HD or 
HDF, suggesting that the observed decrease in myocardial perfusion was not 
due to a reduction in blood flow in the main coronary arteries; this 
strengthens the hypothesis that it is changes in microcirculatory blood flow 
that underpin dialysis induced stunning. A correlation was observed between 
reduction in myocardial perfusion at the 30 minutes scan and the number of 
stunned segments in the short axis view, but only for HD. 
Ultrafiltration volume was strongly correlated with several adverse changes in 
cardiac function, including percentage decrease in stroke volume index and 
cardiac index as well as number of stunned myocardial segments. This 
confirms previous observations that ultrafiltration volume is one of the main 
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determinants of intradialytic myocardial stunning as assessed by 
echocardiography (26). Interestingly, these correlations were observed in a 
group of patients with relatively low ultrafiltration volumes (median 1.7 
litres), suggesting that even relatively small ultrafiltration volumes may 
provoke adverse cardiac effects. Whilst blood pressure (BP) was generally 
stable during both treatments, there remained a correlation between number 
of stunned ventricular segments and fall in systolic blood pressure during 
dialysis; again reinforcing previous findings that a change in blood pressure is 
a second key clinical driver of dialysis induced myocardial stunning. This 
work did not demonstrate a clear association between blood pressure changes 
and myocardial perfusion, although it remains to be seen whether this was 
due to technical aspects of image acquisition preventing measurement of 
perfusion over the entire ventricle or lack of clinical effect.  
Overall there were no significant differences in any of the cardiac function 
variables measured from blood tests studied between HD and HDF. Lower 
troponin-T concentrations post HDF (but not pre-treatment) likely reflect 
greater clearance of troponin-T by HDF. These observations do not, however, 
exclude the possibility that HDF may offer haemodynamic benefits over HD 
in some patients. It should be noted that because of the physically challenging 
nature of this first ever intra-dialytic MRI study, relatively healthy patients 
who had well preserved cardiac function were selected. In addition, due to the 
low ambient temperature in the MR scanner room, all patients experienced a 
significant fall in body temperature, an intervention that has been shown to 
improve intradialytic haemodynamic stability (27). Finally, the participants 
required relatively low ultrafiltration volumes to maintain fluid balance and 
did not suffer from high rates of intradialytic hypotension. Thus it remains 
possible that HDF may be associated with improved intradialytic stability in 
more frail patient groups, in the presence of higher ultrafiltration volumes and 
in the absence of cooling, as suggested by some (but not all) published studies. 
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Here, cardiac index was measured using two MR techniques, PC-MRI and 
cine MRI scans. Measures collected using these methods were shown to be 
highly correlated (r = 0.49, p = 0.000) but to have a systematic error, in 
agreement with previous studies (28–31). The values measured for cardiac 
index using PC-MRI are in agreement with previous studies (29) validated 
using flow phantoms. One of the potential errors between the two methods is 
caused by partial volume effects and choice of ROI selection. PC-MRI flow 
measurement has a potential to slightly underestimate actual flow volume due 
to averaged phase-velocity near vessel wall (28). However, a major advantage 
of PC-MRI is that it only needs semiautomatic segmentation on a single slice, 
whereas cine MRI scans require segmentation on multiple short axis slices, 
and is critical on the choice of the basal and apical slice chosen for end-diastole 
and end-systole, as shown in Figure 4.4-8 and partial voluming.  Further, the 
number of patient’s breath holds is significantly reduced for a single-slice PC-
MRI acquisition compared to cine MRI. Previous studies have assessed MR 
measures against both non-contrast enhanced and contrast enhanced (CE) 
two-dimensional echocardiography (2DE) and three-dimensional 
echocardiography (3DE) using MR cine data (30) and PC-MRI (31).  
4.7 Conclusion  
In summary, this chapter has shown novel intradialytic MRI assessments 
which provide further support for the hypothesis that haemodialysis 
treatment provokes a reduction in myocardial perfusion that in turn causes 
stunning of the myocardium and a fall in cardiac index (32). Ultrafiltration 
volume and change in blood pressure were confirmed as important 
determinants of myocardial stunning. This phenomenon was observed even in 
relatively well patients with preserved cardiac function at baseline and in the 
presence of intradialytic cooling. Novel results include the demonstration in 
tandem of significant changes in perfusion, contractility and haemodynamics 
that occur as early as 1 hour into dialysis, and also that the reduction in 
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contractility observed during dialysis contributes to the fall in cardiac index 
(i.e. changes in stroke volume index and cardiac index are not due solely to a 
reduction in circulating volume). There remains therefore an urgent need to 
better understand the factors that contribute to intradialytic myocardial 
stunning and develop more effective strategies to ameliorate it.  
In future studies we will collect baseline echocardiogram measures for 
comparison with MR measures of cardiac function. Future studies will also 
aim to study the association between intradialytic changes in myocardial 
perfusion and contractility in greater detail by employing higher spatial 
resolution acquisitions and multi-slice coverage of ASL perfusion measures. In 
addition, as well as the effect of reductions in cardiac index on the perfusion 
and function of other organs will be studied, including the effect of dialysis on 
residual renal function by monitoring perfusion and T1 in the kidney. As the 
kidneys of dialysis patients will be more challenging to image in comparison 
to healthy patients due to the likelihood of lower blood flow, areas of fibrosis 
and multiple renal cysts, a robust imaging scheme is needed for the 
assessment of kidney health. Chapter 5 of this thesis aims to optimise arterial 
spin labelling and T1 measures in the kidneys of healthy subjects to ensure 
such reproducibility and accuracy of the techniques for future assessments in 
chronic kidney disease. 
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5 Optimisation of Readout Schemes for Renal 
Arterial Spin Labelling 
 
This chapter describes the optimisation of renal perfusion measures using a 
flow alternating inversion recovery (FAIR) ASL scheme. Previously, a number 
of 2D readout schemes have been proposed for renal ASL, these include 
gradient echo based methods of balanced fast field echo (bFFE) and gradient 
echo echo-planar imaging (GE-EPI) or spin echo based schemes of spin echo 
EPI (SE-EPI) and turbo spin echo (TSE). Alternative 3D methods include 3D 
gradient and spin echo (GRASE) and 3D TSE. However, to date there is no 
general consensus on the optimum readout scheme for renal ASL. This 
chapter aims to compare four 2D readout schemes to determine the optimal 
readout scheme for pulsed ASL (PASL) for use in future studies in Chronic 
Kidney Disease. 
The work in this chapter has been presented as an oral presentation at the annual 
conference of the International Society of Magnetic Resonance in Medicine (ISMRM), 
Toronto, 2015 (p0256). 
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5.1 Introduction  
Tissue perfusion is a potentially important measure of kidney health. 
Perfusion measures inform on the delivery of nutrients and oxygen to the 
tissue. Typically, renal function is determined via serum creatinine 
measurements to estimate glomerular filtration rate (GFR), however these 
methods are not highly sensitive and changes in GFR may develop relatively 
late in the progression of Chronic Kidney Disease (CKD). Renal perfusion is 
an alternative parameter which can be used to monitor renal function. A 
method to provide reliable and reproducible perfusion assessment of the 
kidney, in conjunction with precise morphological information, would 
significantly improve the assessment and monitoring of CKD. Arterial spin 
labelling (ASL) provides a MRI technique for the non-invasive quantitative 
assessment of tissue perfusion.  
Renal ASL methods were summarized in Chapter 1. The majority of renal ASL 
studies in the literature have employed the pulsed ASL technique of flow-
sensitive alternating inversion recovery (FAIR) scheme (1–9).  A pubmed 
search of renal ASL using the keywords of ‘renal ASL’ and ‘kidney ASL’ 
shows that of renal ASL publications to date, 19 renal ASL publications 
employ a FAIR scheme with 3 using a pCASL technique.   
In the FAIR scheme, two images are collected: a selective image which 
contains non-inverted arterial blood and a non-selective image in which 
inflowing blood is magnetically inverted (Figure 5.1-1). By subtracting the 
non-selective (label) image from the selective (control) image a perfusion 
weighted difference image is formed. Often in the ASL scheme, pre-saturation 
and post-saturation pulses are applied immediately prior to and following the 
labelling pulse, this ensures that the perfusion weighted difference signal is 
zero over the imaging plane at post label delay of 𝑡 =  0 s, and is not 
dominated by differences in the inversion efficiency between the selective and 
non-selective slab.  
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Figure 5.1-1: A) Position of selective (control, shown in light blue) and non-selective 
(label, shown in white) slabs in FAIR ASL scheme and imaging slices and B) 
Subtraction of label image from control image yields a perfusion weighted (PW) 
difference image.  
T1 maps are necessary for the quantification of renal perfusion; however T1 
values can also be used as an imaging based marker to provide information on 
the health of the kidney. It has been demonstrated in animal models that renal 
T1 mapping techniques can be used to differentiate between severities of acute 
kidney injury (AKI) (10), and for the measurement of renal fibrosis and 
inflammation (11). Importantly, it has been shown that T1 measures can detect 
changes to the tissue before they are apparent from renal histology. In the 
work of Hueper et al. (10), it was shown that renal T1 relaxation times were 
increased after inducing acute kidney injury (AKI) in the mouse kidney, and 
that T1 correlates with subsequent kidney volume loss at 28 days post AKI. In 
the work by Breidthardt et al (12), the association between  renal perfusion and 
T1 relaxation times was assessed. This work demonstrated that renal cortical 
perfusion values positively correlated with estimated GFR and that T1 
negatively correlated with estimated GFR. This work highlights the need for 
robust imaging schemes for measurement of perfusion and T1 relaxation times 
A 
B 
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in the kidney as these parameters can be translated to important markers of 
renal health.  
5.2 Readout Schemes  
A number of different readout schemes have been implemented in the 
literature for renal ASL studies (Table 5.2-1). This overview will first describe 
2D readout schemes, and then introduce 3D readout schemes.  To determine 
the optimal readout scheme for renal ASL, a number of variables must be 
considered. The optimal readout scheme is one that should have a short echo 
time (TE) in order to provide the highest image SNR and reduce the amount 
of signal dephasing and distortion. The short intrinsic T2 and T2* in the 
abdomen (T2 ~70 ms, T2* ~ 40 ms at 3T) leads to rapid signal dropout and loss 
of perfusion signal at longer echo times.  
2D Readout scheme Number of 
published studies 
Example published papers 
bFFE/TrueFISP 10 (4–6,13–19)  Martirosian et al. MRM 51:353-361, 
2004, Heusch et al., JMRI 40:84–89, 
2014, Gillis et al., BMC Nephrology 
15:23, 2014 
GE-EPI  1 (9) Sokolska et al, ESR, 1594:1–13, 2014 
SE-EPI  1 (4)  Gardener et al., MRM 63:1627-1636, 
2010 
TSE  4 (2,7,8,20) Robson et al., MRM 61:1374-1387, 
2009  
Table 5.2-1: List of 2D readout schemes with number of current published studies of 
each and example papers.  
The ideal readout scheme should also be collected in a short shot length to 
enable multiple slices through the kidney to be acquired prior to the recovery 
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of the ASL signal. Secondly, if the acquisition is respiratory triggered, then it is 
important to acquire all the images within a respiratory cycle, and ideally all 
within the flat component of the respiratory cycle where there is minimum 
motion, as illustrated in Figure 5.2-1. Finally, a 2D readout scheme requires a 
low specific absorption rate (SAR) so that a short temporal spacing can be 
achieved when collecting data from multiple slices.  
 
Figure 5.2-1: A) ASL signal curve showing optimal part of curve to sample for 
maximum signal (in blue box). B) Respiratory trace showing end expiration where 
ASL images should be acquired to minimise motion artefacts (in blue box).   
The following section reviews each of the readout schemes used in the 
literature; each has some optimal qualities. In order to determine the best 
readout scheme, these parameters need to be assessed and the trade-offs 
considered.  
Echo planar imaging (EPI) is one of the most commonly used techniques for 
ASL of the brain due to its relatively short scan time (21–29). However, in the 
body, ASL EPI readouts have echo times of > 10 ms and are susceptible to 
signal inhomogeneities which may limit their use in regions close to 
geometrically irregular soft tissue-air or tissue-bone boundaries. Either 
gradient echo (GE) or spin-echo (SE) based EPI can be used. A GE-EPI pulse 
sequence diagram is shown in Figure 5.2-2 
A B
H 
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Figure 5.2-2: Pulse sequence diagram of a GE-EPI scheme.  
A GE-EPI is more dependent on field homogeneity than SE-EPI, and so phase 
shifts resulting from field inhomogeneities, static tissue susceptibility 
gradients and chemical shifts are not cancelled. SE-EPI is routinely used for 
diffusion weighted imaging (DWI) in the body. However since EPI is a single 
shot technique, the echo time for high spatial resolution acquisitions covering 
the FOV required of the abdomen (~ 288 x 288 mm) can become very long 
resulting in poor image quality, especially for GE-EPI.  
The major advantage of EPI is that it has a short acquisition time of 20 – 30 ms, 
leading to the ability to image multiple slices at the peak of the ASL signal 
curve, thus low variance is expected in the perfusion weighted ASL signal 
across multiple slices. Secondly, all images can be collected at a given point in 
the respiratory cycle when using a respiratory triggered acquisition. Finally, 
the SAR for EPI schemes is also relatively low, especially for GE-EPI. A GE-
EPI scheme has been used for renal ASL in the work by Sokolska et al. (9) 
where it was combined with pseudo-continuous ASL (pCASL) labelling to 
assess feasibility and within subject repeatability of renal perfusion measures. 
A SE-EPI scheme was employed by Gardener et al. (4) to acquire multiple 
slices across the kidney. In this work, different breathing strategies were also 
assessed to determine the optimal method to overcome respiratory motion.  
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A balanced fast field echo scheme (bFFE) is widely used as the image readout 
for renal ASL (3,5,6,14). This is a gradient echo based scheme which consists of 
RF pulses that are repeated every TR with no spoiling gradients. The balanced 
gradients result in longitudinal and transverse magnetisation being 
maintained, and so T1 and T2 contrast are both evident in a bFFE image. The 
bFFE scheme starts with a RF pulse of less than 90o (typically around 35o for 
body imaging) and all spins are in the steady state in the first TR. Before the 
next TR, gradients are balanced in the slice, phase and frequency encoding 
directions so that the net gradient is zero. A bFFE pulse sequence is shown in 
Figure 5.2-3.  
Figure 5.2-3: A bFFE pulse sequence  
The bFFE scheme is advantageous as it provides a very short TE and high 
image SNR. However, the shot length of a bFFE scheme is reasonably long at 
approximately 300 ms for a typical abdominal FOV with 3 mm voxel 
resolution. This can lead to multiple slices not all being acquired at the peak of 
the ASL signal curve, and so one would expect there to be a greater variance 
in the image perfusion weighted signal across slices, particularly in 
comparison to EPI. Further, the SAR of a bFFE readout scheme is higher than 
for EPI resulting in longer temporal slice spacing.  However, bFFE schemes 
are limited by their sensitivity to field homogeneity, with banding artefacts 
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apparent in areas of off-resonance in the image. Martirosian et al. (6) was the 
first to use a bFFE readout scheme with FAIR ASL in the human kidney. In the 
work by Heusch et al (13) a FAIR ASL scheme was applied with a bFFE 
readout for functional evaluation of transplanted kidneys. Gillis et al. (5) 
measured inter-study reproducibility of ASL MRI at 3T using a FAIR scheme 
combined with a bFFE readout, and concluded that ASL at 3T provided a 
repeatable method of measuring renal perfusion. 
Another alternative scheme is turbo spin echo (TSE). A TSE pulse sequence is 
shown in Figure 5.2-4. TSE uses a series of 180o refocusing pulses following a 
single 90o pulse to generate a train of echoes. By changing the phase encoding 
gradient for each echo in the TSE sequence, a different line of k-space is 
acquired for each echo. This results in the acquisition of multiple lines of k-
space within a given repetition time (TR).  
 
Figure 5.2-4: TSE pulse sequence diagram  
In the TSE scheme, the time saved by scanning multiple lines of k-space at 
once means it is possible to lengthen the TR which allows more time for T1 
recovery, resulting in an improved signal-to-noise ratio. A higher number of 
phase encoding steps can also be used which will allow for an improvement in 
spatial resolution. Further, susceptibility induced signal losses are low in a 
TSE scheme. However, the echo time of a TSE scheme is typically 50 ms so 
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some blurring in the images will occur due to T2 decay. The shot length of TSE 
is long at ~160 ms, similar to a bFFE scheme, which can lead to slices being 
acquired at different points in the ASL signal curve, leading to variance in the 
perfusion weighted signal across slices. A limitation of the TSE scheme is the 
high SAR due to the multiple refocussing pulses leading to a long temporal 
spacing.  
Alternatively, 3D schemes of either 3D TSE (30) or 3D GRASE (gradient and 
spin echo) (1,31) have been implemented. In the white paper for the 
implementation of ASL in the brain (21), a segmented 3D GRASE technique is 
recommended due to high SNR and time efficiency. However, for abdominal 
imaging where breath holds are required, a segmented technique relies on 
multiple breath holds all being held at the same point in the respiratory cycle 
for accurate reconstruction of the data, which is limiting.  A recent publication 
by Robson et al (30), compared 3D TSE and 2D TSE schemes and no significant 
differences were found between the SNR of the schemes or the quantitative 
perfusion measures obtained. This work comments that although it takes 
more time to acquire a 3D image than a 2D slice, the need for multiple 
averages of a 2D image for sufficient SNR leads to a 3D approach being faster 
and providing increased spatial coverage. This work was focussed on the use 
of ASL for renal tumours, and in one case a renal mass was missed using 2D 
compared to 3D readout. 
5.3 Methods to overcome the respiratory motion 
 
Free breathing, respiratory triggered and breath holding techniques are all 
used in the literature for renal ASL. A breath hold acquisition increases the 
total scan time and although it can decrease respiratory motion compared to 
free breathing, it does not completely eliminate it. Further, breath holding is 
not tolerable for all subjects, especially patients. Also, data are generally 
averaged over multiple breath holds for increased SNR, which requires 
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subjects to hold their breath at the same point in the respiratory cycle, which is 
unlikely. Alternatively, respiratory triggered data can be acquired in which 
bellows are placed around the subject’s abdomen to monitor respiration and 
to trigger the readout to a given point in the respiratory cycle (generally end-
expiration). Data can also be respiratory triggered using a navigator to 
measure the position of the acquired slice according to the movement of the 
diaphragm. In the work by Gardener et al. (4) it was determined that a free-
breathing, respiratory triggered approach was the optimal technique for 
acquiring robust data in a short scan time. This work also discussed the use of 
background suppression, which uses additional non-selective inversion pulses 
to null the static signal, and has been show to improve ASL sensitivity in the 
brain (32).  However,  Gardener et al. (4) showed that despite background 
suppression improving the images visually it can reduce the signal to noise 
ratio (SNR) of the perfusion data, and thus led to an underestimation of 
perfusion. It is also difficult to realign data that has been background 
supressed as there is not sufficient signal in the control/label images.  
Techniques for minimising respiratory motion were also assessed in the work 
by Robson et al. (8) where a pCASL labelling scheme was combined with a 2D 
scheme. It was shown that controlled breathing combined with retrospective 
image sorting, based on the respiratory position during image acquisition, led 
to robust data from which perfusion could be estimated.   
The remainder of this chapter describes the development of 2D image readout 
schemes for ASL on the 3T Phillips scanner using Multi Transmit and a SENSE 
XL Torso receive coil. The optimisation of the schemes is described, and the 
application of these methods for the assessment of renal perfusion and renal 
T1 mapping outlined. 
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5.4 Development of Renal ASL Readout Schemes Using the Philips 
Pulse Programming Environment (PPE)  
Before scanning could be performed, pulse programming was necessary to 
allow four 2D image readout schemes (bFFE, GE-EPI, SE-EPI and TSE) to be 
used with renal ASL. The aim was to match the 2D readout schemes for 
spatial resolution and the number of slices acquired. Renal ASL is not a 
standard sequence available on the Phillips platform; however a prior patch 
was available to provide some renal ASL capability. Here, the code was 
further modified in the pulse programming environment (PPE) to increase the 
number of slices for each scheme to 5 (which was initially only achievable 
with a patch for the bFFE scheme) and provide a respiratory triggered ASL 
readout for all schemes, this required modification of the code for the TSE and 
GE-EPI schemes. There was also the need to add an ‘end-delay’ option to 
leave a delay period following the readout prior to the next inversion to 
ensure full recovery of the signal. Finally, an option for a ‘pre-label delay’ - a 
delay between the respiratory trigger and the label or control pulse - was also 
coded. When acquiring pilot data for this study it was noticed that for the SE-
EPI scheme, alternate slices were fluctuating in signal intensity. This was 
determined to arise due to a poor 180o pulse profile. To overcome this, the 
default 180o pulse was modified in the code to provide a sharp profile which 
removed this fluctuation due to the much sharper pulse profile. 
 For all readout schemes, five slices with no slice gap were acquired with the 
exception of the TSE scheme, for which three slices were collected with a 5 
mm gap. It was decided to collect 3 slices for the TSE scheme, although it was 
possible to achieve 5 slices, since the temporal slice spacing was considerably 
longer for the TSE scheme compared to other readouts due to SAR 
restrictions, and so there was not enough time to acquire 5 slices before the 
ASL signal had recovered. For TSE, 3 slices with a 5mm gap between slices 
were collected so the same kidney coverage was achieved. The PLD times of 
the ASL recovery curve that are sampled for the TSE and GE-EPI schemes are 
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illustrated in Figure 5.4-1, highlighting the time difference between sequential 
slices for the readout scheme with the largest and shortest temporal spacing 
(Table 5.4-1). 
 
Figure 5.4-1: Temporal slice positioning on the ASL perfusion weighted signal curve 
for the GE-EPI (slice spacing ~ 40 ms) and TSE (slice spacing ~ 480ms) schemes. 
A coronal oblique orientation was chosen for all ASL image readouts so any 
movement was in the plane of the kidney. Also, this orientation ensured that 
the image volume remains within the selective inversion slab throughout the 
entire respiratory cycle. Optimised imaging parameters for each 2D readout 
scheme are summarised in Table 5.4-1. 
 
 
 
 
 
Table 5.4-1: FAIR ASL imaging parameters for each 2D readout scheme. 
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5.5 Methods 
Having optimised the 2D GE-EPI, SE-EPI, bFFE and TSE readout schemes for 
renal ASL, a study was performed in healthy volunteers to determine the 
optimal scheme. The study was approved by the local ethics committee and all 
participants gave informed, written consent. Ten healthy volunteers were 
scanned for approximately one hour on a 3T Philips Achieva scanner with 
Multi-Transit and a 16-channel XL Torso receive coil. To ensure that all 
volunteers had healthy kidney function, blood and urine tests were performed 
and evaluated by a clinician. 
Initially, balanced-Turbo-Field-Echo (bTFE) localiser scans were acquired in 
three orthogonal planes to plan placement of the image and label slabs relative 
to the kidneys and vessels. Coronal-oblique imaging slices were collected 
obliquely across the kidney in descending order (lateral – medial) (Figure 
5.5-1) whilst taking care that the selective inversion slab avoided the aorta.  
This geometry of image readout was acquired on each subject for all schemes. 
All readout schemes were acquired with FOV 288 x 288 mm, in-plane spatial 
resolution 3 x 3 mm2; slice thickness 5 mm and SENSE 2. Use of a SENSE 
factor of 2, allowed the minimum GE-EPI and SE-EPI echo time to be achieved 
and reduced the readout duration thereby minimising susceptibility related 
distortions and signal drop out, and allowed multiple slices to be acquired 
sampling the peak of the ASL signal curve.  
Figure 5.5-1: Positioning of the FAIR scheme selective and non-selective slabs 
relative to the kidneys and aorta. 
The FAIR labelling scheme used a selective inversion slab of 45 mm chosen to 
be 10 mm wider than the imaging volume and a 400 mm non-selective 
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inversion slab (Figure 5.5-1). A Frequency Offset Corrected Inversion (FOCI) 
inversion pulse was used for FAIR labelling which provided a sharp inversion 
profile. To supress any static tissue signal in the perfusion weighted images, 
in-plane WET (Water suppression Enhanced through T1 effects) saturation 
pulses were placed immediately before each selective or non-selective pulse 
and a sinc post-saturation pulse was placed immediately after. In order to 
achieve the maximum perfusion weighted difference signal, accounting for 
the different readout durations (see Table 5.4-1) a label delay (time to the 
centre of k-space for the first slice) was set to 1300 ms for bFFE and TSE and 
1800 ms for GE-EPI and SE-EPI schemes. All data sets were acquired 
respiratory triggered on the inversion pulse. A minimum repetition time (TR) 
of 3 s was defined; this meant that at least this time or longer was allowed 
between each selective and non-selective pulse, depending on the subject’s 
respiration rate.  For a TR of 3 s, a label/control pair would be acquired every 6 
s. In total, 25 label and control pairs were acquired for each renal ASL dataset 
of each readout scheme. 
M0 scans were also collected respiratory triggered with readouts being 
acquired at the same point in the respiratory cycle as the ASL data using a 
trigger delay matched to the PLD. For quantification of perfusion, T1 weighted 
images were also acquired for each readout scheme, these matched the 
geometry of the ASL image.  
5.5.1 𝑻𝟏 Mapping 
To map the T1 relaxation time in the renal cortex, a modified respiratory-
triggered inversion-recovery sequence was implemented. Images were 
acquired at multiple inversion times (TI), with all images collected at the same 
time in the respiratory cycle as the ASL data by introducing an additional 
delay (Tv) following the respiratory trigger and prior to the inversion. This 
sequence is shown in Figure 5.5-2. 
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Figure 5.5-2: Schematic showing the positioning in the respiratory cycle of the 
inversion and image readout for T1 mapping. The respiratory trigger is at end 
inspiration, this is followed by an additional trigger delay (Tv) after which the 
inversion is applied and images are the acquired after a further delay (TI). This is 
shown for a short (TI1 and a long (TI2) inversion time. All image readouts are acquired 
at the same point in the respiratory cycle.  
All schemes were collected with a minimum TR of 6 seconds using a non-
selective slab thickness of 400 mm. T1 measures were acquired at inversion 
times of 200 ms to 1500 ms in 100 ms spacing. For GE-EPI and SE-EPI, slices 
were acquired in a descend order alone. For the TSE and bFFE readout 
schemes, slices were acquired using both an ascend and descend ordering to 
increase the dynamic range (33).  
5.5.2 Reproducibility  
It is important to assess the reproducibility of each readout scheme to ensure 
that the same results are achieved. This is important clinically to ensure that 
any measured changes in the perfusion or T1 value are due to changes in 
health and not from fluctuations in scan results. To assess the reproducibility 
of each readout scheme, all volunteers returned for a second identical scan 
session within 2 weeks of the first scan session. Reproducibility was assessed 
for both ASL perfusion and T1 measures. 
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5.5.3 Data Analysis  
5.5.3.1 Quantification of perfusion and T1 maps 
Analysis was performed using custom written MATLAB programs (Matlab 
version 8.1, The MathWorks, Inc., Natick, MA, USA). ASL perfusion weighted 
difference maps were calculated by subtraction of the non-selective image 
from the selective image. Images were inspected for motion using a home 
written matlab script in which it was possible to view subtraction images and 
then discard misaligned pairs. Motion was evident from edge effects around 
the kidney in the difference image. Example difference images that were 
discarded and acceptable data are shown in Figure 5.5-3. 
 
 
 
 
 
Figure 5.5-3: Example perfusion weighted difference images showing A) data that 
would be discarded and B) data considered acceptable.  
The difference images were averaged to form a single perfusion weighted 
difference image (∆M) for each slice which were then normalised by the M0 
image. T1 and M0 maps were formed by fitting the T1 data to an inversion 
recovery curve. These ∆M, T1, T1b, and M0 maps were then used together to 
calculate a renal perfusion (f) map, in units of ml/100g/min, by fitting the data 
to a kinetic model (Equation 5-1) (34) neglecting transit time and exchange 
time effects. 
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𝑇1𝑏 and 𝑇1𝑡 are the T1 values of blood and tissue respectively, 𝑇𝐼 is the 
inversion time and 𝜆 is the blood tissue partition coefficient which is assumed 
to be 0.8 mL/g for kidneys. To segment the renal cortex, a histogram of the T1 
values in the T1 map was produced and then a threshold determined to create 
a cortex mask. These maps were compared across the readout schemes to 
ensure approximately the same number of voxels were assessed. The average 
perfusion in the renal cortex was then calculated for each slice.   
       
5.5.3.2 Image Assessment 
To assess the quality of each readout scheme, the following quantitative 
measures were assessed in the renal cortex: 
(1) Perfusion weighted image signal-to-noise ratio (PW-SNR). This was 
calculated as the mean perfusion weighted signal divided by the standard 
deviation in the background noise of the perfusion image. The 
background noise was measured by calculating the signal in a region of 
interest (ROI) outside of the kidneys. 
(2) Temporal signal–to-noise ratio of the perfusion weighed image (tSNR): 
calculated as the mean perfusion weighted signal divided by its standard 
deviation over the 25 dynamics.  
(3) Variance in the perfusion weighted signal across the slices (var∆M): 
calculated as the standard deviation in the perfusion weighted difference 
across the slices divided by the mean perfusion weighted signal.  
To illustrate the inter-subject variability in perfusion and T1 measures, box 
plots were produced from the first visit data. A repeated measures anova was 
calculated to determine whether there were any significant differences 
between readout schemes. 
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5.5.3.3 Reproducibility of readout schemes 
To assess reproducibility of each 2D readout scheme, Bland Altman plots of 
the mean perfusion value versus the difference between scan sessions were 
formed, and the 95 % limits of agreement calculated from the mean difference 
between measures plus or minus 1.96 times the standard deviation of the 
difference. Reproducibility was assessed from the coefficient of variance 
(CoV), the ratio of the standard deviation of the differences between visits to 
the mean perfusion measures. CoV values close to zero suggest good 
agreement between measurements. A Friedman mean rank test was also 
performed to inform on whether any readout scheme gave a systematically 
high or low perfusion value. 
Similarly, the reproducibility of T1 measures was assessed using Bland Altman 
plots, CoV measures and the Friedman mean rank test.  
5.6 Results  
M0 images for each 2D readout scheme are shown in Figure 5.6-1 with high 
data quality clear for all readout schemes. The longer echo times for the EPI 
schemes and TSE schemes can be seen to translate to the slight blurring of the 
M0 images. In the bFFE image, the vessels appear brighter than in the other 
schemes due to the high T2/T1 contrast in fluids as these are not supressed.   
Assessment of specific absorption rate (SAR) showed that the TSE scheme had 
the highest SAR at approximately 70 % whilst the SE-EPI, GE-EPI and bFFE 
schemes all had SAR of less than 35 %. A high SAR scheme has a longer 
temporal spacing between slice acquisitions limiting the number of slices that 
can be acquired at the peak of the ASL signal curve.  
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Figure 5.6-1: Example M0 images for each of the 4 readout schemes. Each M0 scan 
was acquired with identical shim values, slice positioning and a FOV of 288 x 288 mm 
with a spatial resolution of 3x3x5 mm. 
Table 5.6-1 shows results of the perfusion weighted image SNR (PWI-SNR), 
temporal SNR (tSNR), and variability of the perfusion signal (var∆M (%)) for 
each readout scheme.    
Readout scheme PWI-SNR tSNR var∆M  (%) 
bFFE 6.2 2.4 26 ± 11 
GE-EPI 6.3 1.5 20 ± 5 
SE-EPI 3.9 2.6 11 ± 3 
TSE  8.5 2.4 20 ± 4 
Table 5.6-1: Perfusion weighted SNR (PW-SNR), temporal SNR (tSNR) and 
variability of the perfusion weighted signal (var∆M (%)) for each scheme. 
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The highest PWI-SNR was for the TSE scheme with the lowest for SE-EPI. 
tSNR was found to be optimal for the SE-EPI scheme and lowest for the TSE 
scheme. The var∆M was found to be lowest for SE-EPI, with the highest 
variability found for the bFFE readout. Perfusion weighted images for each 
scheme are shown in Figure 5.6-2. 
 
 
Figure 5.6-2: Perfusion weighted images (PWI) for each scheme (bFFE, GE-EPI, SE-
EPI and TSE) for an example subject. Timings on each of the images indicates the 
readout time of each. Each scan was acquired with identical shim values, slice 
positioning and a FOV of 288 x 288 mm with a spatial resolution of 3x3x5 mm. 
The range of perfusion values measured from the first scan session is 
illustrated in Figure 5.6-3 for each of the four readout schemes.  
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Figure 5.6-3: Box plot showing renal cortical perfusion values measured from each 
2D readout scheme for the first visit. 
Average renal cortical perfusion across all schemes was 238 ± 12 ml/100g/min, 
the error indicates the standard error of the perfusion values across readout 
schemes. Perfusion values were calculated to be: bFFE = 317 ± 34 ml/100g/min, 
GE-EPI = 251 ± 19 ml/100g/min, SE-EPI = 238 ± 12 ml/100g/min, TSE = 221 ± 22 
ml/100g/min. On performing a Friedman mean rank test, the bFFE readout 
yielded consistently higher perfusion values compared to the other three 
schemes. A repeated measures anova showed that bFFE readouts produced 
significantly higher perfusion values than TSE (p = 0.03). There were no 
significant differences in measured perfusion between GE-EPI, SE-EPI and 
TSE schemes. It is likely that the higher perfusion value for the bFFE scheme is 
due to the presence of vessels in the perfusion weighted image. 
The largest inter-subject variability of perfusion values was found for the 
bFFE scheme and the smallest range for the SE-EPI scheme; this was true of 
both the first and second scan session.  
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Bland Altman plots showing the difference in measured perfusion values 
between visits are shown in Figure 5.6-4. The Bland Altman plots show good 
agreement between measurements for each readout scheme. The most 
reproducible readout scheme was SE-EPI, which had a CoV of 8 %, the least 
reproducible scheme was the TSE scheme with a CoV of 21 %. For each 
readout scheme, there were no significant differences between results from 
study days. 
Figure 5.6-4: Bland Altman plots showing the reproducibility of each readout scheme. 
The mean perfusion value is shown on the x-axis and the difference between the 2 
visits on the y-axis. The lines showing 95% limits of agreement are calculated as the 
mean difference plus or minus 1.96 times the standard deviation of the differences. The 
central line shows the mean difference across all subjects. 
The average renal cortex perfusion value, percentage difference between visits 
and CoV for each readout scheme are listed in Table 5.6-2. 
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Table 5.6-2: Perfusion (ml/100g/min), average perfusion difference between visits 
(%) and coefficient of variance (CoV) (%) for each readout scheme. 
 
Figure 5.6-5 shows box plots of T1 values for each readout scheme.  
Figure 5.6-5: Box plot of T1 values for each readout scheme. Outliers are shown by an 
x. There were significant differences seen between all schemes other than the bFFE and 
GE-EPI schemes.  
It can be seen that SE-EPI and GE-EPI schemes yield a higher T1 value, with 
the Friedman mean rank test showing that SE-EPI results in a systematically 
higher T1 values that the other 3 readout schemes. When looking at the 
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difference in T1 values between the different schemes, a significant difference 
was found (p < 0.05) between all schemes except for between bFFE and GE-
EPI schemes. 
Figure 5.6-6 shows Bland Altman plots of T1 values for the renal cortex for the 
four readout schemes. All measures are reproducible with a maximum CoV of 
3.8 % for GE-EPI and the smallest CoV of 1.7 % for SE-EPI, making this the 
most reproducible scheme.  
 
Figure 5.6-6: Bland Altman plots showing the reproducibility of each 2D readout 
scheme. Average T1 values on the x-axis and the % difference between the 2 visits 
shown on the y-axis. The mean difference and 95% confidence intervals are shown.  
Average renal cortex T1 values for each readout scheme are given in Table 
5.6-3. SE-EPI yielded the highest T1 values, conversely TSE yielded the shortest 
T1 value. The average intra-subject percentage difference between visits was 
highest for GE-EPI and the lowest for SE-EPI. A student’s t-test, showed no 
significant differences in T1 values between visit one and visit two for any 
readout scheme. There was a significant difference when comparing T1 values 
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measured across schemes except for between bFFE and GE-EPI which had a p 
of 0.6 showing there to be no significant differences between these schemes.  
 
Table 5.6-3: Average renal cortex T1 value (ms), average difference between visits 
(%) and coefficient of variance (CoV) (%) for each of the four schemes. 
5.7 Discussion  
Previous renal ASL studies have used a variety of readout schemes in 
combination with FAIR labelling. In this work, a comparison of balanced fast 
field echo (bFFE), gradient-echo EPI (GE-EPI), spin-echo EPI (SE-EPI) and 
turbo spin echo (TSE) schemes is made for renal ASL. For all schemes, multi-
slice coverage could be achieved with five contiguous slices collected for 
bFFE, GE-EPI and SE-EPI and three slices with a 5 mm slice gap for TSE, the 
higher SAR leading to wider readout spacing for the TSE scheme. GE-EPI and 
SE-EPI could achieve whole kidney coverage in the shortest amount of time.  
A summary of the results from perfusion measures for the four readout 
schemes is given in Table 5.7-1. The computed renal cortex perfusion was 
higher for gradient-echo based GE-EPI and bFFE compared to spin echo based 
SE-EPI and TSE schemes.  
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Table 5.7-1: Summary of key results for perfusion 
Perfusion values calculated from the bFFE readout data were significantly 
higher than all other schemes (p < 0.05). This could be attributed to the 
presence of vascular signal in these images. In future work, the increased 
perfusion signal from a bFFE scheme could be removed by the use of vascular 
crushing or by creating a more robust mask from which to exclude vessels. 
This was assessed by removing the segmental arteries from the chosen ROI. A 
box plot was then created for the bFFE data to compare the inclusion and 
exclusion of vessels (Figure 5.7-1).  
Figure 5.7-1: Box plot of perfusion values obtained during the first scan session using 
a bFFE readout scheme. Results are show from a bFFE scheme including vessels and a 
bFFE readout scheme excluding vessels.  
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From this it can be seen that the variance is lower when the vessels are 
removed, and this will also improve the reproducibility of this method.  
When comparing signal-to-noise ratio (SNR), SE-EPI gave a significantly 
lower PWI-SNR compared to the other schemes, however this could be 
attributed to the reduction in vascular signal present in the SE-EPI images. 
This is also supported by the fact that the SE-EPI scheme had the highest 
temporal SNR, suggesting lowest fluctuations from pulsatile vessels.  
SE-EPI was found to display the lowest variance across slices of all the readout 
schemes. This is unsurprising as the SE-EPI scheme has a short shot length per 
slice, and so all slices are acquired at almost the same point on both the ASL 
signal curve and in the respiratory cycle, resulting in a small variance in the 
signal of each slice. Conversely, TSE readouts have a long shot length; this 
yielded the highest variance in signal across slices.  
All 2D readout schemes were determined to be reproducible with a coefficient 
of variance of 21% or less. SE-EPI was found to be optimal, CoV of 11%. 
 Assessing the reproducibility of T1 measures, it was found that all schemes 
were reproducible between the two visits. The CoVs were small for all readout 
schemes, with the largest being 3.8 % for GE-EPI and the smallest at 1.6 % for 
SE-EPI. There were no significant differences in T1 measurements between the 
two visits for any of the readout schemes.  
Comparing the T1 values measured between schemes, showed there were 
significant differences between the T1 values measured from all schemes other 
than between GE-EPI and bFFE. When performing a Monte Carlo simulation 
(Figure 5.7.1) to estimate perfusion values with increasing T1 values, it was 
found that by increasing the T1 value, the fitted perfusion value decreased.   
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Figure 5.7-2: An increase in T1 values leads to a decrease in the fitted perfusion 
values.  
This is important to note, as for situations such as multi-centre studies where 
different readout schemes could be implemented, it is key to keep the readout 
schemes the same, or to understand such systematic differences. Also, it is 
important in patient groups where changes in T1 are likely to occur due to 
effects such as fibrosis or inflammation, that individual subject T1 measures 
are used in perfusion estimation.   
5.8 Conclusion 
 
In summary, this chapter has reviewed and optimised different 2D readout 
schemes for renal ASL and renal T1 measures. Balanced fast field echo (bFFE), 
gradient-echo echo-planar imaging (GE-EPI), spin-echo echo-planar imaging 
(GE-EPI) and turbo spin-echo (TSE) were assessed for temporal and perfusion 
weighted image signal-to-noise ratio (t-SNR and PWI-SNR respectively), 
perfusion values and variance in perfusion signal across multiple slices 
(var∆M). The reproducibility of these readout schemes was also assessed by 
measuring coefficients of variance (CoV) and Bland Altman plots. 
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All schemes were found to be reproducible for both T1 and perfusion 
measures. The most reproducible readout scheme for perfusion measures was 
SE-EPI, which had a CoV of 8 %; the least reproducible scheme was the TSE 
scheme with a CoV of 21 %. T1 measures were highly reproducible with the 
highest CoV of 3.8 % for GE-EPI and the smallest CoV of 1.7 % for SE-EPI.  
When performing a comparison of all four techniques for perfusion measures, 
it was seen that SE-EPI provides optimal temporal SNR, consistency across 
slices, reproducibility between sessions and the lowest specific absorption rate 
(SAR). The measured cortical perfusion was higher for gradient-echo based 
GE-EPI and bFFE compared to spin echo based SE-EPI and TSE schemes and 
perfusion values calculated from the bFFE readout data were significantly 
higher than all other schemes (p < 0.05). 
A comparison of T1 values measured from each of the schemes showed there 
were significant differences between the T1 values measured from all schemes 
other than between GE-EPI and bFFE. SE-EPI yielded the highest T1 values. It 
is expected that T1 values are higher for SE-EPI compared to the other schemes 
as the SE-EPI is governed by only T1 relaxation whereas the bFFE scheme also 
has T2 /T2* effects (35). 
In future work, the techniques optimized in this work for measurement of 
renal cortex perfusion and T1 can be extended to also measure perfusion in the 
medulla and T1 and can be used to assess residual renal function in patients 
with chronic kidney disease. As SE-EPI provides optimal temporal SNR, 
consistency across slices, reproducibility between sessions and the lowest 
specific absorption rate (SAR), in future work, this technique will be used and 
so a SE-EPI T1 mapping technique will be used as this is also needed in the 
quantification of the perfusion measures.  
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6. Conclusion  
 
The work in this thesis has focused on the development and application of 
MRI techniques for the study of Chronic Kidney Disease (CKD). In particular, 
arterial spin labelling (ASL) techniques have been developed for the 
assessment of perfusion in both the heart and kidneys.  
 
In Chapter 3, a modified Look-Locker inversion recovery (MOLLI) ASL 
technique was developed to quantify myocardial perfusion. To optimise this 
technique, simulations were performed for an average heart rate of 1000 ms to 
determine the effect of flip angle and to assess the effect of SNR on the 
standard deviations of the fit for T1 and calculated perfusion values. However 
due to SAR, the flip angle had to be set to 35o (lower than the optimal flip 
angle of 70o). On simulating a MOLLI-ASL scheme with 3 readouts following 
each inversion and 8 LL sets, this resulted in a simulated standard deviation of 
less than 4 % for perfusion quantification and less than 2 % for assessment of 
T1 (this assumes thermal rather than physiological noise).  
 
This MOLLI-ASL technique was first validated in phantoms and then in 
healthy volunteers to assess the need for in-plane saturation and to determine 
the modelling scheme to quantify perfusion. The MOLLI-ASL technique was 
then applied together with phase contrast MRI (PC-MRI) measures to assess 
the changes in perfusion and blood flow in patients with CKD Stage 3 during 
a handgrip exercise challenge. MOLLI-ASL and PC-MRI measures of aortic 
flow were performed at rest and during exercise. Their response was 
compared to that of healthy age-matched controls. The calculated myocardial 
perfusion measured in this study for CKD patients was 1.01 ± 0.22 ml/g/min 
and 1.06 ± 0.17 ml/g/min in healthy controls, in agreement with literature. 
During the handgrip challenge myocardial perfusion was found to increase by 
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163 ± 44 % in healthy controls and 268 ± 68 % in CKD Stage 3 patients. In PC-
MRI data, the healthy control subjects demonstrated a normal physiological 
response to a short period of exercise with an increase in cardiac index (CI) 
achieved primarily through an increase in heart rate with a smaller 
proportional increase in stroke volume index (SVI). The CKD group followed 
a similar response to the healthy control group, but aortic strain was 
significantly lower for CKD patients than healthy controls. Both groups had 
an increase in aortic velocity and aortic area on exercise. This study suggested 
that differences in the physiology of CKD and the healthy population can be 
determined using MOLLI-ASL and phase contrast and that a dynamic 
challenge maximizes sensitivity to changes in the patient group. 
 
In Chapter 4, the first ever intradialytic MRI was performed to provide a 
thorough assessment of cardiac function, structure and perfusion during 
haemodialysis (HD) and haemodifiltration (HDF). This study demonstrated a 
clear reduction in SVI and CI during HD and HDF. Corresponding to the fall 
in CI, reductions in myocardial contractility were observed (less negative 
strain values) which were more evident on the long axis than the short axis 
cardiac views. Myocardial stunning, defined as a greater than 20% decrease in 
cardiac output, was evident from 1 hour into the dialysis treatment for both 
HD and HDF. Analysis of myocardial perfusion from baseline to nadir values 
showed a significant decline in myocardial perfusion during HD and HDF, as 
shown in previous studies employing PET. When correlating the MRI 
measures with clinical data, the ultrafiltration volume was strongly correlated 
with several adverse changes in cardiac function, including percentage 
decrease in SVI and CI as well as number of stunned myocardial segments. 
This confirms previous observations that ultrafiltration volume is one of the 
main determinants of intradialytic myocardial stunning as assessed by 
echocardiography. Blood pressure was generally stable during both HD and 
HDF, however a correlation between number of stunned ventricular segments 
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and fall in systolic blood pressure was seen during dialysis; again reinforcing 
previous findings that change in BP is a second key clinical driver of dialysis 
induced myocardial stunning. This study has achieved the first intradialytic 
MRI measures and provides a model in which other dialysis-based 
interventions can be characterised in detail during an MRI scan to study 
mechanistic effects directly.  
 
In Chapter 5, the assessment of the kidney is studied using ASL. 2D readout 
schemes for renal ASL and T1 measures are reviewed and optimised. The 
readout schemes considered were balanced fast field echo (bFFE), gradient-
echo EPI (GE-EPI), spin-echo EPI (SE-EPI) and turbo spin echo (TSE) for use in 
combination with a FAIR ASL labelling scheme. These schemes were assessed 
for SNR, SAR, perfusion and T1 quantification, variability in the signal across 
multiple slices, and reproducibility across two study days. All schemes were 
found to be reproducible for both T1 and perfusion measures. The most 
reproducible readout scheme for perfusion measures was SE-EPI, the least 
reproducible scheme was the TSE scheme. T1 measures were highly 
reproducible with the highest CoV of 3.8 % for GE-EPI and the smallest CoV 
of 1.7 % for SE-EPI. On performing a comparison of all four readouts for ASL 
perfusion measures, it was shown that SE-EPI provides the optimal temporal 
SNR, consistency across slices, reproducibility between sessions and the 
lowest specific absorption rate (SAR). The measured cortical perfusion was 
higher for gradient-echo based GE-EPI and bFFE compared to spin echo based 
SE-EPI and TSE schemes. In future work, the techniques optimised in this 
work for measurement of renal cortex perfusion and T1 will be extended to 
measures of medulla perfusion and T1 and can be used to assess residual renal 
function in patients with CKD. 
 
This thesis has developed both cardiac and kidney ASL measures for future 
application in CKD which is a chronic disease that leads to both heart and 
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kidney dysfunction. Future work will aim to improve the MOLLI-ASL 
technique by increasing the spatial resolution of the images and acquiring 
multi-slice data to cover the entire of the short axis view of the left-ventricle. 
This will then require comparison of the Belle and iterative model of perfusion 
quantification. This improved technique will then be used to study the 
association between intradialytic changes in myocardial perfusion and 
contractility in myocardial segments to directly correlate with stunning. 
Future studies will also assess the effect of the reductions in the cardiac index 
on perfusion of the kidneys by determining residual renal function.  
 
In order to apply the optimised ASL and T1 techniques developed for renal 
imaging in Chapter 5 to a patient group, the reproducibility and repeatability 
of such measures needs to be assessed in patients where T1 measures may 
change due to fibrosis or inflammation and other structural changes may 
occur such as cysts. In future work ASL and T1 measures will be acquired in 
patients with CKD Stage 3. Other MR measures such as diffusion weighted 
imaging (DWI) blood oxygenation dependent imaging (BOLD) and phase 
contrast of the renal arteries and veins will also be acquired so these multi-
parametric measures can be correlated and a thorough MRI assessment of 
CKD can be performed.  
 
This thesis has developed a novel technique for assessment of myocardial 
perfusion with MRI that can now be translated to other clinical studies to 
assess myocardial health in different patient groups and can be used to assess 
the effects of cardiac interventions. The work in chapter 4 has provided a 
novel technique for intradialytic assessment that can now be used to evaluate 
the effect of dialysis treatments intended to improve stability and limit 
ischaemic injury.  
 
 
